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ABSTRACT 
Tissue engineering has traditionally relied on the use of scaffolds as inert, durable 
materials for seeded cells to re-grow. However, a paradigm shift in the role of 
scaffolds has become necessary towards bio-functional ‘devices’ which directly 
mimic native tissue matrix. It is key to control extracellular matrix remodelling and 
tissue structure by building control cues into the initial cell support matrix. The aim 
of this study was to test the effect and predictability of physical cues, engineered into 
3D native collagen scaffolds by a cell-independent fabrication method, Plastic 
Compression (PC).  
 
Our findings indicated that fluid expulsion during collagen hydrogel compression 
produced anisotropic structuring and could be modelled as an ultrafiltration process. 
A groove/ridge topography engineered on collagen scaffolds through pattern-
template-embossing influenced endothelial cell attachment/orientation and 
keratinocyte stratification in culture. Matrix collagen density and stiffness were 
directly related to its hydration level and could be controlled by limiting the extent of 
compression. Human-Dermal-Fibroblast (HDF) proliferation was proportional to 
matrix stiffness. In addition HDFs, seeded evenly within a PC collagen stiffness 
gradient, migrated and accumulated at the stiff end after 6 days. Bi-layer collagen 
matrices underwent cell-mediated integration, but despite higher cell migration 
across the interface in compliant than in stiff matrices at 24hrs, there was no 
significant difference in interface adhesive strength at 1 week. Core O2 tension in 3D 
spiral constructs directly correlated with total cell number along the diffusion path, 
i.e. consumption path length. This model was used to engineer local cell-mediated 
hypoxia in 3D constructs to generate populations of hypoxia-induced-signalling cells 
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which produced angiogenic factor protein cascades. This in turn induced directed, 
functional micro-vascular ingrowth in vitro and in vivo.  
These data indicate how directing physical cues can be built into the structure of 
biomimetic, tissue-like scaffolds. This helps to understand intricate cell-matrix 
behaviours without reliance on complex biological control mechanisms and points 
the way to using simple physical cues for tissue formation.  
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CHAPTER 1      
INTRODUCTION 
 
1.1 BIOMIMETIC SCAFFOLDS FOR TISSUE ENGINEERING 
Tissue engineering is a multi-disciplinary field where biology, material science, 
modelling and engineering combine towards the development of biological 
substitutes that restore, maintain, or improve tissue function [1]. Tissue engineering 
has traditionally relied on the use of scaffolds as temporary surrogates for the native 
extracellular matrix (ECM) to host cells harvested from natural tissue. In that 
respect, the role of scaffolds was limited to that of ‘cell-friendly’ vehicles that could 
support cell viability/growth and efficiently deliver the cells to a target site (e.g. 
wound bed, bone repair site etc.). However, the field is currently experiencing a 
steady progression away from this minimalist concept of cell scaffolds as largely 
inert (i.e. inoffensive or bio-invisible) and long‐lived as possible. The concept of 
biomimetic scaffold fabrication has instead evolved around the principle that 
scaffolds should confer bio-functionality, along with biodegradability. This need is 
indeed reflected in a recent definition of tissue engineering by Williams as‘’the 
creation of new tissue for the therapeutic reconstruction of the human body, by the 
deliberate and controlled stimulation of selected target cells, through a systematic 
combination of molecular and mechanical signals’’ [2].  
 
The underlying big question then shifts from how functionally durable and stable can 
we make scaffolds to how much dynamic cell‐control information can we get into 
their temporary structure.  In other words, we are now facing a cellular control 
question. It is important, however, to understand that at present incorporation of ever 
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more biological function into scaffolds will come at the price of having to surrender 
some of the excellent properties (e.g. physical function, durability) of conventional 
prosthetic implants (e.g. metals, polymers, ceramics). Furthermore, there is a wide 
consensus that these new forms of clinical implants will only live up to their promise 
if they are cell‐seeded. Indeed this is the basis for rapid expansion of interest in 
technologies for cell acquisition (autologous, allogeneic, even xenogeneic), as adult 
and embryonic stem/progenitor cells. However, it is also increasingly clear that 
production of the cells alone is only part of the answer. Tissue architecture is the key 
to native function in solid 3D implants[3]. This is particularly true in mammalian 
connective tissues, which almost always undergo repair with scarring, rather than 
functional regeneration [4]. Inevitably, then, advanced, biomimetic 3D scaffolds will 
be required to provide the range of controls for cell functions that critically 
determine tissue organization e.g. differentiation, migration, and extracellular matrix 
production [3].  
 
Accumulating evidence now suggests that these key cues most often need to be built 
into the structure of the scaffold extracellular matrix, as they are in nature[3,5]. In 
other words, these are best considered as biomimetic cues, rather than 
supra‐physiological doses of single cytokines, growth factors, or pharmacological 
agents. The exact nature of such cues will depend on the type of tissue we want to 
repair/replace. For highly cellular tissues (e.g., secretory, metabolic, and barrier), 
cellular control will be dominated by cell–cell controls such as cell signalling (e.g. 
growth factor levels), cell perfusion and nutrient (e.g. O2, glucose) consumption and 
cell adhesion. For connective and contractile tissues, the emphasis is on mechanical 
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and substrate properties, 3D topographical and directional cues, including external 
mechanical‐loading, and neuro-vascular innervation. 
 
The spatial dimensions of a scaffold form one of the fundamental criteria as to what 
constitutes biomimesis. It is self‐evident that use of a scaffold, as opposed to a flat 
culture surface, is the essence of growth in three dimensions. From the cell 
viewpoint, the pivotal feature for cells in a scaffold is not that they are able to grow 
in a vertical plane (gravity itself has minimal direct controlling effect on cells as they 
have such small mass). Rather, substrate attachment cues can and do act through all 
three axes of the cell, generating completely new directional information, 
comparable to that in tissues. These can be homogeneous or polarized, in contrast to 
two‐dimensional monolayer cultures that always provide polarized directional cues, 
with a ‘dorsal’ fluid‐covered surface and a ‘ventral’ plastic‐attached surface. Clearly, 
this is not a native system for non-epithelial cells such as fibroblasts or other stromal 
cells.  
 
Early examples of 3D scaffolds concentrated on basic properties of pore size (to 
allow cell 3D penetration and perfusion) and stability (rates of disappearance from 
beneath the cells they support). The bulk fabric of such scaffolds can be divided into 
either: 
 
(1) Synthetic polymer base, especially polylactide/glycolic acids [1,6] 
or 
(2) Bioartificial natural polymers such as collagen/ collagen‐GAG (e.g. Integra) 
sponges [7], collagen gels[8], and fibrin[9]. 
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This has proved to be a key division, seen most clearly in the respective approaches 
to the question of scaffold degradation. It is inescapable that for any form of 3D 
engineered tissue, the initial scaffold must disappear. Importantly, disappearance 
needs to relate to the production of new, replacement tissue from the resident cells. 
Given the diversity of physicochemical conditions at any given 
implant/pathological/injury site, this level of control is almost inconceivable for 
conventional biodegradable polymers. This is because they hydrolyze/dissolve in a 
manner independent of cell activity. On the other hand, scaffolds constructed from 
native protein aggregates commonly are susceptible to metabolism by the normal 
array of extracellular matrix proteases. In other words, biomimetic (native 
protein‐based) scaffolds represent a natural part of the cell-matrix economy 
(participating in biological turnover and remodeling). They will tend to be removed 
by cell action as new matrix is produced. This is not possible for conventional 
polymers, which either disappear too rapidly, providing poor support, or more 
commonly disappear too slowly, inhibiting or counteracting cell‐based renewal[3]. 
The scaffold removal‐replacement cycle is known to be central to tissue formation 
both during growth and natural repair[10-12]. In connective tissues, it is a 
coordinated, cell‐dependent process in which a series of scaffold proteins are 
sequentially deposited and then replaced by more permanent substrates. Although it 
is neither feasible nor desirable to try to mimic the entire sequence, cells clearly will 
not be able to fabricate native structures if they are actively blocked from completing 
the sequence. Such blocking is likely where the mechanical support/attachment cues 
of a synthetic polymer fail to disappear and so dominate the cell mechanical 
environment [3]. 
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A fundamental question to scaffold design is how much or how little similarity with 
the target tissue is needed for it to qualify as biomimetic. In other words, does the 
exquisite design of the target native tissue need to be faithfully reproduced in order 
to achieve adequate function? If true, the objective is equivalent to engineering 
native tissue, which clearly is not realistic at present. The success of tissue 
engineering therefore rests on the assumption that adequate function can be achieved 
via compositions and structures that are much simpler than the native tissues, and 
which are realizable via manipulation of cells and biomaterials in vitro [13]. An 
example of this is bioprosthetic heart valves comprising bovine pericardium that 
yield adequate function despite lacking the trilayered structure of native leaflets [13]. 
Evidently, the development and analysis of tissue models to identify solutions 
consistent with adequate function would aid in identification of realizable objectives 
for achieving similarly successful outcomes. In view of the huge diversity of tissues 
it is possible to mimic, this can be simplified by considering two extreme types of 
construct design: cell‐rich and matrix-rich. Naturally, there are many intermediate 
types, and frequently the aim is to develop one format into the other over a time 
period. However, it is clear that many systems at least start as either cell-rich or 
matrix-rich constructs.  The aim with a cell‐rich construct (an extreme example 
would be engineered cell sheets [14,15]) is to produce 3D structured adherent cell 
masses.  Such constructs most closely resemble embryonic tissue templates (prior to 
full stromal differentiation and matrix accumulation, e.g. limb buds) or soft tissue 
glands and organs (e.g. pancreas and kidney) with limited connective tissue content. 
Matrix-rich constructs, on the other hand, are commonly designed to develop 
significant mechanical function, including support and/or contraction. Examples 
include tube structures such as blood vessels, urothelial replacements, and nerve 
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guides. For many, if not most current applications (particularly for clinical implants), 
mechanical function is paramount, and production of a strong extracellular matrix to 
replace the initial scaffold is essential. Clearly cell layers/sheets alone have limited 
mechanical strength. As a result, 3D cell-rich constructs are important for 
biomimesis of certain tissues and developmental stages, but the overwhelming 
majority must either be designed as, or become matrix‐rich constructs.  
 
Lessons learned from years of grafting experience emphasise the necessity of an 
instantaneous restoration of certain functions (e.g., covering a skin wound or 
repairing a ruptured tendon) without waiting for de novo tissue formation, while at 
the same time creating an environment in which better function is eventually restored 
through regenerative processes (e.g., integration of a bone graft or restoration of 
nerve function). The initial design requirement of an implantable device then seems 
to be that it must mimic the structure and function of the tissue involved sufficiently 
well to form an initial repair template, while providing an environment for final 
structure and function to be reconstituted in situ.  
 
The discussion thus far highlights certain basic elements that a biomimetic scaffold 
must possess; it should be three-dimensional, rich in matrix that is able to undergo 
cellular remodelling, and have built in physicochemical cues for directing cell 
behaviour. Central to this design lays the ability of cells to function as ‘structure 
regulators’ that, given the appropriate environment, can synthesize, dismantle, and 
modify the extracellular matrix. In theory, then, if the right cells are given the right 
environment, a perfect tissue can be grown and maintained using the innate 
processes that have evolved so successfully. Therefore, the complex nature of tissue 
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structure and the ability of cells to create and maintain it dictates that the scaffold 
logically needs to be sufficiently robust to support strictly local cell/tissue function 
(immediate repair) without taking on prosthetic functions which frequently impair 
local cell‐based regeneration. Critically, as discussed above, such scaffolds need to 
be susceptible to cell-mediated remodeling (after implantation).  Because following 
cellular remodelling the actual extracellular matrix environment rapidly becomes 
protein‐based (either as molecular attachment elements or bulk ECM material), 
principally collagen,  this work has focused on how cell controlling cues can be 
adapted and incorporated into the physical structure of 3D biomimetic collagen 
scaffolds. The following section provides a brief introduction into the area of 
collagen-based scaffold fabrication and how this relates to our approach.  
 
1.1.1 Collagen-based scaffolds 
The collagens are a large complex family of molecules that interact with each other 
and the other ECM molecules to provide a huge range of structures and functions 
throughout the tissues of the body. For most soft and hard connective tissues (bone, 
cartilage, tendon, cornea, blood vessels, and skin) collagen fibrils and their networks 
play a dominant role in maintaining the biologic and structural integrity of ECM, 
while being highly dynamic, undergoing constant remodeling[16]. In addition to 
their key functional role as biomechanical structures, the collagens interact directly 
with cells to influence adhesion, growth, differentiation, and many other cellular 
activities in addition to interacting with growth factors and cytokines during tissue 
development and repair. 
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Collagens are a family of proteins (28 molecular species having been identified to 
date[16]) that share a triple helical structure formed from three α‐chains. This 
structure is dependent upon each α‐chain containing an amino acid sequence with a 
repeating (Gly‐X‐Y) tripeptide, where X and Y are frequently proline and 
hydroxyproline. The triple helices may be homotrimers or heterotrimers with various 
α‐chain combinations. The various types of collagen exhibit differences in structure, 
splice variants, the presence of additional non-helical domains, the extent of 
glycosylation and hydroxylation, and their assembly and function [17]. The most 
abundant group within the collagen family are the fibril‐forming collagens (types I, 
II, III, V, and XI) which assemble into highly organized supramolecular fibrils. The 
process of collagen self-assembly is only partially understood and is thought to 
involve no fewer than nine separate steps (Fig.1). The complex structure of fibrillar 
type I collagen presents different morphologies in different tissues performing 
different functions. When associated with HA crystals in bone, it provides rigid and 
shock-resistant tissues with high Young modulus, while it behaves like an elastomer 
with low rigidity and high deformation to rupture in tendon and shows optical 
properties such as transparency in cornea[16]. Other than the fibril‐forming 
collagens, there are non-fibrillar collagens, the most important of which is type IV, 
the principal component of basement membranes, where it integrates other ECM 
molecules (e.g. laminin) into sheet aggregates. In addition, there are also the 
fibril‐associated collagens with interrupted triple helices (types IX, XII, XIV, XVI, 
XIX, and XX) which tend to be located on the surface of collagen fibrils in a 
tissue‐specific manner. Type VI is a microfibrillar collagen that forms a distinct 
network of fine filaments throughout most connective tissues, while the short chain 
collagens (types X and VIII) form hexagonal networks.  
26 
 
 
 
Fig.1 Schematic showing the natural assembly of collagen fibers. (a) Pro-alpha chains 
are synthesized in the lumen of the endoplasmic reticulum, where (b) hydroxylation of 
selected prolines and lysines occurs. (c) This is followed by glycosylation of selected 
hydroxylysines. (d) Three pro-alpha chains self-assemble and (e) form a procollagen 
triple helix. (f) These are secreted into the extracellular space, and (g) the protective 
propeptides are cleaved. (h) Finally, the procollagen self-assembles into fibrils, and (i) 
these aggregate into collagen fibers. Modified from Stevens and George, 2005 [5]. 
 
 
Collagen as a basic biomaterial has been used for a considerable period in various 
forms such as injectable fillers for cosmetic surgery (e.g., Zyplast, Zyderm, 
Contigen)[18], meniscal implants (CMI), and tubes for blood vessel, nerve and skin 
repair (e.g. Integra, Apligraf)[19]. These kinds of applications exploit the low 
antigenicity of collagen (collagen varies little between species) and the lack of 
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harmful breakdown products (because it is an endogenous ECM protein), and have 
established the general clinical acceptability of using collagen from bovine and 
porcine sources. Some studies use atelocollagen in which the proteolytic removal of 
the non-helical, telopeptide extensions to the collagen molecule could further reduce 
the immunogenicity of implanted collagen [20]. This history of collagen usage (in 
terms of safety and biocompatibility) adds to the suitability of using collagen as the 
basis for more advanced tissue engineering applications. 
 
We can distinguish between two general strategies that have been employed for 
utilisation of collagen as a biomimetic protein for scaffold fabrication. The first, 
top‐down approach, takes a complex collagen‐rich matrix (whole connective tissue, 
sometimes, the actual tissues from cadavers or animals) that resembles the required 
architecture and removes all cell components. The second, bottom‐up approach, 
starts with the molecular building blocks and aims to assemble them into a scaffold. 
Therefore, while the top‐down approach tends to break down or reduce the 
complexity of native tissues, the bottom‐up approach works to assemble or engineer 
increasing complexity using simple, isolated collagen-based building blocks. 
Examples of each approach with some of their applications are summarised in Table 
1. 
 
 
 
 
 
 
28 
 
TOP-DOWN APPROACH 
Decreasing Complexity 
BOTTOM-UP APPROACH 
Increasing Complexity 
EXAMPLE APPLICATION EXAMPLE  APPLICATION 
Small 
Intestinal 
Submucosa 
(SIS) 
(from bovine 
jejunum) [21] 
Ureter/Urethra repair 
Bladder augmentation 
Dural/Skin Substitute 
Vascular Grafts 
Rotator cuff repair 
Collagen 
Hydrogels 
-Cell-mediated   
contraction [8] 
-Fibrilar alignment     
(e.g. by magnetic 
fields,tethering, 
uniaxial-tensile 
loading) [22-24] 
-Plastic     
Compression[25-
27] 
 
 
Skin-substitutes(e.g. 
Apligraf) 
 
Nerve repair  
 
Skin,muscle,blood 
vessel,bladder,bone, 
corneal  constructs 
Urinary-
Bladder 
Submucosa 
[21] 
Orthopaedic-soft tissue 
repair 
  Porous Scaffolds 
-Sponges (freeze-
dried dispersions of 
collagen fibers +/- 
cross-linking)[28-
31]  
-Foams [32] 
 
 
 
Absorbable-wound 
dressings 
Absorbable-haemostatic 
sponges 
Dermal Substitutes (e.g. 
Integra, Neuragen, OrCell) 
Growth factor (e.g. BMP) 
/drug release depots 
Bone tissue engineering 
 
Acelular 
Dermis 
[21,33] 
Skin Substitutes Fibrous Scaffolds 
Molecular self-ass- 
embly of collagen 
into fibrils / fibers 
and  bundles [34] 
 
Nerve repair 
Amniotic 
Membrane 
[35,36] 
Corneal repair Electrospun 
Collagen 
Nanofibers 
(combined   with 
other materials e.g. 
elastin,gelatin,glyco
-saminoglycans, 
silk,fibrinogen, 
chitosan,synthetic 
polymers)[34,37-
40] 
Bioresorbable-vascular 
grafts 
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Table 1. Comparison of the two general strategies employed for utilisation of collagen 
as a biomimetic protein for scaffold fabrication, i.e. by progressive reduction in 
complexity of native, living tissues (left hand columns) vs. by assembly (engineering) to 
increase the complexity of isolated elements (right hand columns). The table 
summarises examples of each strategy with their relevant applications.  This study is 
focused on the use of Plastic Compression fabrication for engineering structure in 
collagen hydrogel scaffolds (highlighted).  
                  
The advantages of using native ECM grafts are that (1) although they are 
predominantly collagen, they also contain the other ECM proteins in their final 
relative proportions [21], (2) some of their 3D structure is maintained [21,41] and (3) 
a dense, native collagen matrix is provided immediately [21]. However, use of 
‘ready-made’ ECM has several limitations: (1) newly added cells have to repopulate 
a very dense, relatively impervious material, which can be slow, uncontrolled, and 
associated with major remodelling, (2) it is critical that all debris of the previous cell 
population is removed to avoid the problems of human and non-human 
grafts/transplants (residual antigens in animal tissues or cryptic infectious materials 
represent a major immunity/infection hazard), (3) removal of such cellular and 
macromolecular elements through the dense 3D structure, without disrupting it, is 
clearly problematic and (4) use of human (cadaveric) materials tends to have the 
same supply‐limit problems of many other transplant organs. Therefore, when 
regeneration is considered to be the ultimate aim, it is unlikely that this approach 
alone will be sufficient to recapitulate the cellular responses observed during de novo 
tissue development. Because the cellular component is so intimately related to the 
matrix component in all tissues, as previously discussed, integrated cellular/ECM 
scaffolds which are simpler in terms of their composition and architecture represent 
the most promising emerging technologies for regenerative repair [3].  This approach 
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enables cells and matrix to develop in parallel to recapitulate the developmental 
pattern of tissue generation and furthermore allows the rational incorporation of 
factors such as alignment, architecture, growth factors, differentiation, and so forth, 
based on increased understanding of regenerative processes. 
 
Extensive work has previously been carried out on porous collagen scaffolds, in 
particular collagen sponges, as these provide a useful substrate for the bulk delivery 
of cells[42,43]. However, due to their large pore size, their 3D architecture which the 
cell perceives is pseudo‐3D (see next section), and is therefore unlikely to provide 
the kinds of topographic/mechanical cues conducive to the alignment required in 
many tissues. Indeed, their primary usefulness has been in tissues in which initial 
fiber alignment is not necessarily critical for function (e.g. skin replacement). In 
contrast to collagen sponges, collagen hydrogels comprise nanoscale fibers and 
therefore represent true 3D substrates. They have a long track record as potential 
scaffolds for tissue modeling and repair/regeneration applications [8,9,44]. Although 
they have been developed for a variety of therapeutic uses, including the sustained 
delivery of soluble factors, their major application is as substrates for the growth and 
delivery of cells [45], which can be easily seeded interstitially within the fibril 
network. This is because collagen hydrogels provide the necessary engineering 
properties desired in a non-immunogenic ECM-like scaffold, including water 
retention capacity, tenacity for holding cells in stretched position, nano/micro-
porosity to allow cells to grow and arrange in 3D (after seeding), biodegradability to 
create space for nascent cells and pore inter-connectivity to allow free flow of 
oxygen and nutrients in and around the growing cell mass[46]. 
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The general principal underlying collagen hydrogels is that purified fibrillar collagen 
(typically type I but occasionally other types or blends) in acidic solution can be 
adjusted to physiological (neutral) pH and temperature to form a stable gel [47]. 
Solubilised collagen monomers are known to spontaneously self-assemble into 
native type fibrils under physiological conditions [48]. This process is essentially 
pre-programmed into the protein primary and helical structure and is driven by 
electrostatic, hydrophobic and covalent interactions between monomers [49]. Gels 
take between 5 and 30 minutes to set at physiological pH and room temperature, 
allowing them to be molded into shape and/or seeded with cells. Fibrillar collagen 
gels therefore comprise a network of intertwined collagen fibrils of indeterminate 
lengths, various thicknesses, and no inherent orientation. Importantly they have a 
large excess of fluid (>99.5%) to collagen protein (0.1 and 0.5%) [50], which is 
typically two orders of magnitude lower collagen density than native connective 
tissues. This results in  poor mechanical properties which, together with the lack of 
orientated architecture, forms a principal limitation in the use of collagen hydrogels 
as scaffolds for tissue engineering applications [9,13,33,50]. It is well known that 
cells seeded within a collagen hydrogel can expel some of this excess interstitial 
fluid from the gel [8] and increase the collagen density  by around one order of 
magnitude by exerting traction forces on their surrounding fibres [51]. This process, 
however, can take several days and gives only a modest increase in mechanical 
strength with limited precision and control. 
 
Brown et al. previously reported that a compressive load can be applied on 
hyperhydrated collagen hydrogels to rapidly expel a large proportion of the fluid 
content through the basal surface of the gel. This takes a small fraction of the time 
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required for cell-driven compaction and takes the process to much higher collagen 
densities (>20% wet weight) without cell damage [25]. The development of the 
Plastic Compression (PC) fabrication process (see Chapters 2 for full description of 
method) was critically influenced by the realization that the excess fluid present in 
untreated collagen gels is a result of the casting rather than any inherent swelling 
property of the polymer i.e. this fluid is not bound and does not form any part of the 
native collagen structure. In fact, this is a major cause for the poor mechanical 
properties of pre-compressed gels [52]. PC of collagen hydrogels rapidly produces 
dense fibrillar collagen sheets (100-200µm thick) with a tissue-like architecture, 
strong mechanical properties (approaching those of native tissue collagen) and 
biomimetic function (e.g. supporting high cell viability) [25]. This process is 
versatile in terms of the volumes, densities, and shapes that can be produced (e.g. 
sheets can be layered or rolled up), thus creating the possibility to fabricate a wide 
range of final scaffold structures. Indeed, several studies have demonstrated the 
suitability of PC collagen scaffolds in engineering biomimetic tissue constructs e.g. 
skin [53], bladder [27], muscle [54], blood vessel [55], bone [26] and cornea [56].  
 
1.2 ORGANISATIONAL LEVELS OF SCAFFOLD STRUCTURE 
Regeneration and production of functional tissue is the ultimate goal in Tissue 
Engineering. The human body comprises about 100 trillion cells, with about 260 
different phenotypes, that divide, differentiate and self-assemble over time and space 
into an integrated system of tissues and organs[46]. Evidently, biomimetic tissue 
enginering is no mean task. Artificial biomaterial scaffolds designed to support cell 
and tissue growth have traditionally aimed on a macroscopic level to match the gross 
architecture and mechanical properties of the organs they are to replace (e.g. hard 
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scaffolds for bone and elastic for bladder, veins, and arteries), without recreating the 
complexity and, nano-, micro- and meso-scale detail observed in real organs, at the 
level of the cell-matrix interaction[5]. However, this organisational complexity is not 
only intrinsic to the native structure of organs, but also vital for their specific 
functionality (Fig. 2). It is self-evident, therefore, that the structure of a biomimetic 
cell scaffold should incorporate the length-scale hierarchical organisation of the 
target tissue, and not merely provide a morphologically ‘correct’ cell carrying 
template.  
 
Fig.2 Hierarchical organization of bone over different length scales. Bone has a strong 
calcified outer compact layer (A), which comprises many cylindrical Haversian 
systems, or osteons (B). The resident cells are coated by multiple cell membrane 
receptors that respond to specific binding sites (C) and the well-defined nano-
MACRO-LEVEL 
MICRO-LEVEL 
NANO-LEVEL 
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architecture of the surrounding extracellular matrix (D). Modified from Stevens and 
George, 2005  [5]. 
 
While real tissue structure is remarkably characterised by continuous variation across 
the whole length-scale spectrum (i.e. from subcellular to cellular and organ level), 
our ability to reproduce this into the structure of scaffolds is currently far below 
optimal[5]. It is possible, however, to make a defined distinction between nano-
/micro-scale and macro-scale structural elements that can be engineered into the 
structure of scaffolds to improve their cell-regulating capacity and ultimately their 
bio-functionality.  Such properties affect not only cell survival, signalling, growth 
and reorganization, but also play major roles in influencing cell shape and gene 
expressions that relate to cell growth and the preservation of native differentiated 
phenotypes[57]. In this section we discuss important aspects of hierarchical native 
tissue organisation and present recent advances in attempts to incorporate such 
elements into the structure of biomimetic scaffolds. In the context of this work 
particular emphasis is placed on physical structure (as opposed to chemical structure) 
fabrication.  
  
1.2.1 Biomimetic elements of nano-/micro-scale scaffold structure  
In the body the nanoscale structure of the ECM provides a natural web of intricate 
nanofibers to support cells and present an instructive background to guide their 
behavior [58,59]. Unwinding the fibers of the ECM reveals a level of detail 
unmatched outside the biological world. Each fiber hides clues that pave the way for 
cells to form tissues as complex as liver, heart, kidney and bone. Cells are highly 
sensitive to their surroundings. Typically between 10 and 50 µm in diameter, cells 
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respond to environmental features at all length scales from the macro down to the 
molecular. The outer membrane of a typical cell is covered by at least six different 
receptor systems that can be activated by interactions with adjacent cells, ligands in 
the surrounding ECM, and secreted signaling molecules [5,60]. Hundreds of 
different proteins play a role in the composite stimulation of cell receptors, which in 
turn determine a plethora of responses, including cell migration in the early embryo, 
coordinated organogenesis, and wound repair throughout adult life [58,59]. 
Collectively, these extrinsic factors make up a highly defined and specialized cell 
microenvironment, which is essential for correct tissue development and continued 
function.  
 
The ECM takes a variety of forms in different tissues and at different stages of 
development in the same tissue [60,61]. Diversity arises through combinations of 
specific molecular interactions between numerous isoforms, ratios, and geometrical 
arrangements of collagens, elastins, proteoglycans, and adhesion proteins such as 
fibronectins and laminins. This creates an environment that is replete with 
informational cues. In addition to this, a wealth of molecular mechanisms modulates 
the dissemination of this information. For example, the ECM plays a major role in 
regulating growth factor signaling, acting as a local reservoir for latent forms, and 
rapidly releasing and activating them on demand [62].  
 
Each ECM protein carries multiple motifs that target/bind specific cell surface 
receptors. The transmembrane integrin receptors, with more than 20 members 
identified, are the most extensively characterized, and they recognize motifs such as 
Arg-Gly-Asp (RGD) within proteins of the ECM such as fibronectin and vitronectin 
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[63]. These receptors tether the cell cytoskeleton to the fibers of the ECM, forming 
local focal adhesions. When bound, integrins activate a cascade of intracellular 
signaling pathways, leading to changes in gene expression and affecting most aspects 
of cell behavior. They modify differentiation, proliferation, expression of ECM 
proteins, activation of growth factors, and the maintenance of survival signals to 
prevent apoptosis [64-66]. For example, the 3D ECM environment in vivo strongly 
influences changes in cell shape that affect the differentiation process [61]. 
Importantly, the binding of integrins and the formation of focal adhesions, their 
structure, localization, and function in 3D tissues is substantially different from their 
binding and formation in 2D culture [67]. This is a key concept that highlights the 
role of a 3D nanofibrous matrix for maintaining cell phenotypic shape and 
establishing natural behaviour patterns, and should be carefully considered when 
engineering biomimetic scaffold structure at the nano-/micro-scale (see below). 
 
While it is accepted that matrix surface chemistry tends to exert stronger influences 
on biological responses and rates, such as cell differentiation and division, ECM 
physical cues (e.g. topographic features, mechanical properties, 3D spatial 
organization etc.) have been shown to have a far greater influence on cell orientation, 
locomotion and direction of the cell-extracellular matrix[3]. The role of the ECM 
physical microenvironment appears, however, not to be limited to these functions, as 
suggested by recent findings that endorse its direct influence on cell lineage 
specification. For example, cell phenotype has been shown to be extremely sensitive 
to tissue level elasticity and compliant matrices that mimic brain tissue are found to 
be neurogenic, whereas stiffer matrices that mimic muscle are myogenic and 
comparatively rigid matrices that mimic bone prove to be osteogenic [46]. Indeed, in 
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many aspects of tissue engineering it is now becoming clear that physical cues are at 
least as important as chemical ones, and frequently more critical to regulate 
[3,4,68,69]. Unfortunately, our knowledge of the role and operation of 
material‐based cues remains far less clear.  
 
In considering the role of cell-ECM architectural organisation in scaffold design, it is 
first essential to determine the meaning and ambiguities behind the concepts of 2D 
and 3D cell culture. It is clearly evident that many cells respond differently when 
cultured in 3D compared to traditional 2D cultures, and often adopt more in vivo like 
morphologies[39]. Culturing cells in 3D radically alters the mechanical signals from 
those provided in 2D, thus affecting cell-receptor ligation, intercellular signaling and 
critical cell behaviours such as cellular migration[39]. A 3D environment also 
influences the diffusion and adhesion of proteins, growth factors and enzymes, 
which ensures cell viability and optimal function[46]. Furthermore, it is well 
established that scaffold architecture affects cell attachment and spreading. Cells 
binding to fiber-based scaffolds with micro-scale architectures flatten and spread as 
if cultured on flat surfaces, which is almost universally regarded as 2D culture 
(Fig.3). Incorporation of pores/grooves/channels of cellular dimensions into that 
substrate may be taken to represent a form of pseudo‐third dimension in the system 
(Fig.3). This is a consequence of the large pore size, which presents to seeded cells 
as a series of effectively flat surfaces, but in all three planes. In other words, where 
spacing of scaffold support elements is far larger than cell dimensions, most cells can 
only attach to one surface at a time, effectively 2D monolayer conditions. 
Biomimetic, i.e. true 3D culture can only be assumed where cells are able to attach to 
the substrate through most of their membrane surface. For example scaffolds with 
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nano-scale architectures have larger internal surface area to volume ratios to adsorb 
proteins, presenting many more binding sites to cell membrane receptors[5,34,40]. It 
is thus not surprising that several cell types, including osteoblasts, fibroblasts, 
smooth muscle cells, neural and embryonic stem cells show increased attachment 
and proliferation on various nano-fibers compared to non-fiber based materials [34].  
It is important to clarify, however, that 3D cell attachement is not such a simple 
concept as it appears, because the possibility for attachment is almost never the same 
on all sides of the cell in 3D scaffolds. Even where 360‐degree attachment is 
possible, cell behaviours such as locomotion, neighboring cells, and structural 
asymmetries in the scaffold will tend to lead to local differences in attachment. 
 
 
Fig. 3 Shematic showing how scaffold architecture affects cell binding and spreading. 
Cells binding to scaffolds with fiber-based microscale architectures flatten and spread 
as if cultured on flat 2D surfaces (A). Scaffolds containing pores/grooves/channels of 
cellular dimensions provide a pseudo‐third dimension in the system as cells are 
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presented with a series of effectively flat surfaces, but in all three planes (B). Scaffolds 
with nanoscale architectures can support  true 3D culture as they have larger surface 
areas to adsorb proteins, presenting many more binding sites to cell membrane 
receptors, allowing cell attachment to the substrate through most of their membrane 
surface (C).Modified from Stevens and George, 2005  [5].  
 
The diverse nature of tissue architectures requires that different microenvironments 
are provided for their repair/regeneration. This prinicipal can be demonstrated in the 
employment of scaffolds with tissue-specific pore sizes. For example, in 
regenerating bone tissues in vitro, some researchers have indicated the need for pore 
sizes ranging from 200 to 400 µm, while scaffolds with pore sizes between 20 and 
125 µm have been used for regenerating adult mammalian skin and 45–150 µm for 
regenerating liver tissues[57]. Early work on synthetic polymer and native protein 
3D scaffolds (polylactic‐glycolic acids and collagen‐GAG sponges [1,6,7]) 
concentrated on identifying ideal ranges of pore size, frequently in random, non-
directional materials[70,71]. These were developed to facilitate adequate nutrient 
exchange and space for cell in-growth, population expansion or matrix production. 
Furthermore, a high porosity and pore interconnectivity have been conventionally 
perceived as critical properties in ensuring spatially uniform cell distribution, cell 
survival, proliferation and migration[57]. However, such criteria can only operate 
successfully at early culture stages. By definition, effective and dynamic cell growth, 
and matrix accumulation, must inevitably lead to infill (i.e., loss) of the initial pore 
structure. In addition to limiting cell perfusion, this effect will therefore generate 
randomly distributed pockets of cells and extracellular matrix, which mirror the 
random or homogeneous spatial distribution of the original pores. This is generally 
not a good biomimetic template for spatial organization in tissues, but rather 
resembles the disorganized structure of scar tissue formation throughout the body 
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[3,4]. Present understanding suggests, then, that scaffold structures designed on the 
pores‐for‐perfusion strategy will generate poor templates for biomimetic structures. 
Rather, it is critical that cell guidance cues (e.g. topography) are built into the initial 
scaffold structure [3,72].  Importantly, introduction of such anisotropic (i.e. 
directional) cues (channels, fibers, planes) into 3D scaffolds inevitably and 
automatically generates structures which facilitate nutrient perfusion[3,50]. 
 
Micrometer-range topographic features such as grooves/ridges, pits and channels are 
key ECM architectural cues whose role in directing cell behaviour has been well 
established for decades [72-75]. Studies are currently exploring how substrate 
topography, if engineered with similar nano-scale structural features, can be used to 
control cell function. Micro-/nano-scale alterations in topography elicit diverse cell 
behavior, ranging from changes in cell adhesion, cell orientation, cell motility, 
surface antigen display, cytoskeletal condensation, activation of focal adhesion  
kinases (FAKs), and modulation of intracellular signaling pathways that regulate 
transcriptional activity and gene expression [72,73,76,77]. It is not only the scale of 
topography (nm vs. µm scale) that modulates cell behavior but also its pattern (e.g. 
ridges/grooves, steps, pillars, and pits) and symmetry (e.g. orthogonal or hexagonal 
packing of nanopits) [73]. Furthermore, several studies have established that similar 
scale topographic features may elicit similar biological effects independent of the 
underlying material chemistry. For example, there is close agreement between 
smooth muscle cell behaviour on both nano-patterned poly(methyl methacrylate) and 
poly(dimethylsiloxane) substrates, whereas the differing surface chemistry of the two 
polymers is unlikely to result in the same adsorption of proteins [78]. This 
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emphasises once again the important (even dominating) role that ECM physical cues 
play in regulating cell functions in native tissue. 
 
Fiber orientation is an intrinsic, critical element of matrix 3D micro-architecture that 
not only directly determines its mechanical properties [79], but also provides a 
dynamic (i.e. adaptable by matrix remodelling) topographic cue to resident 
cells[37,39]. Indeed, there is a remarkable diversity in terms of tissue-specific 
orientation of fibrils e.g. parallel and aligned in tendon, concentric weaves in bone, 
orthogonal lattices in cornea, and meshlike in skin. Many cell types are known to 
orient and often move rapidly along fibres of a fairly narrow range of diameters (5–
50 µm). For example, cell alignment and migration have previously been 
demonstrated on fibrous shear‐aggregated fibronectin substrates for Schwann cells, 
neurites, macrophages, and fibroblasts [80,81]. Importantly, cell alignment also leads 
to parallel alignment of newly deposited collagen fibrils as the ECM is 
remodelled/replaced, thus providing a tool for feedback regulation in  this structure-
function cycle.  
 
Because of the dimensions of cells and cell processes, 3D guidance by patterns of 
channels, galleries and gaps are most likely to range from ~1 to 50 µm. This 
contrasts with the scale of surface features capable of orientating cell membrane 
receptors in 2D monolayer, which reach down to <20 nm [72,82]. This difference is 
key because it is clear that there is a close inverse relationship in 3D materials 
between the presence of scaffold material (a fiber or ridge) and its absence (as pores, 
cavities, or channels). For example, in a 3D bundle of parallel aligned fibers, resident 
cells either migrate along adjacent fibers or through the channels formed by the 
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spaces between fibers. The factor of space to move helps us to understand why cells 
can be aligned by nanopatterns in 2D monolayer (with a free dorsal surface) but 
would not easily migrate on these where the 3D gaps or channels are substantially 
less than the nuclear diameter. This is perhaps clearly illustrated through the 
contrasting requirements in neural regeneration where glial cell migration is 
obstructed by channels smaller than the nucleus, whereas axon migration, not 
involving nuclear translocation, is unaffected [3]. Scaffold channelling (and its 
dimensions), then, is a key element distinguishing topographical control of cells in 
2D and 3D. 
 
The material properties of the ECM constitute the third element in what could form a 
triad of factors that underpin nano-/micro-scale scaffold structure (the other two 
being ECM chemistry and architecture, as discussed above).  Material properties of 
the ECM include ECM density, mechanical properties (e.g. stiffness/compliance, 
elasticity/viscosity etc.) and importantly anisotropy, i.e. the direction of material 
properties. In contrast to many current assumptions, cells in vivo almost never lie 
within mechanically homogeneous substrates[3,83,84].  In 3D natural systems cell 
attachment to the ECM is essentially an interaction with a pleomorphic landscape, in 
the form of integrin attachment through fibronectin, vitronectin, or minor, 
pericellular collagen‐types, including basement membrane type IV collagen. Less 
obvious is the influence of cell‐substrate ligand density. For example, stiffness of the 
cell‐ECM ligand interface will be proportional to the number of integrin‐ECM 
interactions/µm
2
, as well as ligand elasticity[3]. Importantly, continued remodeling 
of more complex 3D matrix structure is the accumulated consequence of cell motility 
and traction which is itself directed by the mechanical properties of that substrate, as 
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seen in the phenomena of durotaxis and haptotaxis (where cell migration occurs 
along a rigidity or ligand density gradient, respectively). This suggests that in 3D 
systems, resident cells presented with random or mechanically homogeneous 
scaffolds will tend to deposit random or homogeneous ECM structure, reminiscent 
of scar tissue [4]. Biomimetic 3D structure is only likely, then, where cell‐scale, 
biomimetic mechanical features (together with structural guidance cues e.g. 
topography) are available in the initial scaffold, in the form of tissue‐like 
inhomogeneity and anisotropy [3]. This in turn argues that cell scaffolds need to 
have meso-scale structure from the start; in other words, they need to be biomimetic 
tissue templates rather than random porous sponges or meshes. 
 
 
 
1.2.2 Biomimetic elements of macro-scale scaffold structure  
Many tissue engineering approaches must supply a scaffold that immediately mimics 
the functional architecture of the damaged tissue. A good example would be 
replacement of heart valves which need to be functional from the outset, as opposed 
to a bone repair site which could be supported and immobilized until functionally 
mature. Such functionally active biomimetic implants therefore are effectively 
mimicking traditional grafts by assuming certain key properties of the undamaged 
tissue. Previous work has indeed primarily focused on engineering homogeneous 
tissues that can mimic the gross architecture of an organ. To this end, construct 
fabrication has made use of native (e.g. collagen, fibrin, fibronectin) or synthetic 
(e.g. polylactic acid, glycolic acid, capriolactone) biomaterial scaffolds that function 
as integral units that provide three dimensional support to cultured cells [85].  An 
alternative approach, recently reported, is that of sheet-based engineering, i.e. layer-
by-layer tissue reconstruction using either cell sheets [86] or biomaterial sheets [25]. 
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This carries the potential for engineering composite tissue structures with 
macro/micro-scale heterogeneity e.g.  osteo-chondral, nerve-fascia and vascular wall 
structures.  
 
Cell-sheet engineering involves the use of temperature-responsive polymer culture 
surfaces that facilitate the non-destructive (protease free) harvest of cultured cells as 
intact sheets. Cell sheets have been applied directly to a range of regenerative 
therapies such as oesophageal and tracheal replacement, skin and corneal 
reconstruction and cardiac tissue repair, without the use of traditional scaffold-based 
methods [86-88]. However, unlike the scaffold-based approach, engineered tissues 
created using cell sheets contain relatively little ECM and therefore are not suitable 
for the generation  of matrix-rich, cell-sparse tissues, such as skin, tendon,  bone or 
cartilage [86]. Another limitation of the cell-sheet approach is the difficulty in 
production of organ-like structures that possess a 3D organizational architecture such 
as that encountered in cardiac tissue and liver. These difficulties could be overcome 
by layering individual cell-sheets to produce millimeter thick tissues and by 
integrating multilayer cell sheets with other biomaterial sheet scaffolds that could 
provide structural support to the construct.  
 
An important example of biomaterial sheet scaffolds is that of Plastic Compressed  
collagen sheets [25]. As described above, Plastic Compression (PC) involves the 
irreversible, cell-independent removal of fluid from collagen hydrogels  to rapidly 
produce dense, mechanically strong collagen sheet scaffolds (~100/200 µm thick)  
that can support a high cell viability [25]. The ability to integrate cell sheets with 
biomaterial sheet scaffolds could provide new opportunities to apply sheet-based 
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engineering to complex tissue reconstruction [86]. Indeed, the concept of layered 
fabrication, whereby 3D objects are engineered with layer-by-layer building via the 
processing of solid sheets, is currently being explored in Solid Freeform Fabrication 
(SSF) techniques which use computerized fabrication to rapidly produce highly 
complex 3D physical objects using data generated by computer-aided design (CAD) 
[57]. However, successful utilisation of this approach will critically depend on 
optimal and functional integration of the construct’s individual components (i.e. 
layers) [89-93].  Integration of engineered interfaces is therefore a key component of 
scaffold macro-scale architecture, and effectively not different form host-implant 
integration, which is in many ways the same process as that seen during natural 
tissue repair.  
 
In addition to its homo-/heterogeneity, the dimensions (i.e size, thickness) of a 
scaffold are a key element of its macro-level structure. This is because cell perfusion 
becomes an acute problem for engineered large/thick constructs (>3mm
3
) due to 
limitations in passive diffusion of nutrients (e.g. glucose, oxygen) to the construct 
core, both in vivo and in vitro [94]. It has been proposed that layer-by-layer assembly 
of (sheet-based) constructs could be used to circumvent this problem by carrying out 
layer integration at multiple steps, prior or during implantation [95], or by multi-step 
transplantation in vivo [96], effectively reducing the minimum passive diffusion 
distance to a single cell or matrix sheet layer. As discussed above, this approach 
requires effective integration of construct layers and zones, in order to give 
functional, integral tissue. Undoubtly, however, the optimum approach for successful 
large construct fabrication must rely on engineering angiogenesis, i.e. inducing the 
formation of a functional microvascular network that is integrated with the other 
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scaffold components and can support their viability. Evidently, scaffold structure 
should be engineered around this necessity, by being accommodative or, ideally, 
facilitative to angiogenic induction.  
 
In the previous section we discussed the importance of nano-/micro-topography as a 
cell guidance cue. The 3D spatial organisation of sheet-based scaffolds could provide 
an additional form of cell guidance, termed interface guidance. Though less rigid 
than fiber‐based guidance, this could mimic at least as many natural, tissue guidance 
systems. Guidance by micrometer diameter fibrils in general works by constraining 
cell motility/migration to only one plane at a time. That is, if cells can only migrate 
up/down a fiber, e.g. in the y plane, its movement in the x and z planes (i.e., off the 
fiber) is constrained. In such systems, changes in guidance direction will be limited 
by the constancy and range of orientation of the scaffold fibers, as well as by the 
efficiency of cell guidance (i.e., the percentage of cells or time cells are guided by 
the topography). In contrast, interface guidance is an example of single plane 
constraint. In this case, restriction of motion is in only one plane, with movement 
permissible in both the other two planes, that is, between adjacent sheets (i.e. within 
the interface) This can be demonstrated between compacted sheets of plastic 
compressed collagen, formed into many thin layers (e.g. as a spiral 3D construct). In 
effect, the collagen sheets form dense and relatively (i.e., slowly) impervious barriers 
producing relative containment between the planes, that is, in the z plane only. 
However, free cell motion between the layers or interfaces, and along the length of 
the construct is possible, such that cells follow the interface [54]. It is important to 
note that while constraint here is achieved entirely by the density of the substrate (in 
this case collagen), this is gradually degraded by migrant cells. This emphasizes the 
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importance of temporary, early cues to guidance. Despite the temporary nature of 
such interfaces in vivo, the initial guidance they provide over the first 1–3 weeks is 
retained even after ingrowing tissues have broken down and delaminated many of 
the sheets by 5 weeks post-implantation [54]. In culture, resident cells grown in such 
spiral constructs tend to take on a flat discoid morphology, appearing to be long and 
thin when sectioned in both transverse and longitudinal planes [54]. This form of 
guidance is clearly similar to that seen in growth, repair, and maintenance of tissue 
gliding function, particularly in dynamic connective tissues, notably in fascia, 
gliding surfaces between organs and conduit structures such as nerves and blood 
vessels [97-99]. Cell guidance through engineered interfaces represents a relatively 
simple, but so far underexploited, biomimetic approach to the control of tissue 
structure. Its potential role for improving scaffold bio-functionality is further evident 
in the clear correlation between sheet/layer 3D spatial organisation and perfusion of 
resident cells within the participating layers[100].  
 
1.3 EFFECTS OF SCAFFOLD PHYSICAL STRUCTURE ON CELL 
BEHAVIOR 
1.3.1 Effects of scaffold topography on cell function 
Engineering scaffold topography is a non-invasive and non-biological method of 
regulating cell function, because textured substrates serve simply as an extracellular 
physical milieu without involving biomolecules (chemical patterning). Topography 
could, however, provide a biomimetic cell-stimulating cue, because cells in vivo 
contact mesoscale structured, not smooth, interfaces. Topography can be classified 
with regards to its scale and pattern. Because basement membranes of various tissues 
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are composed of complex mixtures of nanoscale (5–200 nm) pits, pores, protrusions, 
striations, particulates, and fibers, nano-topography may be more biomimetic in 
affecting cell behavior than micro-topography[101]. With regards to pattern, studies 
have examined whether cells align along anisotropic topographies such as ridges and 
grooves, while for isotropic topographies, such as evenly or randomly distributed 
pits or protrusions, studies have mainly focused on how these affect collective cell 
functions, such as differentiation and proliferation[73]. In addition to scale and 
pattern, a fundamental distinction can be made on the basis of whether the patterned 
substrate is two- or three-dimensional (i.e. if it allows interstitial, as well as 
superficial cell seeding), as cell reaction to surface topography cannot be safely 
extrapolated to non-epithelial (e.g. stromal) cell types such as fibroblasts. Despite 
this limitation, the majority of studies investigating the role of topography in cell 
function regulation have been carried out on 2D substrates[73].  
 
Topographic cell reaction on 2D substrates 
Cell orientation and migration along the anisotropic direction of ridges and grooves 
produced using lithographic techniques or micromachining has long been observed 
on 2D substrates (i.e. monolayer culture) [73,102,103]. Along with elongated cell 
shape, the cell cytoskeleton also displays directional organization. Orientation of 
actin filaments or microtubules was identified as the primary event in contact-guided 
cell alignment[102,103]. Interestingly, however, even when microfilaments or 
microtubules were destroyed with pharmaceutical disruptors, cells still displayed 
contact guidance[104]. Additionally, localization of focal adhesion proteins (e.g. 
vinculin) has been  positively correlated with cell alignment[105].  
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Most of the early studies of substrate topography used several millimetre sized ridges 
and grooves. However, it is now clear that the scale of anisotropic topography plays 
an important role in deciding cell alignment. Cell orientation generally increases 
with increasing groove depth but decreases with increasing groove width or pitch 
[73]. At the microscale, with increasing groove depth and decreasing groove width, 
cells tend to bridge the ridges without descending into the grooves, while vinculin 
formation has been found to display ridge-width-dependent anisotropic 
orientation.With the development of lithographic techniques, recent studies have 
focused on whether cells align on nanoscale ridges and grooves and, if so, how small 
the topographic size can become while still inducing contact guidance. Teixeira et al. 
observed that human corneal epithelial cells aligned on ridges, produced by e-beam 
lithography, as small as 70 nm wide[106]. Aligned axonal outgrowth was also 
observed on 100- to 400-nm-wide nano-imprinted grooves[107]. The minimum 
effective dimension of grooved features has now fallen to as low as 11 nm[72]. 
Importantly, a study using polystyrene nanogrooves (~70-nm depth) has shown that 
stem cell–derived osteoblasts displayed anisotropic orientation not only in cell/actin 
but also in mineralized matrix, suggesting that topography could also direct cellular 
synthetic activity[108].Topographic scale also affects whether cells bridge between 
ridges or conform to grooves throughselective focal adhesion formation on ridge 
tops or down to groove floors[109]. While cells tend to bridge the ridges without 
descending into narrow/deep micro-grooves, at the nanoscale, epithelial cells on 150-
nm-deep grooves descended into 2.1-µm-wide grooves but formed bridges over 950- 
to 330-nm-wide grooves[106].These findings demonstrate that cells can sense micro- 
and submicroscale topography and react to it by bridging or conforming in a 
selective manner. 
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Relative to obvious changes in cell shape on grooved substrates, gene expression and 
differentiation of aligned cells is currently being investigated. Fibroblasts cultured on 
V-shaped 3-µm deep micromachined grooves displayed greater FN mRNA and 
protein levels than planar controls, while osteoblastic cells cultured on multigrooves  
displayed higher osteopontin and osteocalcin mRNA than cells on flat surfaces[110]. 
Importantly, it has been shown that in fibroblast cultures on lithographic 
microgrooves early upregulation of several genes involved in cell signaling (e.g. 
Developmentally regulated GTP-binding protein DRG, Protein kinase C substrate, 
Basic fibroblast growth factor receptor 1 precursor), cytoskeletal organisation (e.g. 
Tubulin beta-3 Chain), transcription (e.g. Transcription initiation factor IIE, 
Chromodomain-helicase-DNA-binding protein 1 (CHD-1))  and translation (e.g. 40s 
ribosomal protein S6, Eukaryotic translation initiation factor 3 beta subunit)  was 
followed by down-regulation on day 5[111].  It has been suggested that topography-
induced changes in morphology may have mechanotransductive effects, accounting 
for some of the gene regulation changes observed. Dalby et al. have proposed that 
distortion of the cell nucleus (e.g. during cell alignment) will alter the relative 
positions of chromosomes and their accessibility for transcription, thus changing 
gene expression. As the cells align, and thus take on far less random morphologies 
than those produced on flat surfaces (where the cells may spread in all directions), 
nuclear shape (and chromosomal arrangement) is being restricted throughout the new 
tissue being formed, which may result in gene down-regulation. This suggests that 
mechanical forces effect both morphological and biochemical cellular behaviour. 
 
When surfaces are uniformly or randomly textured with topographic features (nodes, 
pits, protrusions, pillars, channels, etc.) with no directional order (i.e. isotropic), cells 
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do not generally display anisotropic alignment. Instead, such cues operate by 
controlling more collective cell functions (e.g. division, differentiation etc.) [73]. As 
with anisotropic topographies, scale is a key determinant of whether cells exhibit 
specific behaviours on isotropically patterned substrates. The ability to precisely 
control topographic feature scale is therefore a prerequisite to their use as cell 
directing cues. Lithographic techniques provide well-defined topographies in the 
range of mm to 250 nm (photolithography) or down to 10 to 20 nm (e-beam 
lithography)[101]. Photoresist thickness or reactive ion etching provide further 
control over feature height or depth. However, cell response to isotropic 
topographies produced using lithographic methods is often inconsistent. For 
example, fibroblasts have been shown to display greater proliferation on 2- and 5-
µm-diameter nodes (0.5 µm high) than on 2- and 5-µm-diameter wells (0.5 µm 
deep), whereas cells on 10-µm nodes and wells did not differ from planar 
controls[112]. Furthermore, while progenitor cells displayed greater proliferation on 
5- to 40-µm-diameter posts than did on planar controls, macrophage spreading was 
much less on 5-µm-diameter features than on smooth surfaces[73]. Recently, the 
ability to assess cell reaction to nano-topography has been developed using polymer 
demixing and colloidal lithography, because they can produce large areas of 
nanotextured surfaces economically and at reasonable uniformity.  Using polymer 
demixing, Dalby et al. demonstrated that fibroblast focal adhesion formation and 
spreading are greater on 13-nm-high islands but lower on 95- nm-high islands, than 
on planar controls[113].  In contrast, endothelial cells on colloidal lithographic 
pillars (100 nm high, 168 nm diameter) displayed lower spreading and decreased 
cytokine production than cells on planar surfaces[114]. These findings suggest not 
only that cell response is specific to the dimensions of topography, but also that there 
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is substantial variation in topographic cell reaction between different cell types. 
Although comparison of the effects of isotropic topographies may currently be 
difficult, because of diversity in topographic size, shape, uniformity, and even 
chemistry[115], a tentative trend can be drawn for a limited range of nano-
topographic scale such that collective cell functions are positively stimulated at 
smaller nano-topographic scale (~10 nm in height or depth), but this reduces with 
increasing feature size  up to approximately 100 nm[73]. 
 
Topographic cell reaction in 3D substrates 
Fibrous and porous 3D substrates present cells with a complete spectrum of 
surface/interface attachment site densities. Indeed, the density of binding sites 
adjacent to some parts of the cell surface can approach zero, such as within parallel 
fiber bundles, pore/channel openings, between scaffold layers and at cleavage 
planes. Clearly, local absence of scaffold material adjacent to motile cells can come 
to define the front and rear of motion. In this case, no material equates to no contact 
and so represents the direction of least resistance, thus providing a guidance cue. 
Such guidance is most easily seen in scaffold channeling. The concept of 
topography‐regulated cell migration is dominated by the statistical availability of 
sufficient scaffold binding sites for the cell to apply traction force, and adjacent gaps 
in the scaffold into which the cell can actually move (i.e. space to move). Indeed, a 
similar principle has also been described for the influence of cell‐substrate adhesion 
site density on cell migration speed [116].  
 
Recent studies have demonstrated the feasibility of using the alignment reaction of 
cells to fibre-based topographies to guide cells through/along channels within 3D 
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scaffolds. For example, fibroblasts seeded within dense collagen scaffolds, 
incorporating aligned soluble phosphate-based glass fibers (PGFs), showed 
alignment along these fibers[117], suggesting that cells will be guided by the 
microchannels (30-40µm diameter) left  after the PGF has dissolved.  
 
Specificity of cell reaction to patterned topography  
As discussed above, certain cell phenotypes show greater sensitivity to particular 
nanoscale features than others. For example, osteoblasts have been found to adhere 
preferentially to carbon nanofibers in competition with chondrocytes, fibroblasts, 
and smooth muscle cells [118]. These cell type-specific effects/behaviors serve to 
highlight one of the main (yet unsurprising) challenges faced in understanding cell-
material interactions: cell behaviours differ. In other words, conclusions drawn from 
one cell type cannot be readily applied to another. While this might appear as a 
practical limitation at first glance, it also provides an incentive for understanding 
potential opportunities presented by this behavioural specificity. For example, 
studies have shown that topography alone can be used to elicit different responses 
from the same cell phenotype (e.g. uroepithelial cells seeded on titanium surfaces 
engineered with well-defined nanometer topographies displayed modified cell 
morphologies and cytokine production to cells cultured on flat titanium controls 
[114]). This has important implications for utilisation of a scaffold’s physical 
structure as a self-sufficient controller of cell function. 
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1.3.2 Effects of scaffold mechanics on cell function 
Cell proliferation   
The role of substrate mechanics in directing cell behaviour has long been 
investigated and is now well established [44,119-122]. It is becoming increasingly 
evident that cell interaction with the extracellular matrix (ECM) produces two 
different but concurrent signalling mechanisms. (1) Ligation-induced signalling, i.e. 
ECM ligand-receptor mediated signalling (e.g. RGD-Integrin binding), which 
depends on ECM surface chemistry, and (2) traction-induced signalling, which 
depends on mechanical stimuli transmitted through the ECM.  Discher et al  have 
discussed how substrate mechanics modulate cell phenotype and proliferation in a 
manner similar to biochemical signals[123]. These studies have been performed on a 
variety of substrates, more commonly on the collagen-coated silicone or 
polyacrylamide gels[124]. A study using a more biomimetic ECM composed of 
hyaluronan and fibronectin,  found that adult human dermal fibroblasts cultured on 
stiffer substrates had a higher cytoskeletal modulus and an increasingly stretched and 
organized actin cytoskeleton, exerted greater traction on the substrate  and 
proliferated normally only on the stiffest hydrogels[125]. In this study, however, 
cells were seeded on the surface and not within the substrate. In order to fully 
understand cell proliferation in the context of specific tissues, it is important to create 
a three-dimensional environment that mimics as closely as possible the cell-matrix 
interaction in vivo. This has necessitated the development of physiologically 
relevant, tissue-engineered constructs that resemble native tissue and whose 
mechanical properties can be controlled to allow detailed correlation with cell 
responses [13,122]. 
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Collagen is the most abundant protein of the extracellular matrix and thus collagen-
based substrates provide perhaps the most physiological and mammalian biomimetic 
environment in which cellular function can be studied. Many studies have replicated 
the findings of Bell et al. who demonstrated that fibroblasts cultured within (hyper-
hydrated) low density collagen hydrogels contract the matrix into a denser, ‘tissue-
like’ structure [126] (Fig.4). However, starting collagen density in this model is 0.2 
to 0.5% (1-2 orders of magnitude lower than tissues) and does not reach more than 1-
2% after cellular contraction. When such collagen gels are mechanically restrained to 
a stiff backing material (container) as ‘attached’ matrices, the contraction forces of 
resident cells generate an isometric tension (no gel contraction). As the stiffness of 
the collagen matrix increases, cells eventually proliferate. However there is little or 
no proliferation in the same gel when it is unattached and free floating, i.e. unable to 
develop isometric tension,with a significant proportion of cells undergoing apoptosis  
[127,128]. In addition to differences in their growth response, fibroblasts undergo 
significant morphological changes during mechanical unloading of collagen 
matrices. Fibroblasts in attached matrices have polarized cell morphology and form 
prominent actin stress fibers, resembling proliferating cells of granulation tissue, but 
these cells undergo loss of stress fiber organization when gel attachment (and thus 
stress) is released [129].  
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Fig.4 Plot showing cell-mediated contraction of a hydrated collagen lattice (gel) by 7.5 
x10
6
 fibroblasts, expressed as reduction in gel diameter. Adapted from Bell et al, 
1979[8]. 
The isometric tension that develops in attached collagen matrices is said to be 
equivalent to that found in skin wounds[130,131], though this has been 
questioned[3]. Wound healing is an example of a physiological response that 
critically depends on an orchestrated sequence of events, involving cellular adhesion, 
infiltration and proliferation along with appropriate migration and differentiation 
[130]. Unlike fibroblasts of mature dermis that are quiescent and stationary, 
fibroblasts of granulation tissue are proliferative and motile[132]. The stress–
relaxation model has been used to study fibroblast activation and quiescence during 
wound repair.  Based on this, the assumed mechanically-linked switch from 
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proliferation to quiescence/apoptosis has been interpreted as a  feature of fibroblasts 
at the end of cutaneous repair, at which stage granulation tissue regresses [133-138]. 
Extrapolation of this model to physiological repair is, however, difficult as it does 
not take into account the extremely low stiffness of the collagen gel-cell substrate 
used.  
Cell-mediated collagen matrix contraction results not only in changes in fibroblast 
tensional homeostasis[139] but inevitably in changes in collagen matrix 
stiffness[122]. Whereas the effect on fibroblast proliferation of endogenously 
generated tension[128,131] or  exogenously applied cyclic strains [140] have been 
extensively studied in the collagen gel model, the influence of matrix stiffness is not 
well understood.  This is part due to technical difficulty of precisely controlling the 
density, and so modulus of collagen hydrogels, in the same way that has been 
possible for polyacrilamide-based substrates. However, removal of  interstitial fluid 
from collagen hydrogels through a cell-independent process, such as plastic 
compression (PC) fabrication [25], would allow sufficiently precise control of the 
matrix hydration level (water content and so collagen density) to control stiffness 
modulus over a range. This creates the possibility to directly test the effect of 3D 
matrix stiffness on cell proliferation within a mechanically controllable, but 
biomimetic environment, with important implications for understanding repair and 
regeneration. 
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Cell migration  
Understanding the mechanisms of cell guidance would provide an invaluable tool for 
understanding cell-matrix physiology, designing biomimetic scaffolds and ultimately 
engineering functional tissues. It is already well established that directional 
movement of cells is an important component of developmental patterning, wound 
healing and tumor metastasis [141,142]. While cells migrate in response to cues such 
as gradients of soluble chemoattractants [143,144], they also appear to receive 
additional signals from the insoluble ECM. Changes in bound adhesive ligands, 
topographic features, and stiffness across a substrate are all thought to guide the 
migration of cells [122,145-148].  
The use of patterned adhesivity and topography to organize cells is now a widely 
used strategy in tissue engineering. When substrates are patterned with ECM coated 
regions and nonadhesive regions, cells only attach to the ECM-coated regions [149], 
while cells exposed to a gradient of immobilized ECM proteins migrate up the 
gradient (haptotaxis) [150]. Cells also organize and align in response to topographic 
cues, including surface grooves and ridges (substrate guidance) [151], as discussed 
above. However, in contrast to the maturity of engineering surface adhesivity and 
topography, cell guidance systems based on controlled substrate mechanics 
(e.g.stiffness) are only now being developed [68,125,152-154].  
A recent study based on an ECM composed of hyaluronan and fibronectin, found 
that adult human dermal fibroblasts migrate faster on softer substrates and 
demonstrate more dynamic lamellipodia activity [125]. Perhaps more significantly, 
in addition to having an effect on the speed of migration, substrate stiffness has also 
been implicated in controlling the direction of cell movement. A previous report 
59 
 
suggested that cells migrate preferentially towards stiffer surfaces, a phenomenon 
termed durotaxis [119] In this study, the durotactic response was observed in isolated 
cells, as cells were seeded at low density to reduce interfering by cell-cell contacts. 
Another study of mechanotaxis, using polymer cell culture surfaces containing 
micrometer-scale regions of variable stiffness, showed that over several days 
fibroblasts and endothelial cells accumulated preferentially on the stiffer regions, 
even in the presence of cell-cell contacts [68]. These studies used 
polyacrylamide/PDMS surfaces of varying stiffness [68,155,156] which introduced 
two major limitations in terms of experimental design. Firstly, cells must be seeded 
on top of the polymer surface and not within a physiological three dimensional 
environment. Any observations of cellular response, then, must be extrapolated to 
engineering of three dimensional structures.  Secondly, most of these patterned 
surfaces presented the cells with sharp boundaries between soft and stiff regions 
(step gradients) instead of smooth gradients as is the case with chemotactic 
signaling. The ability to engineer continuous stiffness gradients within biomimetic 
3D matrices would enable investigation of the phenomenon of durotaxis within a 
native micro-environment. Furthermore, incorporation of such drivers of 
physiological cell movement into a scaffold’s structure would provide an invaluable 
tool for controlling locomotion-dependent cell processes, such as ECM remodeling, 
that ultimately influence its architectural organization and mechanical properties. 
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Cell-mediated interface integration  
Previous studies on interface integration have primarily focused on fibro-cartilage 
engineering and repair [157] or fibroblast-mediated integration relevant to skin or 
tendon [158]. Adhesion strength has been found to correlate with collagen deposition 
[90,159,160] and length of culture period [158,161,162]. Cell migration has also 
been suggested as one of the mechanisms mediating integration of closely apposed 
structures [158,160]. However, most studies of cartilage-cartilage or osteo-chondral 
integration have been based on explant cultures [91,92,161,163,164]. The resulting 
lack of tight control over individual parameters such as the architectural organization 
of the interface, cell density and substrate stiffness has hindered full understanding 
of the type of connections and the cellular mechanisms by which mechanical 
linkages are generated across the interface.   
 
Tissue engineering provides the necessary flexibility to tailor the mechanical and 
degradation properties of a material, and in particular to incorporate gradients of 
material properties, which is of paramount importance in reconstruction of tissue 
interfaces. For example, to mimic the anterior cruciate ligament (ACL)-bone 
interface, a triphasic scaffold has been developed that consists of a soft-tissue phase 
formed from a highly degradable poly(D-L-lactide-co-glycolide) (PLGA) mesh 
fused to a fibrocartilage phase of more-slowly-degrading PLGA, which itself was 
fused to a stiffer bone phase made of aPLGA and bioactive glass composite[33]. The 
soft-tissue and bone phases were seeded with fibroblasts and osteoblasts, 
respectively, and over several days the scaffold supported cell growth while 
maintaining phase-specific matrix deposition[33]. 
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As discussed above, an important regulator of the processes that facilitate cell-
mediated interface integration, namely cell migration, proliferation and collagen 
deposition is matrix stiffness [68,122,123,125,165-167]. Indeed, it has been 
suggested that identification of variations in matrix stiffness could provide a useful 
method for assessing interface integrity at step-off edges during cartilage 
repair[168]. As resident cells lay down extracellular matrix (mainly collagen) at the 
interface between layers of sheet-based scaffolds, during in vitro culture [25] or in 
vivo, post implantation [54,169], matrix density and stiffness increase. Increasing 
matrix stiffness would, in turn, be expected to affect the integration process by 
feedback regulation of critical cell functions[122]. The ability to predictably control 
matrix stiffness at an interface, and therefore downstream cell responses, could thus 
provide an important tool for modelling and regulating multi-layer integration within 
sheet-based scaffolds (and other types of heterogeneous, multi-component scaffolds), 
as well as host-implant integration.  
 
1.3.3 Effects of scaffold 3D spatial organisation on deep O2 cell perfusion 
As we have already discussed, the native 3D structure of most tissues is 
characterized by specific and essential 3D cell-matrix architecture at the nano- and 
micro-scale [170,171]. By culturing cells in appropriate spatial locations and by 
engineering the density and fibrillar architecture of their supporting ECM this 3D 
tissue geometry could be mimicked [25,172-175]. Attempts to build such spatially 
biomimetic systems have been developed around 3D collagen scaffolds [176] in 
which the rapid fabrication process of  plastic compression (PC) is used to produce 
controlled collagen densities to levels comparable with native tissue [25]. However, 
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in the process of solving many of the basic questions of directly engineering simple, 
living collagenous tissues with biomimetic structure, it is now important to tackle the 
perceived, but poorly understood question of deep O2 cell perfusion which is key to 
cell survival in engineered constructs.  
Given the obvious limitations of mass transport (without microvascular perfusion) in 
3D culture a clear evidence-based understanding of the formation and effects of 
prevailing O2 tension gradients on deep cell behaviour is essential [177-181]. 
Previous work has examined the formation of such diffusional oxygen gradients in 
statically cultured cardiac constructs and their effects on spatial cell distribution and 
cell viability[178]. Indeed, cardiovascular engineering is a particularly stark example 
of potential 3D construct/in vivo mismatch. In this, as in other types of static culture, 
O2 / nutrient gradients form from the surface to the core of the 3D construct. In 
contrast, even the earliest naturally perfused vessel will have a reverse radial 
gradient from the core to the outer layer[182].  
This mismatch in O2/ nutrient gradient direction is a direct consequence of a 
scaffold’s 3D spatial organisation, which inevitably determines cell spatial 
positioning and distribution. In particular, recent studies have shown that layering 
cells specifically compromises deep O2 cell perfusion[173]. Importantly, there is 
substantial evidence that in matrix-rich ECM systems diffusion distance and matrix 
density contribute, but do not dominate gradient formation [94,173]. In contrast, the 
role of cell O2 consumption in determining the local O2 microenvironment is evident 
in the remarkable variation of O2 tension prevailing in different tissues. For example, 
while respiratory epithelium and outer skin layers are exposed to atmospheric levels 
of O2 (21%; 160mmHg), physiological hypoxia (1 -10% O2; 7.6-76mmHg) is by far 
the most common natural environment for most mammalian tissues[183]. 
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Furthermore, a substantial body of literature already suggests that different cell types 
are exposed to different ranges of O2 tensions, governed by their own metabolic 
activity (i.e. O2 requirement) and spatial positioning, and respond differently to 
varying O2 tension. It is well known, for example, that the wall of pulmonary blood 
vessels is home to a number of distinct cell phenotypes, including inner and outer 
layer pulmonary arterial smooth muscle cell (PASMC) types [184-186] which, by 
their nature, generate steep O2 gradients both across (radial gradients) and  along 
(longitudinal gradients) the vessel axis[182]. Outer PASMCs (i.e. furthest from the 
lumen) are not only more contractile, but respond to chronic hypoxia by reducing 
contractility. In contrast, inner PASMCs (adjacent to the vessel lumen) show no 
change in their contraction profile [184]. It is possible, therefore, that cells in specific 
spatial locations within tissues develop and adapt to utilise defined ranges of O2 
tension. Unintended or uncontrolled tendencies for O2 gradients to produce locally 
inappropriate cell phenotypes or behaviours would then be a serious problem, even 
detrimental to scaffold biofunctionality. Consequently, controlling cell spatial 
positioning/distribution, in addition to cell density, is an important element of 
scaffold 3D spatial organisation as it provides a key directing cue for regulating deep 
O2 cell perfusion and generating spatially biomimetic O2 gradients in artificial 3D 
tissues where they are functionally important. 3D engineered tissue models provide 
an ideal route to study this question. 
Cell responses to changes in O2 Microenvironment  
It is becoming clear that changing local O2 tension can affect multiple aspects of cell 
phenotype and behavior, including proliferation and differentiation [187-189]. 
Furthermore, cells appear to respond to changes in their O2 microenvironment in a 
tissue specific manner. For example, while in most well-oxygenated tissues, hypoxia 
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regulates angiogenesis through growth of new capillaries, in cartilage, which is 
avascular, sustained hypoxia upregulates the synthesis of major matrix components, 
such as proteoglycan and collagen type II[190].  
Mammalian tissues operate in oxygen tensions ranging from 1-10% O2 (pO2 between 
of 7.6-76 mmHg) [191], termed physiological hypoxia. This range is distinct from 
‘pathological’ hypoxia (<1% O2 or <7.6 mmHg), where O2 tension is low enough to 
compromise cell metabolism and damage/kill cells. Culturing cells under 
physiological hypoxia is currently employed as a strategy to control cell behavior in 
vitro, in particular, up-regulating the production of angiogenic signaling 
molecules[173,192].  
As O2 tension drops in a tissue, cells primarily respond by up-regulating Hypoxia 
Inducible Factor I alpha (HIF-Iα), which is a transcriptional activator [193,194]. 
HIF-Iα is considered to act as a regulator of O2 by controlling cell production of 
potent angiogenic proteins, for example vascular endothelial growth factor (VEGF) 
[194] (Fig.5). Angiogenesis in vivo relies on gradients of angiogenic factors guiding 
endothelial cells, and ultimately vessels, to tissue areas where O2 and nutrients are 
required [195-197]. In particular, gradients of VEGFA165, basic fibroblast growth 
factor (bFGF) and platelet derived growth factor (PDGF) have been shown to direct 
endothelial cell (EC) migration and differentiation[195,196].  
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Fig.5 Diagram showing how angiogenesis and arteriogenesis are regulated by HIF-1. In 
ischaemic tissue, reduced O2 availability induces the expression of the HIF-1α subunit 
and HIF-1 transcriptional activity, leading to increased expression of genes encoding 
placental growth factor (PLGF), vascular endothelial growth factor (VEGF), 
angiopoietins 1 and2 (ANGPT1, ANGPT2) and platelet-derived growth factor B 
(PDGFB), which bind to cognate receptors (VEGF-R1, VEGF-R2, TIE2 and PDGF-R). 
This promotes the mobilization and recruitment to ischaemic tissue of circulating 
angiogenic cells, the activation, proliferation and survival of endothelial cells, and the 
interaction of endothelial cells with pericytes and vascular smooth muscle cells. This 
response mediates the budding of new blood capillary branches (angiogenesis) and the 
remodelling of existing blood vessels to accept increased blood flow (arteriogenesis). 
Modified from Semenza, 2007 [198]. 
 
The ability to induce a controlled angiogenic response within an engineered 3D 
construct would clearly be the most biomimetic, and therefore ideal, solution to the 
problem of poor deep O2 cell perfusion (current alternatives include culturing 
constructs in perfusion bioreactors [199]). It is self-evident, then, that reproducing 
these complex angiogenic factor gradients within a tissue construct would have huge 
therapeutic and experimental value. As we discussed above, scaffold 3D spatial 
HYPOXIA/ISCHAEMIA 
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organisation (which directly controls cell density and position) could provide a tool 
for generating functionally useful cell O2 consumption gradients, in other words, 
engineering local cell-mediated physiological hypoxia. The idea would be to induce 
cells to act as factories producing a complete, potentially functional cascade of 
angiogenic proteins that can generate a physiological angiogenic response on 
demand. Additionally, the ability to induce controllable cell-mediated, and therefore 
physiologically regulated hypoxia[200], at predictable spatial locations in tissues 
would make it possible to direct the angiogenic response to any chosen point in 3D. 
 
It is well documented that cell-generated angiogenic cascades (following prolonged 
exposure to reduced O2) result in a more functional vasculature. This is almost 
certainly because the component proteins work best in concert to orchestrate vessel 
formation [201,202]. Simple addition of unbalanced levels of single factors such as 
VEGF has been shown to result in the formation of non-functional, ‘leaky’ vessels 
[201]. Consequently, it is proposed here that well-orchestrated biomimetic 
production of angiogenic factors with feedback regulation (angiogenic engineering) 
is only likely to be a practical proposition using whole cell systems. By these means 
the need to reproduce a complex sequence of angiogenic proteins is conveniently 
avoided by harnessing the innate biological programming. This can be achieved by 
engineering controlled cell hypoxia, i.e. mimicking physiological tissue hypoxia, 
which automatically  elicits physiological angiogenesis in the body [197,203]. 
 
A major advantage in the use of  scaffolds for tissue fabrication is the potential to 
control cellular micro-environments by customizing parameters such as diffusive 
properties, cell densities and 3D spatial positioning [55,173]. Previous work by this 
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group has shown that high density seeding of 3D collagen constructs with human 
dermal fibroblasts  (HDFs) produced rapid reductions of core O2 tension (~25mmHg 
/ 3.2%), i.e. at the low end of physiological hypoxia [173]. Importantly, this elicited 
a multifold up-regulation of VEGF gene expression up to 8 days, in a spatially 
predictable manner, with highest expression in the core vs. mid and surface layers 
[173]. This contrasts with other studies where cells have been incubated (e.g. by gas 
chamber culture) in a low O2 atmosphere, i.e. exposed to locally-uncontrolled, global 
hypoxia [204-208]. Cell hypoxia in the present model is created by local cell O2 
consumption and measured directly in specific construct locations (core and surface).  
 
By controlling the seeding cell type, density and position, therefore the total cell-
depot O2 consumption, it is possible to define accurately where and when the 
hypoxia will develop within the 3D construct (i.e. core O2 < surface O2) [173]. This 
makes it possible to engineer distinct populations of Hypoxia-Induced Signaling 
(HIS) cells that function independently of other cell populations, such as responding 
endothelial cells (ECs). Importantly, since hypoxia in this model is cell-generated, it 
is also physiologically regulated, as it has been shown that cells respond and adapt to 
tissue hypoxia in a time and O2 concentration-dependent manner[200]. Hence, a by-
product of this model is a surprisingly potent source of basic knowledge on how 
cells regulate their angiogenic signalling in time, space and O2 tension. Indeed, 
exposing HDFs to physiological hypoxia in this model produced only modest 
reductions in cell viability, at the construct core, after 5 days static culture [173]. 
Furthermore, the possibility to precisely engineer the other key controllers, i.e. 
diffusion path length, matrix density/diffusion coefficient, matrix anisotropy (by 
using plastic compression fabrication), makes this system predictable and 
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mechanistic. This presents the potential to model the behavior of HIS cell 
populations and to apply these predictions (e.g. rate of response, hypoxia trigger 
level etc.) to optimize engineered angiogenesis, and ultimately the ability of 
scaffolds to support deep O2 and nutrient cell perfusion.  
 
1.4 THESIS OVERVIEW 
The purpose of this work was to understand how physical cues can be adapted and 
incorporated into the structure of 3D biomimetic scaffolds for controling/regulating 
cell behaviour. Plastic Compression (PC) was employed as a cell-independent 
fabrication method to engineer structure in collagen hydrogel scaffolds, thus 
removing the need to rely on cellular activity from the initial scaffold fabrication 
stage. Since these are native collagen materials, scaffold structure not only directs, 
but is itself also directed by dynamic cell functions (e.g cell locomotion), through 
ECM synthesis and remodelling. PC fabrication has enabled the deliberate 
introduction of desired cues into the initial scaffold structure to test their individual 
effect on cell function at the beginning of a physiological feedback cycle.  Native 
collagen Type I was used as scaffold material, as collagen is the most abundant 
mammalian connective tissue protein, therefore providing a biomimetic 
microenvironment. The central question addressed by this study was to what extent 
is cell behavior regulated by physical cues and how these can be buit into the initial 
scaffold structure, as cell controlling/regulating tools. 
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1.4.1 Hypotheses under test: 
1. Fluid loss from collagen hydrogels undergoing Plastic Compression will result in 
accumulation of retained collagen fibrils at the fluid leaving surface (i.e produce a 
collagen density gradient along the compression axis) which will limit the discharge 
rate over time. Gel compression can thus be modelled as an ultrafiltration process 
with cake layer formation. 
2. Embossing a customised pattern template on the surface of 3D collagen hydrogel 
scaffolds will generate a permanent topography of controlled dimensions (width, 
depth, pitch). Surface topography will influence the attachment, morphology and 
orientation of endothelial cells cultured on acellular scaffolds (2D culture), while 
interface topography will influence the stratification of keratinocytes seeded on 
fibroblast-seeded scaffolds (3D culture).  
3. The stiffness of collagen hydrogels will be directly related to their collagen 
density and therefore to their hydration level. The proliferation rate of human dermal 
fibroblasts (HDFs) will be closely related to collagen matrix stiffness such that stiffer 
matrices will support higher proliferation rates. 
4. HDFs seeded within a 3D collagen matrix containing a stiffness gradient will 
preferentially migrate towards the stiff end of this gradient. 
5. Layered collagen matrices can undergo cell-mediated integration, while interface 
adhesive strength will depend on matrix stiffness at the interface.  
6. O2 consumption by resident cells (pulmonary artery smooth muscle cells), rather 
than matrix density/diffusion coefficient or diffusion path length, is the predominant 
factor controlling O2 tension in the core of 3D nano-fibrillar collagen scaffolds. 
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7. Spatially controlled hypoxia-induced angiogenic factor signalling by fibroblast 
populations, exposed to local cell-mediated hypoxia in 3D collagen matrices, will 
promote directed endothelial cell migration and tubule formation in vitro and in vivo. 
1.4.2 Objectives: 
Establish basic operating conditions for engineering physical structure in 3D 
collagen hydrogel scaffolds, using Plastic Compression (i.e. cell-independent) 
fabrication, and use the embedded resident cells as the sensing system (cyto-sensors) 
in order to quantify the effect of scaffold built-in cues on cellular responses.  
 
Aims of study: 
1. Develop a functional model of the Plastic Compression process that correlates 
fluid discharge rate to applied compressive load/pressure, duration of compression, 
gel initial volume and fluid leaving surface area. 
2. Quantify the dimensions (width and depth) of topographic features (grooves) 
embossed on collagen hydrogel scaffolds and test the effect of surface and interface 
topography on epithelial cell responses in 2D and 3D culture, respectively.  
3. Test the ability to increase collagen hydrogel matrix stiffness by removing 
interstitial fluid and increasing collagen density.  
4. Test the effect of increasing collagen matrix stiffness on fibroblast proliferation 
over a 7 day culture period.  
5. Test the ability to engineer a continuous stiffness gradient within a 3D collagen 
matrix and test its effect on the direction of fibroblast migration over a 6 day culture 
period.  
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6. Test the effect of matrix stiffness on cell-mediated interface integration of bi-layer 
collagen hydrogel scaffolds by quantification of interface adhesive strength and cell 
migration across the interface over a 7 day culture period. 
7. Measure O2 tension in the core of 3D collagen constructs to identify the relative 
contribution of key factors such as matrix density/diffusion coefficient, diffusion 
path length, cell density and consumption path length on deep O2 cell perfusion.  
8. Test the ability of HDF populations, exposed to local cell-mediated hypoxia, to 
upregulate production of angiogenic factor protein cascades in 3D collagen 
constructs. Test the ability of spatially controlled hypoxia-induced signalling to 
induce a directed angiogenic response by quantifying endothelial cell migration and 
tubule formation in 3D in vitro culture and in in vivo implanted constructs over 2 
weeks. Assess the functionality of infiltrating host blood vessels by extended real-
time monitoring of O2 tension in the core of implanted constructs.  
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CHAPTER 2 
MATERIALS & METHODS 
 
2.1 Cell culture  
Adult human dermal fibroblasts (HDFs) and male New Zealand white rabbit dermal 
fibroblasts (RDFs) (<10 passages) were cultivated in complete culture media 
composed of Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 
10% (v/v) fetal calf serum (FCS, First Link,UK), 2 mmol/l glutamine (Gibco Life 
Technologies, UK), 1,000 U/ml penicillin and 100 mg/ml streptomycin (both from 
Gibco Life Technologies, UK).  
Human primary keratinocytes were cultivated in KER- medium (80% DMEM, 20% 
HAM’s F12, 2% glutamine, 10% FCS, 0.2% hydrocortisone, 0.1% insulin, 0.1% 
T3/T, 0.1% choleratoxin, 2.5% adenine). 
Human umbilical vein endothelial cells (HUVECs) were cultured in endothelial cell 
growth medium (Promo Cell, Germany) supplemented with ECGS/H (0.4%), fetal 
calf serum (2%), epidermal growth factor (0.1ng/ml), hydrocortison (1 μg/ml) and 
basic Fibroblast Factor (1 ng/ml). 
Pulmonary arterial smooth muscle cells (PASMC’s) were isolated from elastic 
intrapulmonary arteries from five normal 14 day-old Large White piglets. All piglets 
were kept in accordance with the NIH (USA) Guide to the Care and Use of 
Laboratory Animals (1996) and Home Office (UK) regulations. Immediately after 
death, the lungs were removed and 1 cm lengths of the main intrapulmonary artery 
dissected from both lower lobes. PASMCs were isolated by dissection and enzyme 
dissociation from the outer (50%) medial layers, as described previously[209]. The 
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cells were grown in F12-Hams medium supplemented with 20% fetal calf serum 
(First Link, West Midlands, UK), 2 mM glutamine and penicillin/streptomycin (1000 
U/ml; 100 mg/ml, Gibco Chemicals) and used between passages 3 and 8. For 
removal of cells from monolayer culture, flasks containing cells were washed with 
PBS, and incubated with trypsin (0.5% in 5 mM EDTA, Invitrogen,UK) for 5 min at 
37
0
C. 
2.2 Formation of collagen gels  
Collagen gels were prepared as described by Eastwood et al. [210]. Briefly, for 
forming 5ml gels a collagen gel mixture composed of 4 ml acid soluble collagen type 
I (2.20 mg/ml; First Link, UK) and 0.5ml 10× DMEM (Gibco Life Technologies, 
UK) was neutralized by 235.5 μl of 5M NaOH, using the indicator colour change 
from yellow to cirrus pink. While still in liquid form, 4.5 ml collagen solution was 
mixed with 0.5-ml cell suspension at the desired cell density. For acellular gels, 
0.5ml of medium containing no cells was mixed with the collagen solution. The 
neutralized collagen suspension was poured into round/rectangular wells (depending 
on application, see separate chapters) and incubated at 37
0
C in a 5% CO2 humidified 
incubator for 30 min.  
2.3 Plastic Compression of collagen gels 
Following setting and incubation, gels were compacted by a combination of 
compression and blotting, as described by Brown et al. [25]. Briefly, a 165µm thick 
stainless-steel mesh (mesh size 300µm) and a layer of nylon mesh (50 µm mesh size) 
were placed on double layer absorbent whatman paper (grade 1: 11µm, 185mm 
diameter). The collagen matrix was placed on the nylon mesh, covered with a second 
nylon mesh and loaded with a 120 g metal block for 5min at room temperature 
leading to formation of a flat collagen sheet (50-100 µm thick) protected between 
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two nylon meshes (Fig.1). Compressed collagen matrices were peeled off the nylon 
meshes and placed in culture wells containing 5 ml complete culture medium. Plastic 
Compression did not significantly reduce cell viability[25].  
 
 
Fig.1 Schematic showing the plastic compression fabrication process. Collagen gels are 
compressed under fixed mechanical loading over a porous support substrate (blotting 
paper) so that rapid fluid removal (~99% fluid loss within 5 min) is achieved by a 
combination of compression and blotting. Compression for typically 5min produces 
collagen sheets of ~100- 200µm thickness (depending on initial gel volume/thickness).  
 
2.4 Scanning electron microscopy 
Compressed gels were washed in 0.1M phosphate-buffered saline (PBS) and fixed in 
2.5% gluteraldehyde in 0.1M PBS for 1 hr at 5 
o
C. Gels were then washed twice with 
0.1M PBS, fixed with 0.1% osmium tetroxide in 0.1M Na cacodylate buffer for 1 h 
at room temperature and dehydrated through an alcohol series with air-drying. Dry 
specimens were mounted onto stubs, gold-palladium sputter-coated, and viewed in a 
JEOL 5500LV SEM.  
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2.5 Histology and immunohistochemical staining 
After culture collagen constructs were fixed in 4% neutral buffered formaldehyde. 
Sections of approximately 5 mm in thickness were made by cutting samples in a 
plane perpendicular to the construct’s surface. The constructs were dehydrated 
through a xylene-ethanol series and embedded in paraffin for routine histology. 
Cross sections, 7 μm thick, of the paraffin embedded collagen constructs were 
stained using the hematoxylin-eosin technique and observed with an Olympus BX41 
microscope, while images were captured with an Olympus DP70 CCD camera. 
For immunofluorescent staining cultured constructs were washed in 5ml PBS, fixed 
in 100% ice-cold methanol for 1h and incubated for 30 min with primary and then 
secondary antibody (see separate chapters for specific antibodies used). After 
washing with PBS, bound antibody was localised using a fluorescence Olympus 
BX41 microscope at approximate absorption 495 nm, and fluorescence emission 519 
nm, and captured using a Olympus DP70 CCD camera. 
Immunohistochemical stainining was carried out using Vectastain ABC-HRP kit 
(Vector Laboratories, USA) according to the manufacturer’s instructions. After 
dewaxing and serum blocking (0.25% Triton-X in PBS for 15 min, followed by 30 
min incubation with 10% goat serum), the sections were incubated with primary 
antibody for 30 minutes at room temperature, rinsed in PBS, and incubated with 
biotinylated secondary antibody for 30minutes (see separate chapters for primary 
antibody used). Sections were then incubated with Vectastain ABC Reagent, 
followed by peroxidase substrate solution until desired stain intensity developed. 
Peroxidase substrate used was DAB (brown) (Vector Laboratories, USA), with 
haematoxylin counterstaining.   
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2.6 Statistical analysis 
For each experimental condition a sample size of n=3 or more was used, as noted. 
Data is expressed as mean±standard deviation, unless mean±standard error is noted. 
Statistical analysis was carried out using T-test where a maximum of 2 groups was 
used per analysis or oneway ANOVA (or Kruskal-Wallis test for non-parametric 
distribution) accompanied with multiple comparison tests for analysis of 2 or more 
groups, using SPSS 14 software. Differences were considered significant when 
p<0.05, unless otherwise noted.  
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CHAPTER 3 
MECHANISMS OF STRUCTURE GENERATION DURING 
PLASTIC COMPRESSION OF NANO-FIBRILLAR COLLAGEN 
HYDROGEL SCAFFOLDS 
 
Operator control of cell/matrix density of plastically compressed collagen hydrogel 
scaffolds critically depends on reproducibly limiting the extent of scaffold 
compaction, as fluid expulsion. During compression the main (basal) fluid leaving 
surface (FLS) acts as a filter, allowing out fluid and solutes but retaining collagen 
fibrils, cells and some macromolecules [25]. This fluid-filtration (‘caking’) effect 
results in the formation of multiple layers of compacted lamellae (1 to 5 µm thick) of 
collagen fibrils running parallel to the FLS, throughout the body of the gel, with the 
densest layer forming at the FLS. The presence of lamellae has previously been 
identified both by birefringence and transmission electron microscopy and was 
measurable as an increase in mean collagen fibril density in compressed vs. non-
compressed gels [25]. The formation of this dense lamellar layer might explain why 
over time, for sufficiently high pressures, the flux ceases to become pressure-
dependent and becomes time-dependent [53], a problem commonly encountered with 
ultrafiltration of macromolecules (gel layer formation or fouling)  [211,212]. In this 
study we used ultrafiltration theory to develop a functional model of the compression 
process. We hypothesised that the FLS of a collagen hydrogel undergoing 
compression behaves as an ultrafiltration membrane.   Increasing accumulation of 
collagen material at the FLS during compression (equivalent to concentration 
polarisation) produces anisotropic structuring, but also increases the FLS hydraulic 
resistance (RFLS; m
-1
), which in turn reduces the volumetric discharge rate (Q; m
3
/s) 
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through the FLS, cross-sectional area (A; m
2), as predicted from Darcy’s law for a 
pressure-driven membrane operation (Fig. 1) [213]:             
                                                      
FLSR
PA
Q
.
.


  
 
where ΔP is the hydraulic pressure difference across the FLS (Pa) and μ is the 
dynamic viscosity of water (Pa.s). Darcy's law is valid for incompressible, 
homogeneous Newtonian fluids moving slowly through a rigid porous medium with 
uniform porosity under isothermal and steady state conditions, assumptions that 
generally hold true in our model (i.e. water flowing slowly through a homogeneous, 
isotropic collagen matrix). Importantly, the above equation, neglects the 
inhomogeneity in the thickness (or mass) of the collagen lamellar layer arising from 
time-dependent accumulation of collagen fibrils at the FLS [213]. However, Ho and 
Zydney have shown that in membrane fouling during protein microfiltration  this 
spatial variation (if it occurs in our model)  has relatively little effect on the flux 
decline due to the self-leveling nature of the cake growth process[214]. 
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Fig. 1 3D Schematic showing the plastic compression process and how Darcy’s law can 
be applied to calculate the discharge rate (Qout). Pressure (P) is applied on a collagen 
hydrogel, placed on blotting elements (BE), by applying a compressive load. This adds 
to the hydrostatic pressure (ρgh) of the gel’s fluid (gel height h, water desity ρ) to 
create a hydraulic pressure difference (ΔP) across the fluid leaving surface (FLS) 
which forces fluid out of the main FLS area (AFLS). The pressure and the hydraulic 
resistance of the FLS (RFLS) are the key factors determining the discharge rate.  
We tested the hypothesis that while compressive load, i.e. applied pressure, is the 
primary determinant of flux at the beginning of compression (load-dependent phase), 
increasing FLS collagen density (CFLS) (measured by X-ray attenuation) and 
therefore increasing RFLS become the key factors governing flux as the process 
proceeds (flow-dependent phase). Experimental data were used to derive empirical 
equations describing these two consecutive, but distinct, phases of the compression. 
We developed a model integrating these two phases and used this to predict changes 
in fluid loss over time for a range of applied pressures. The model predictions were 
then compared to experimental data. This allowed us to test the hypothesis that 
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changing pressure over time, to match changes in RFLS, could maintain a steady flux 
during plastic compression of collagen hydrogels.  
3.1 RESULTS 
Testing of compression parameters 
The effect of varying the FLS cross-sectional surface area (A) on discharge rate was 
tested first. As expected from Darcy’s law for a pressure-driven membrane operation 
(see Chapter 3 introduction), the initial (0-1 min) rate of fluid loss was linearly co-
related to A (3.6 < 9 < 19.6 cm²) (Fig.2).  
 
Fig. 2 Correlation of discharge rate with FLS surface area and FLS collagen density. 
Plot of initial (0-1 min) discharge rate for 5ml cylindrical collagen gels (initial collagen 
density 0.168%) of varying FLS area (3.6, 9, 19.6 cm
2
) and for 5ml cylindrical collagen 
gels (FLS area 9cm
2
) of varying initial collagen density (0.168, 0.12, 0.08 %). All gels 
were allowed to compress under their own weight (n=5 for each point). 
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In contrast, increasing the initial FLS hydraulic resistance (RFLS) by increasing the 
initial collagen density (CFLS ) from 0.08 to 0.12 and 0.168% indicated that a near 
inverse-linear relation exists between the initial (0-1 min) rate of fluid loss and CFLS 
(0.168 < 0.12 < 0.08%), confirming that CFLS and RFLS are directly correlated (Fig. 
2).  
To test the effect of varying the hydraulic pressure difference across the FLS (ΔP) on 
discharge rate we applied a range of compressive loads/pressures (0, 10g/P=109 Pa, 
90g/P=980 Pa and 120g/P=1306 Pa) on 5ml collagen gels (A=9cm
2
) and measured 
fluid loss over 12 min.  As expected, increasing the compressive load resulted in a 
higher initial discharge rate and a greater cumulative volume of fluid being expelled 
from the gel (Fig. 3A, B).  Figure 3B shows that the discharge rate decreased 
exponentially with time for all compressive loads tested.  The maximal initial (0-1 
min) rate of fluid loss was achieved with application of a 90g load (P=980 Pa) (Fig. 
3B). Application of a 120g load (P=1306 Pa) did not significantly increase the rate 
of fluid loss (Fig.3A), but instead induced deformation along the x-y plane of the gel 
(indicating fluid loss along this plane), such that after 5 min of compression, gel 
diameter had increased from 34.16±0.95 mm to 37.8 ±1.43mm. This increase was 
statistically significant (p<0.05, n=4), demonstrating that during unconfined 
compression a threshold was crossed between pressures of 980 Pa and 1306 Pa 
where the nature of the process changed substantially, in effect fluid flow and 
deformation becoming multi-axial (Note; up to this point compression on blotting 
elements ensured that flow occurred overwelmingly uni-directionally, along the 
vertical axis of the gel). Importantly, a 15ml gel compressing under its own weight 
had the same initial discharge rate as a 5ml gel compressed with a 10g load (Fig. 
3B), implying that gel weight acts additively to external load. The increase in initial 
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(0-1 min) discharge rate observed with increasing compressive load was not linearly 
correlated with the increase in applied load. Instead, a 3 and 19 fold increase in load 
(from 5 to 15 and 95g, respectively)  resulted in approximately 1.4 and 2 fold 
increase in discharge rate, respectively, consistent with the idea that increasing RFLS 
gradually limited the effect of compressive load on discharge rate during 
compression. 
 
 
Fig.3 Change in rate of fluid loss during plastic compression.  (A) Plot of cumulative 
fluid loss (%) vs. time for 5ml cylindrical collagen gels (initial collagen density 0.168%, 
FLS area 9 cm
2
) compressed under their own weight (self-compression) or by 
application of a 10, 90 or 120 g load, * p<0.05. 
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 (B) Plot of discharge rate vs. time for 5 ml cylindrical collagen gels undergoing self-
compression or compression with a 10 or 90g load. The discharge rate of a 15 ml 
collagen gel undergoing self-compression is shown for comparison with a 5 ml gel 
compressed with a 10g load (n=5 for each loading condition). 
 
Structure-generating mechanisms of Plastic Compression  
Based on previous work on Plastic Compression by this group showing that the uni-
directional outflow of fluid from a single surface results in retention of collagen at 
the leaving surface [25], comparable to particle accumulation (caking) at a filtration 
surface (Fig. 4A), the formation of this layer was examined further. Preferential fluid 
loss and increased collagen density at the FLS could be seen macroscopically (based 
on the lighter area of the FLS, Fig.4B) and by coomassie-blue staining (in which dye 
staining of a denser protein (collagen) line was evident at the FLS, Fig.4C). SEM 
analysis of the same FLS structure (Fig.4D) showed multiple layers of compacted 
lamellae (1 to 5 µm thick) made up of collagen fibrils running parallel to the FLS. 
These ran parallel to the FLS, throughout the body of the gel, with the densest layers 
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forming at the FLS (Fig.4D). We hypothesised that these anisotropic, biomimetic 
structures [25] were generated by the directionability of fluid flow and so fibril 
accumulation which would translate into a collagen density gradient along the 
compression axis of the gel. This prediction suggests that the highest collagen 
density would be at the FLS, as shown in Fig. 4A. 
 
Fig. 4 Meso-scale structure generation during plastic compression of collagen 
hydrogels. (A) Schematic showing the structure-generating effect of fluid loss for a 
collagen gel undergoing plastic compression. At the beginning of compression (t=t0), the 
gel is homogeneous throughout its body, having a uniform collagen density (C0).  Over 
time (t=t1) the directional egress of fluid from the FLS results in compaction of fine 
lamellae (1 to 5µm thick) of collagen fibrils, parallel to the FLS with the densest layer 
forming at the FLS. This results in a collagen density gradient along the compression 
axis of the gel, such that C1>C2>C3. (B) Macroscopic view of a 5 ml collagen gel after 5 
min compression. The lighter area (arrowed) seen at the FLS formed due to greater 
loss of indicator-containing fluid at the FLS, compared to the gel’s body. (C) Image 
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showing a coomassie blue-stained collagen gel after 5 min of compression. The darker 
area (arrowed) seen at the FLS shows the increased density of collagen at the FLS 
compared to the gel body. (D) SEM image of the cross-section of a 5 ml collagen gel 
(FLS area 9 cm
2
) after 5 min compression with a 90g load. Multiple layers of packed 
fine collagen fibril networks (lamellae), typically 1-5µm thick, can be seen throughout 
the body of the gel but by far the densest layer is seen at the FLS (arrowed) 
(bar=20µm).     
As a measure of collagen fibril compaction, the relative positions of marker carbon 
particles, trapped between collagen fibrils, were measured during compression (Fig. 
5A). For this analysis 8 prominent carbon aggregates were identified within a 
carbon-loaded gel (after setting) and their positions relative to the FLS were 
measured over time (15 min) in 45-60s intervals. While all particles showed a 
gradual reduction in their relative position over time, this occurred faster for particles 
closer to the FLS, indicating that collagen compaction occurred preferentially in the 
lower collagen gel layers than at the top and middle sections during compression 
(Fig. 5B). This differential would tend to generate delamination (i.e. lamella 
formation) as seen in Fig. 4D. 
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Fig. 5 Analysis of the spatial distribution of collagen compaction along the compression 
axis (A) Setup used in the collagen compaction assay. The collagen gel was allowed to 
compress under its own weight, within the syringe, for 15 min. Clearly visible carbon 
particles (white arrows) can be seen trapped within the polymerized collagen hydrogel 
(image taken at start of compression). (B) Analysis of the compaction of material in 
each layer of the gel, as indicated by the loss of relative heights of 8 carbon particle 
aggregates over time (shown by the horizontal lines within the bars).Note that while 
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those that start at the top of the gel just drop down with little change in height 
(minimum compaction and loss of fluid), those starting in the gel middle or lower either 
compact dramatically by the end of PC or are unmeasurable before the end of the PC 
process. 
Preferential fluid loss at the main (bottom) fluid-leaving surface would imply that 
FLS collagen density (which determines the FLS hydraulic resistance) and not 
average gel collagen density is the key determinant of discharge rate. We found that 
a self-compressing 5ml gel of 0.2% initial collagen density had a significantly higher 
(p<0.05) initial (0-1 min) discharge rate compared to a self-compressing 10 ml gel of 
0.1% initial collagen density that was pre-compressed to remove 50% of its fluid, to 
produce a 5ml gel with 0.2% average collagen density (Fig. 6A). It is assumed that 
pre-compression of the 10ml gel resulted in an anisotropic distribution of collagen 
density along the compresson axis with the highest density occurring at the FLS (as 
in all other PC tests). This pre-compression in turn increased the FLS hydraulic 
resistance which limited the subsequent discharge rate. We thus tested whether 
inverting the gel between the initial and final compression stages would abolish the 
rate-limiting effect of increasing collagen density at the FLS (typical where there 
was no inversion).  This 180
o 
inversion of gel position, so fluid flow direction, would 
effectively place the gel upper surface at the bottom, making it the new FLS. Fig. 6B 
shows that there was no significant difference in % fluid loss over 2 time windows 
(0-1min and 1-2 min) of compression when this top-bottom gel inversion was 
performed. This test confirms the fluid flow rate-limiting nature of the FLS and 
suggests that reversal of fluid flow direction, during PC processing, could be a 
powerful tool in controlling both average flow rates and the resultant collagen micro-
structure (Fig. 4D).  
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Fig. 6 Close dependence of discharge rate on FLS collagen density. (A) Comparison of 
the initial (0-1 min) discharge rate of a self-compressing  5ml gel (0.2% initial collagen 
density) (1) to that of a self-compressing 10 ml gel (0.1% initial collagen density) which 
was  pre-compressed to remove 50% of its fluid (2) (this produced a 5ml gel with 0.2% 
average collagen density), *p<0.05 (n=4 for each condition).  (B) Comparison of the % 
fluid loss within 0-1min (1) and 1-2 min ( (2) and (3) ) of compression when 5ml gels 
were compressed with a 10g load.  Gels were either left in their initial position ( (1) and 
(2) ) or inverted after 1 min of compression to place the FLS at the top (3), *p<0.05 
(n=4 for each condition).  
 
Load-dependent vs. flow-dependent phase 
The above findings led to the hypothesis that while the initial flux depends on 
compressive load (load-dependent phase), later stage flux becomes flow dependent. 
This will occur as the RFLS becomes limiting (generating a flow-dependent phase), 
i.e. the FLS behaves like a typical ultrafiltration membrane with a built-up cake 
[211]. With further build up of collagen fibrils and increasing cake density, the RFLS 
89 
 
would subsequently become the key factor governing the flux during the flow-
dependent phase (and ultimately the practical end-point of compression).  
Figure 7 shows a plot of initial (0-1 min) flux (J0) vs. pressure (P) for 5ml gels (FLS 
area=9cm
2
, initial collagen density=0.168%) compressed with a range of 
compressive loads. 
 
Fig.7 Analysis of the two consecutive flux phases during the plastic compression 
process. Plot of initial (0-1 min) flux (J0) out of collagen hydrogels vs. Pressure (P), 
during compression with a range of compressive loads. The linear part of the curve 
represents the ‘load-dependent’ phase of the compression (flux depends on pressure) 
while the plateau region represents the ‘flow-dependent’ phase of the compression (flux 
is almost independent of pressure). The best-fit line is given by   
,  R
2 
= 0.9539. 
 
While for small applied pressures (40-130 Pa) J0 was proportional to P (load-
dependent phase), the flux-pressure relation became non-linear as P increased above 
700Pa, i.e. the flux gradually became less dependent on compressive load as a flow-
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dependent phase was established. These experimental data could be fitted with 
empirical equation (1): 
 
        R
2 
= 0.9539       (1) 
 
Quantification of RFLS 
By applying Darcy’s law it was possible to quantify the RFLS for collagen gels (5ml, 
0.168 % initial collagen density) compressed with a 10g load (see Chapter 3 
Methods section). The RFLS was found to increase exponentially with time during 
compression (Fig. 8A). Correlation of RFLS with gel cumulative fluid loss showed a 
rapid increase in RFLS when >60% of the gel’s fluid content was expelled (Fig. 8A). 
This correlated closely with the decrease in discharge rate previously identified at 
this point (Fig. 3A, B).  Since discharge rate in the final stages of compression was 
too low for reliable measurement, RFLS for highly compressed gels (>93% total fluid 
loss) was directly measured by permeability test.   In the test  the resulting collagen 
membranes, obtained from compression of collagen gels (5ml) with a pressure of 
1306Pa for 5min (~96% fluid loss), were subjected to a constant flux filtration test 
with a set flow rate (1 or 9 ml/min)  while the pressure required to deliver such a 
flow rate was measured (see Chapter 3 Methods section). The value of hydraulic 
resistance obtained was RFLS = 1047±343 nm
-1
. This value was used to predict the 
discharge rate out of 5ml collagen gels compressing for 5min with a pressure of 
1306Pa. Figure 8B shows that there was no significant difference between predicted 
and experimental values of discharge rate, indicating a good estimation of RFLS. This 
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was also supportive of the hypothesis that fluid loss during compression could be 
reliably modeled as an ultrafiltration process.   
 
 
Fig. 8 (A) Change in FLS hydraulic resistance (RFLS) during plastic compression. Plot 
of FLS hydraulic resistance (RFLS) vs. time and cumulative fluid loss (%) for a 5 ml 
cylindrical collagen gel undergoing compression with a 10g load. (B) Comparison of 
predicted (1) and experimental (2) values of discharge rate for cylindrical collagen gels 
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(5ml) compressed with a pressure of 1306Pa for 5min (96% fluid loss). A value of RFLS 
= 1047 nm
-1 
was used to calculate the predicted discharge rate (by application of 
Darcy’s law). 
 
Correlation of RFLS with CFLS 
In order to quantify CFLS, we first quantified the collagen density gradient formed 
along the compression axis of the gel at various stages of compression, by measuring 
the attenuation of X-rays transmitted through the gel. This provided direct 
information on water distribution, and thus of collagen density along the 
compression axis (Fig. 9A, B).  The variation in % collagen density along the 
compression axis at four stages of compression (0, 60, 80 and 98% fluid loss) is 
shown in figure 9C, D (note: the 1.4 to 2 fold collagen density gradient observed was 
in the range reported by a previous study where collagen density along the 
compression axis was quantified by measurement of fluorescence intensity of 
fluorescein-labeled collagen monomers incorporated in the collagen gel [215]).  
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Fig. 9 Quantification of collagen density along the compression axis at various stages of 
compression. (A) Schematic showing the setup used to measure the attenuation of X-
rays, transmitted through a collagen gel. Gels were placed between 2 glass slides and 
mounted vertically, in the scanner chamber. X-axis denotes the compression axis of the 
gel. (B) X-ray radiograms of collagen gels prior to compression (I) and after 
compression (98% fluid loss) (II).  White areas in compressed collagen gels (arrowed) 
show areas of lower water content (higher x-ray intensity), at the FLS.   
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(C) Representative traces of % collagen density vs. distance from the FLS along the x-
axis of the gel for three levels of compression (0, 60 and 80%). (D) Detailed plot of 
collagen density (%) vs. distance from the FLS along x-axis of gels compressed to 98% 
fluid loss (n=4).  
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Figure 10A shows a plot of 1/CFLS (%) vs. % cumulative fluid loss (FLcum). 
Experimental data could be fitted with empirical equation (2a): 
    
          R
2
 = 0.9946      (2a) 
                                                                          
Eq. 2a could be rearranged to Eq. 2b: 
 
                                       (2b) 
 
where Cfls, C0 (the gel  initial collagen density) and FLcum are expressed as a 
percentage. 
RFLS was linearly correlated to CFLS (Fig. 10B). Experimental data could be fitted 
with empirical equation (3): 
  
                 R
2
 = 0.9972                        (3)                                             
 
where  Rfls is in nm
-1 
and Cfls is expressed as a percentage. 
Eq. 2b was combined with Eq. 3 to obtain Eq. 4: 
 
                                             (4)                                                      
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Fig. 10 Correlation of FLS collagen density (CFLS) with FLS hydraulic resistance (RFLS). 
(A) Plot of 1/CFLS (%) vs. FLcum (%). The best-fit line is given by   
 ,      R
2
 = 0.9946. (B) Plot of RFLS vs. CFLS (%).The 
best-fit line is given by    , R
2
 = 0.9972.  
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Compression model development and validation  
For gels undergoing compression with a constant compressive load, the 
instantaneous flux (J) during compression could be obtained by dividing the initial 
flux (J0) by the fold increase in RFLS as shown in Eq. 5a: 
  
                                                                           (5a)                
where R0 is the initial FLS hydraulic resistance expressed in nm
-1
. 
 
Combining Eq.4 with Eq.5a and substituting for R0 = 68C0/ 0.97 we obtain Eq.5b: 
 
                                                                             (5b) 
 
From Eq.5b, and integrating flux with respect to time (t), we obtain Eq. 6a: 
 
                                                                       (6a) 
 
where A is the FLS area (in cm
2
), V0  is the initial gel volume (in ml), Jo is the initial 
flux (in ml min
-1
 cm
-2
) , t is time (in min) and FLcum  is expressed as a percentage 
(note Jo is a function of applied pressure can be calculated using Eq.1). 
Combining Eq.5b with Eq.6a, we obtain Eq.6b that relates J with t : 
 
                                                                                                   (6b) 
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Combining Eq.5a with Eq.6b, we obtain Eq.6c that relates RFLS with t : 
 
                                                                                               (6c) 
 
Eq.6a was used to model FLcum over time for collagen gels compressed with a range 
of pressures (130, 707, 4900 and 9100 Pa). Model data were compared with 
experimental data, showing a close correlation (Fig. 11). The greatest difference 
between experimental data and model predictions was seen at low pressures (130 and 
707 Pa), especially towards the end of the compression period (4-5 min) where 
experimental values were substantially below those expected. This effect 
progressively disappeared with higher pressures (4900 and 9100 Pa), suggesting that 
the model could be a better fit for higher pressures.  
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Fig. 11 Compression model validation. Comparison of experimental and model values 
of cumulative fluid loss (%) over time for cylindrical (A, B) and cuboidal (C, D) 
collagen gels compressed with a range of pressures (A: 130 Pa, B: 707 Pa, C: 4900 Pa, 
D: 9100 Pa).     
 
We finally tested the effect of varying the pressure over time, in proportion to the 
increase in RFLS, on discharge rate. Figure 12 shows the profile of discharge rate vs. 
time when a constant pressure of 707 Pa was applied on a 10 ml gel (C0=0.168%) for 
the full 5 min compression period. Use of Eq.6c to calculate the RFLS at 1 min 
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predicted a 2 fold increase in RFLS between 0 and 1 min (reflected by a ~50% 
decrease in discharge rate over the period) (Fig. 12).  To match this increase in RFLS  
the pressure was increased to 1414 Pa at 1 min. This resulted in a significant 
(p<0.05) increase in discharge rate relative to the base rate at 1 min. However, this 
effect was only transient as discharge rate fell back to the base rate by 2 min.  There 
was  a gradual dissipation in the effect of increasing pressure with time, such that a 4 
fold increase in pressure to 2828 Pa at 2 min, matching a 4 fold increase in RFLS from 
0 to 2 min, resulted in a less pronounced, but still significant (p<0.05), increase in 
discharge rate (Fig. 12). These effects were in agreement with the model prediction 
of a rapid (exponential) increase in RFLS with time. Therefore, based on the 
correlation developed to predict the RFLS increase with time (Eq.6c), it is possible to 
apply a gradual increase of pressure (or load) to compensate for the increase in RFLS, 
to achieve a near-linear discharge rate.           
 
Fig. 12 Effect of changing pressure during compression on discharge rate.  Plot of 
discharge rate vs. time for 10 ml collagen gels (initial collagen density 0.168%) initially 
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compressed with a pressure of 707 Pa. The pressure was either left unchanged (707 Pa) 
during compression (1-5 min), doubled to 1414 Pa at 1 to 5 min to match a 2 fold 
increase in RFLS at 1 min or increased to 1414 Pa between 1 and 2 min, then further 
increased to 2828 Pa between 2 and 5 min to match the 2 and 4 fold increases in RFLS  at 
1 and 2 min of compression, respectively. Enhanced flow rates at 1 and 2 min due to 
this progressive increase in pressure were significant (*p<0.05) (n=4 for each loading 
regime). 
 
3.2 DISCUSSION 
Original Hypothesis: Fluid loss from collagen hydrogels undergoing Plastic 
Compression will result in accumulation of retained collagen fibrils at the fluid 
leaving surface (i.e produce a collagen density gradient along the compression axis) 
which will limit the discharge rate over time. Gel compression can thus be modelled 
as an ultrafiltration process with cake layer formation. 
 
The primary objective of this study was to develop a functional model of the plastic 
compression process, to reproducibly and accurately predict the effects of interstitial 
fluid removal from collagen hydrogels. The dependence of a hydrogel scaffold’s 
spatial dimensions on its fluid content makes this a key determinant of the density of 
any element retained within the scaffold during the compression e.g. collagen fibrils 
and cells [50]. Collagen fibrillar density directly determines matrix mechanical 
properties in a number of ways. It is clear from this and other studies for example 
that compression of collagen hydrogels changes their behaviour generally from 
poroelastic to viscoelastic [52]. This will therefore also change cell behaviour 
[44,123,166]. However, this study has shown how much asymmetric meso-scaled 
anisotropy (layering) the PC process introduces to an initially isotropic structure. 
This is key to the importance of PC as a mechanism for generating tissue-like or 
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biomimetic properties. Such anisotropic structures regulate critical biological control 
processes such as mass transport and nutrient perfusion to deeper cells [216]. These 
parameters are subsequently regulated by cellular synthetic and metabolic activity, 
both of which are direct functions of cell density. Successful and optimal use of the 
plastic compression fabrication process within tissue engineering, then, critically 
depends on our understanding and precise control of how fluid is expelled from the 
collagen nano-fibre network. Importantly, this also provides clues as to how cell-
generated tissue structures are built up naturally.  
The transient mechanical behavior of a collagen hydrogel is related to its interstitial 
fluid flow, which is governed by the hydraulic permeability (k).  Previous studies 
have already established that the hydraulic permeability of hydrogels (e.g. agarose 
gels [217], matrigel [218,219]) and indeed tissues (e.g. cartilage [220], dermis [221], 
arterial intima [222] and basement membrane [223,224] ) is deformation-dependent. 
However, quantification of the hydraulic permeability of hydrogels (by applying a 
pressure gradient and measuring the flow rate) is difficult because of flow-induced 
matrix compaction, which can deform the matrix (i.e. change of the flow-path 
length) and thereby alter the parameter being measured. Furthermore, measurement 
of the simple average hydraulic permeability (kavg) of  collagen hydrogels 
undergoing plastic compression would be a seriously limiting, even flawed 
understanding as the  real (and key biomimetic) properties are dominated at the cell-
molecular levels by structural asymmetry and anisotropies . Such complex structures 
are generated by the PC process in this system, as demonstrated in terms of collagen 
density and hydraulic permeability in this study. The fact that they can be controlled 
and tuned to materials for tissue engineering needs represents a major processing 
opportunity. The model presented here is based on the hypothesis that loss of fluid 
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from a collagen hydrogel, during compression, can be modeled as an ultrafiltration 
process with a compressible cake formation. Filtration theory has previously been 
used to predict the hydraulic resistance of the arterial intima under compression 
[222], while importantly collagen has been shown to significantly contribute to the 
hydraulic resistance of the aortic wall [225] and synovium [226]. Indeed, interstitial 
conductivity correlates negatively with collagen concentration [227]. In our model, 
fluid-filtration through the FLS results in increasing accumulation of retained 
collagen material at the FLS which correlates with increasing FLS hydraulic 
resistance. This has a limiting effect on flux over time, as indicated by the non-linear 
pressure-flux relation. Interestingly, non-linear pressure-flux relations have 
previously been reported for arterial wall and cartilage [227].  The finding that 
increasing pressure over time only resulted in a transient increase in flux further 
supports the hypothesis that the FLS behaves like an ultrafiltration membrane with 
cake or gel layer formation [211]. Empirical quantification of RFLS, which is a 
compound measure of FLS hydraulic permeability (kFLS) and FLS collagen lamellar 
(cake) layer thickness (δFLS), i.e.RFLS = δFLS/kFLS, did not require differential 
estimation of either of these parameters, both of which change with time, thus 
circumventing this problem. The experimental setup shown in figure 13 (Methods 
section) could be used to estimate kavg for highly compressed gels, assuming that the 
high stiffness modulus (~2MPa [166]) prevented significant pressure-induced 
compaction of the gel during testing.  For gels compressed to remove 96% of their 
fluid (gel thickness≈250μm) a value of kavg =2.82±1.64x10
-16
 m
2 
could be obtained 
(using Darcy’s law), which was in the range of hydraulic permeability previously 
reported for 5% agarose gels [217]. However, this value represents the gel’s average 
hydraulic permeability and is only an approximation of kFLS.  
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In our model FLS hydraulic resistance (and permeability) were assumed to directly 
correlate with FLS collagen density (i.e. porosity). While this was a reasonable 
assumption (as shown by the linear correlation of experimental values, Fig.10B), it 
might be an oversimplification, since the permeability of a fibrous structure has been 
shown to also depend on additional factors such as fibre orientation[228]. Indeed, 
most of the permeability models established for fibrous materials are only suitable 
for specific ranges of porosity (e.g. drag-force theory is more applicable to highly 
porous materials). Similarly, our model might be more applicable for a certain range 
of porosities, which might be reached more quickly with higher pressures. This 
could explain the model’s better fit for higher pressures.  It is important to note that 
while the actual fouling mechanism(s) (e.g. pore blocking, cake filtration etc. [229]) 
mediating an increase in RFLS  during compression remain to be examined, this is 
unlikely to be caused by concentration polarization (i.e. increase in local osmotic 
pressure resulting in lower effective driving pressure, as seen in reverse osmosis), as 
collagen fibrils have only weak inherent swelling potential (i.e. osmotic activity) at 
neutral pH [52]. Furthermore, while beyond the scope of this study, investigation of 
the effects of cell-seeding (and cell type) on RFLS (e.g. magnitude, rate of change) is 
an essential requirement for wide-range application of the PC process within tissue 
engineering and will be the focus of future work (as outlined in the Future Work 
section). 
This study indicates that control of fluid loss from a collagen hydrogel scaffold could 
be achieved by alteration of one or more parameters; compressive load, duration of 
compression, gel initial volume, and FLS area. Importantly, while the model (flow-
dependent phase) was constructed based on data obtained from testing cylindrical 
gels, its predictive ability was also satisfactory with cuboidal gels (Fig.11 C, D), 
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suggesting that it could be applied to multiple gel geometries. Modifications of the 
plastic compression technique could further facilitate the fabrication of desirable 
scalar or directional structural features within scaffolds. For example, the axial 
direction of compression (short vs. long axis of the construct) could determine the 
final construct dimensions and  (average) collagen density reached, while the 
introduction of a second (or more) FLS(s) during compression could provide control 
over the spatial configuration of collagen density anisotropy within the scaffold (e.g. 
symmetric vs. asymmetric structural anisotropy). Moreover, it has been shown that a 
further increase in collagen density (from 12.6 to 23.1%) and mechanical properties 
could be produced by subjecting the material to a secondary compression process 
(double compression) [52,230]. The ability to control the flux, as well as the 
cumulative fluid loss, during compression of cell-seeded scaffolds is equally 
important as it has been shown that the severity of cellular damage depends on both 
the magnitude and the duration of fluid shear stress [231]. Indeed, cell injury in 
articular cartilage under load depends both on compressive stress and strain rate 
[232]. Importantly, collagen fiber architecture determines the level of shear stress 
experienced by cells within 3D matrices [233]. Specifically, fibers oriented along the 
flow direction shield cells more effectively from shear stress, which might explain 
why plastic compression results in only a small (~10%) reduction in cell viability 
(fibril orientation in lamellae is in the Z (vertical) plane) [25].  
We showed that directional fluid outflow through the FLS causes differential gel 
compaction (bottom greatest, top least (Fig.5B) ) which must generate lamination 
forces in the gel, parallel to the FLS. This would indeed explain the formation of 
separate 1-5µm lamellae in the gel body.  Importantly, while collagen density was 
anisotropically distributed along the compression axis,  collagen density lateral to the 
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central compression axis was relatively uniform (data not shown), which was in 
agreement with the findings of a previous study [215].  The development of such 
uniaxial anisotropic structuring could provide a useful tool for engineering on 
demand spatially distinct gradients within the scaffold (e.g. stiffness, haptotactic or 
chemotactic gradients) and thus a means of regulating cell behaviour (e.g. cell 
migration, proliferation and differentiation). For example, durotactic gradients could 
be used to guide cells (e.g. fibroblasts) within a 3D collagen matrix [167] (see 
Chapter 6).  The ability to generate localised 3D structures and zones at a meso-scale 
could also have important implications for tailoring the structure of the collagen 
fibril network (e.g. fibril diameter, alignment and porosity) to match the native 
architecture of  specific tissues [50]. Indeed, confined compression of collagen gels 
has also been shown to induce collagen fibril and cell alignment through a contact 
guidance response [215]. Furthermore, 3D structural features could be superimposed 
with nano- or  micro-scale topographic patterns (e.g. by template embossing [25]), 
thus providing an additional tool for regulating epithelial cell function (e.g. 
alignment, attachment, contact guidance) [73] (see Chapter 4). Importantly, control 
of local matrix density could allow the density and distribution of a resident cell 
population to be precisely engineered to native tissue levels [50].  
We have shown that the collagen density of these nano-fibrous scaffold materials 
(and by extrapolation porosity [234]) is critically related to fluid outflow. PC 
fabrication could therefore be used to precisely control collagen density and scaffold 
hydro-permeability, in a predictable manner [235]. Since compressed collagen 
matrices comprise nano-fibrillar meshes with corresponding nano-porosity, they 
have predictable properties in terms of small and macro-molecule transport to and 
from resident cells.  Notably nutrients such as oxygen and glucose have rapid access 
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to deeper cells (being much smaller than the matrix nanopores) [173,236] whilst 
macromolecules such as proteins (e.g. cell products, growth factors etc.) will have 
much longer transit times [237].  Indeed, we have shown that IgG antibodies and 
cell-secreted Matrix Metalloproteinases (MMPs) and vascular endothelial growth 
factor (VEGF) are partially retained within compressed collagen scaffolds (see 
Chapter 9). This diffusional asymmetry could be further enhanced, or used to mimic 
actual tissue function (e.g. the anisotropic hydro-permeability in compressed 
articular cartilage [220]), by the incorporation of predictable nano-micro scale 
structural asymmetry.  
 
3.3 CONCLUSIONS 
The advent of the plastic compression fabrication process has made it entirely 
feasible to construct collagen-based, biomimetic tissues (including a resident cell 
population) without the need for metabolic/synthetic input from cells [25]. This is a 
key stage in understanding how to engineer collagen nano-fibrous materials with the 
control and precision that we currently engineer other forms of polymer materials. In 
other words, it is now possible to progressively shift from cell cultivation to the 
engineering of new tissues [50]. However, such bulk matrix production will critically 
depend on successful process scale-up. The current model defines parameters 
(compressive load, time, gel volume and FLS area) that enable precise and 
predictable control of the process and of the 3D tissue-like structures produced. It is 
an important tool, therefore, for engineering scaffold properties such as cell/matrix 
density, mechanical properties and complex (e.g. anisotropic) mesoscale structure in 
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a highly controlled manner. Furthermore, this work paves the way for process 
automation and up-scaling. 
 
3.4 MATERIALS & METHODS 
Collagen gel preparation and compression  
Collagen gels were prepared as previously described [210] . Briefly, a 5 ml collagen 
gel mixture composed of 4 ml acid soluble collagen type I (First Link, UK) of 
varying collagen concentration (2.1, 1.5 or 1 mg/ml) and 1 ml 10×DMEM (Gibco 
Life Technologies, UK) was neutralized drop-wise by 5M NaOH. For preparation of 
10 and 15 ml gels, 8 and 12 ml acid soluble collagen type I (2.1 mg/ml) was mixed 
with 2 and 3 ml 10×DMEM, respectively, and neutralized with NaOH.  Neutralised 
collagen solution was poured into either round wells of varying surface area (3.6, 9, 
19.6 cm²) or into rectangular moulds (size: 2.2 (length) x 0.7 (width) x 6 (height) cm, 
FLS= 1.54 cm
2
) made from Derlin polymer blocks (Intertech, UK) and incubated at 
37°C in a 5% CO2 humidified incubator for 60 min. 
Following setting and incubation, gels were compacted by a combination of 
compression and blotting [25], as shown in figure 1 (see Chapter 2). Briefly, a 
165µm thick stainless-steel mesh (mesh size 300µm) was placed on water-soaked 
double layer absorbent Whatman paper (grade 1: 11µm, 185mm diameter). The 
collagen gel was placed on the mesh and was either left to compress under its own 
weight (self-compression) or covered with a glass slide and loaded with a metal 
block (10, 90 or 120g) for 12 min at room temperature, in a dry chamber. Use of 
absorbent Whatman paper during unconfined compression ensured that fluid loss 
109 
 
occured overwelmingly uni-directionally along the vertical axis of the gel. Fluid loss 
during compression was quantified indirectly by measuring gel wet weight every 
minute (gel removed from blotting elements, placed on digital weighing device and 
returned to compression station; timer stopped during weight measurements). 
Collagen gels (5ml) cast in custom-made rectangular moulds were compressed while 
within the mould with a metal plunger (70 or 140 g). The use of partially confined 
compression, in this case, allowed application of high pressures (4900 and 9100 Pa, 
i.e. higher than the burst pressure for unconfined compression, ~1300 Pa, where fluid 
loss and gel deformation occured along both the x and z planes). Fluid loss was 
measured every minute, indirectly, by measuring the movement of the plunger-gel 
interface, as it descended. For all loading regimes, 5 separate gel samples were tested 
(n=5). 
Coomassie blue staining 
Coomassie blue (a protein-staining dye) staining was used to visualize differences in 
collagen density between the FLS and the body of the gel after compression. 
Collagen gels (5ml) were cast in 3.6cm
2
 wells. After setting and incubation, gels 
were soaked in Coomassie blue R-250 (0.025% in deionized water) (BDH, 
laboratory supplies, UK) for 1hr and excess stain was removed with 3 washes (15 
min) in deionized water. Gels were self-compressed on double layer whatman paper, 
for 5 min, mounted vertically to expose the FLS, and photographed with a digital 
camera (CANON IXUS 960 IS, Canon inc., Tokyo, Japan).  
SEM analysis of collagen gel structure along the compression axis 
Collagen gels (5ml, FLS area=9 cm
2
) underwent plastic compression with a 90g load 
for 5 min.  Dry specimens were fractured transversely (perpedicular to the FLS 
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plane) to expose the internal structure along one edge. They were mounted vertically 
onto stubs, gold-palladium sputter-coated, and viewed in a JEOL 5500LV SEM.  
Collagen Compaction Assay 
 Activated carbon particles were used to examine the compaction of collagen during 
the compression process. Directly after neutralization, 10 mg of activated carbon 
(Aldrich, UK) was added to 3.5 ml of collagen. The solution was briefly agitated to 
achieve an even distribution and poured into the barrel of a 2 ml syringe (2-mL Luer 
BD syringe, ref 300185, Becton Dickinson, S. Agustin del Guadalix, Madrid, Spain) 
with its tip removed. After 30 minutes the syringe with the polymerized collagen gel 
was transferred onto double layer absorbent whatman paper. The gel was detached 
from the wall of the syringe with a spatula and allowed to self-compress (under its 
own weight). The compression process was filmed in real time with a digital photo 
camera (CANON IXUS 960 IS, Canon inc., Tokyo, Japan) and the images were 
analyzed with ImageJ (v.1.41, NIH, Bethesda, Maryland, US) by measuring the 
changing positions of 8 large carbon particles within the hydrogel, relative to the 
FLS, over time (15 min). The viscoelastic behavior of collagen gel in confined 
compression [215]  resulted in minimal gravitational force transfer on carbon 
particles, preventing any significant carbon particle accumulation towards the bottom 
of the gel during compression [44]. This ensured that carbon particle position was a 
reliable marker of local collagen gel compaction around each particle. 
Measurement of FLS hydraulic resistance 
 Collagen gels (volume = 5ml) were cast in round wells of 9cm2 surface area. 
Following setting and incubation, gels were compressed with a 10g load on a porous 
substrate, in this case water-soaked double layer Whatman paper, for 15 min. The 
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discharge (Q) through an area (A) of a compressing gel was calculated every minute, 
indirectly, by measuring the change of gel wet weight. The FLS hydraulic resistance 
(RFLS) was calculated by adapting Darcy’s law (Fig. 1A):  
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The discharge rate at the final stages of compression was extremely low and varied 
significantly between samples. To measure RFLS directly, a constant flux stirred cell 
ultrafiltration unit was used (Fig. 13) to deliver a set flow rate through collagen 
membranes (240±55 µm thick, calculated from histological specimens in cross-
section). For this a pressure of 1306 Pa was applied on collagen gels (5ml) for 5 min 
(giving ~96% fluid loss). The collagen membrane to be tested was assembled in a 
16.9 ml stirred cell, with a membrane area (A) of 5cm
2
. An integral HPLC pump 
capable of delivering flow rates in the range of 0.1-20ml/min was used to pump 
deionized water through the collagen membrane (Fig. 13). The flow rate (Q) was set 
at either 1or 9 ml/min and the transmembrane pressure (pressure difference across 
the collagen membrane, TMP) was measured by an on-line pressure sensor 
integrated with the HPLC. For flow rates of 1 and 9 ml/min TMP was measured to 
be 0.04 and 0.13 MPa, respectively, corresponding to a pressure gradient of 166 and 
540 MPa/m through the collagen membrane, respectively. No TMP fluctuations or 
declines were recorded, indicating that collagen membrane permeability remained 
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constant during testing. At least 5 samples were tested. RFLS was calculated using 
Darcy’s law equation: 
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Fig. 13 Schematic of experimental setup for stirred cell ultrafiltration unit, used to 
measure the hydraulic resistance of compressed (96% fluid loss) collagen gels 
(membranes).  
 
Measurement of FLS collagen density 
The attenuation of X rays, transmitted through a collagen gel, was used to provide 
information on water and therefore collagen distribution along the compression axis 
of the gel, for various levels of compression [238]. All specimens were tested by a 
laboratory microtomography system (Skyscan 1172), which was used to provide two 
dimensional X-ray digital radiograms. The scanner was equiped with a Hamamatsu 
113 
 
1.3Mp X-ray camera, which has a camera pixel size equal to 22.82 µm. The X-ray 
beam was produced using a source voltage equal to 70 keV, a source current equal to 
141 µA, and an aluminium filter 0.5 mm thick. The manufacturer software was used 
to control the scanning process and acquisition of the X-ray projections. The images 
were stored on the computer hard drive in 16-bits tiff files, which were converted to 
8-bits bmp files, which enabled quantitative analysis of the 256 grey values (0-black, 
256-white). Image analysis was carried out using Image J software (NIH). Collagen 
gels (10 ml) were cast in 9 or 3.66 cm
2
 round wells (gel diameter 3.45 or 2.2 cm 
respectively) and were then either left uncompressed (no fluid  loss) or allowed to 
compress under their own weight to remove 60, 80 and 98 % of their fluid. Four 
samples (of each gel diameter) were tested for each level of compression. Specimens 
were placed between 2 glass slides and mounted vertically, in the scanner chamber 
(Fig. 9A). This enabled better visualization of the FLS. We did not follow full micro-
tomography protocol, as measurement of required parameters was done successfully 
based on only single projections for each sample. The ratio of X-ray intensity 
relative to the densest area of the gel was calculated along the compression axis 
(relative X-ray internsity, Ir). For each sample, Ir along the compression axis (x-axis) 
was the average of three measurements of Ir at 3 positions (top, middle and bottom) 
along the gel’s vertical axis (Fig. 9A).  Importantly, the path length of material 
through which the radiation beam passed was the same for all points along the 
compression axis, irrespective of level of compression. X-ray intensity was inversely 
proportional to fluid (water) content along the compression axis of the gel. The gel 
was divided into 25μm thick layers (along the compression axis) and the volume of 
water per layer was calculated from the distribution of total water volume (measured 
as gel wet weight) along the compression axis. The collagen density in each layer 
114 
 
was then calculated as a % of the layer’s water content. FLS collagen density was 
taken as the average collagen density in the bottom 5 layers of the gel (i.e. the 
average of the 5 highest collagen density values). 
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CHAPTER 4 
ENGINEERING TOPOGRAPHY IN 3D COLLAGEN 
SCAFFOLDS: EXPANDING REGULATION OF EPITHELIAL 
CELL FUNCTION FROM SURFACES TO INTERFACES 
 
Topographic patterning provides a useful tool for regulating cell function, such as 
adhesion, proliferation, differentiation and contact-guidance. While current (e.g. 
lithographic) techniques allow precise control of topographic pattern (anisotropic vs 
isotropic) and scale (nano- vs micro-topography) , they are only applicable to 2D 
surface patterning, which compromises their relevance to 3D tissue engineering. In 
this study we developed a novel method for rapid fabrication of micro-textured 3D 
collagen scaffolds. We employed a two-step process to firstly increase matrix 
stiffness, by removing interstitial fluid from collagen hydrogels using Plastic 
Compression, followed by embossing a customized pattern template of parallel-
aligned phosphate-based glass-fibers on the scaffold’s surface. We hypothesised that 
varying the width and depth of the engineered grooves/ridges would directly 
influence epithelial (endothelial) cell responses (adhesion, orientation, elongation) in 
2D culture. Furthermore, we developed an in vitro model of the dermo-epidermal 
junction as an exemplar of engineered topography at an interface, to test its effect on 
epithelial (keratinocyte) cell responses (stratification, differentiation) in 3D culture.   
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4.1 RESULTS 
Topographic engineering by pattern template embossing 
We were able to produce pattern templates composed of two different phosphate-
based glass fibre (PBG) diameters by changing the pulling speed from 100 to 300 
RPM. There was a decrease in fibre diameter with increasing RPM speed, as 
expected. The 100 RPM fibres averaged out at approximately 53µm and the 300 
RPM fibres at approximately 36µm (table 1).  
 
 
Table 1.   Dimensions of grooves embossed in collagen substrates patterned with two 
different phosphate-based glass fibre diameters. Values of phosphate-based glass fibre 
diameter for the two pulling speeds tested (100 and 300 RPMs), as measured by light 
microscopy, and corresponding values of embossed groove width, as measured by 
SEM, and depth, as measured by AFM. Values represent the mean ± standard 
deviation (SD). For each RPM 30 fibres were tested, while for SEM and AFM 
measurements, five fields were analysed per construct (4-5 grooves/field), with 4 
constructs per condition. 
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Embossing the pattern template of parallel aligned PBGs onto the upper (i.e. non 
FLS) surface of compressed collagen sheets resulted in a regular pattern of grooves 
and ridges, as shown by SME (Fig.1). Average groove width, as quantified by SEM, 
was 30.5±3.3 and 49.5±11.6µm for 36µm and 53µm dameter fibres, respectively 
(table 1).  Average groove separation distance was 50-100µm, corresponding to the 
spacing of PBGs on the pattern template. Therefore, the pattern template was 
faithfully embossed onto the surface of collagen substrates.  
 
Fig.1 SEM and AFM analysis of patterned topography. Low (a) and high (b) 
magnification SEM images of patterned collagen substrates embossed with a pattern 
template comprising 36µm diameter fibres, showing a regular pattern of grooves and 
ridges.  
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(c) The 3D profile of patterned substrates was characterised by AFM. Panel (d) shows 
the tip of the AFM probe at a groove on the substrate surface. Panel (e) shows a digital 
snapshot of the imaging software used to analyse groove depth.  
 
AFM was used to characterize the profiles of embossed topographic features and to 
quantify groove depth.  This analysis confirmed successful embossing of a regular 
pattern of grooves and ridges on the surface of collagen substrates (Fig.1). Average 
groove depth was 0.95±0.49 and 1.55±0.31µm for 36µm and 53µm dameter fibres, 
respectively (table 1). There was a significant discrepancy between the values of 
groove depth measured by AFM and the expected values, calculated based on the 
values of groove width measured by SEM, as shown in Fig. 2. For 36µm diameter 
fibres expected groove depth was 8µm, while for 53µm fibres it was 17.7µm, i.e. 8 
and 11 fold difference, respectively. Therefore, while groove width could be 
precisely controlled by varying the fibre diameter, this method only allowed limited 
control over control of groove depth. 
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Fig.2 Schematic showing how the expected groove depth (d) can be calculated based on 
the groove width (x), measured by SEM and the radius (r) of the glass fibre embossed 
on the substrate surface, using the equation d=r-√ [r2- (x/2)2].  
 
2D culture model 
Human umbilical vein endothelial cells (HUVECs) were cultured on the surface of 
smooth (non-patterned) and patterned collagen substrates to test the effect of micro-
topography on endothelial cell adhesion, morphology and orientation. For 
quantification of cell adhesion HUVECs were seeded on smooth or patterned 
substrates at a density of 2x10
4
cells/cm
2
 and were allowed to attach for 4hrs before 
substrates were washed to remove non-adherent cells. Collagen substrates patterned 
with 36µm diameter fibres supported the maximum number of adherent cells, which 
was significantly higher than the number of cells adhering on smooth substrates and 
substrates patterned with 53µm diameter fibres (p<0.05) (Fig.3). There was no 
significant difference in cell adherence between smooth substrates and substrates 
patterned with 53µm diameter fibres.  
d 
x 
r 
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Fig.3 Comparison of HUVEC adhesion for smooth (non-patterned) substrates and 
substrates patterned with a template of 36µm or 53µm diameter fibres. Cells were 
seeded on substrates at a density of 2x10
4
 cells/cm
2
 and allowed to attach for 4hrs 
before washing substrates with PBS to remove non-adherent cells. Substrates were 
visualised using a light microscope. The number of cells per x20 microscopic field was 
counted manually. Five fields were analysed per substrate with 4 substrates tested per 
condition. Bars represent standard deviation of the mean,* p<0.05.  
 
Analysis of endothelial cell viability/proliferation, by Alamar blue assay, showed 
that endothelial cells did not proliferate on smooth or grooved collagen substrates 
over 48hrs of culture. Differences in cell number between smooth and grooved 
substrates at 24 and 48hrs were not significant (p>0.05) (Fig.4). These results 
indicated that while the presence of micro-patterns or their dimensions appeared to 
have no effect on cell proliferation, topographic patterning was not disruptive to 
endothelial cell viability.  
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Fig.4 Endothelial cell viability/proliferation on smooth substrates and substrates 
patterned with a template of 36µm or 53µm diameter fibres. Endothelial cells were 
seeded on each construct at a seeding density of 5x10
3
 cells/cm
2 
and cultured for 24 or 
48hrs. Cell number was quantified by Alamar blue assay. Four constructs were tested 
for each condition. Bars represent standard deviation of the mean. 
 
SEM was used to analyse the morphology and orientation of endothelial cells 
cultured on collagen substrates for 48hrs. While cells cultured on smooth substrates 
and substrates patterned with 53µm diameter fibres maintained a round morphology, 
the majority of cells cultured on substrates patterned with 36µm diameter fibres were 
more elongated and appeared to align with the direction of the grooves (Fig.5).  
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Fig.5 Endothelial cell alignement on collagen substrates with a patterned groove 
topography. SEM images showing single endothelial cells on the surface of smooth 
(non-patterned) substrates (a) and substrates patterned with a template of 36µm (b) or 
53µm (c) diameter fibres, 48hrs post seeding. While endothelial cells in images (a) and 
(c) have a round morphology, cells in image (b) appear elongated, aligning in the 
direction of the engineered grooves (arrows).  
Cell elongation index (ratio of cell major axis to cell minor axis) was almost 3 fold 
higher on substrates patterned with 36µm diameter fibres than on smooth substrates 
and substrates patterned with 53µm diameter fibres (Fig.6a). Furthermore, while 
65% of cells aligned with the groove direction on substrates patterned with 36µm 
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diameter fibres, only 10% of cells were aligned on substrates patterned with 53µm 
diameter fibres. This difference was statistically significant (Fig.6b). 
a) 
 
b) 
 
Fig.6 Endothelial cell orientation on smooth and patterned substrates. (a) Comparison 
of the cell elongation  index (ratio of cell major axis to cell minor axis) for endothelial 
cells cultured on smooth (non-patterned) substrates and substrates patterned with a 
template of 36µm or 53µm diameter fibres for 48hrs. (b) Comparison of the percentage 
of cells aligned with the direction of engineered grooves for substrates patterned with a 
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template of 36µm or 53µm diameter fibres. At least 10 random fields were analysed per 
sample, with 4 constructs tested per condition. Bars represent standard deviation of the 
mean,* p<0.05. 
 
3D culture model 
An in vitro 3D model of the dermo-epidermal (DE) junction was developed to test 
the effect of topography on epithelial cell responses at an interface. Collagen 
constructs were prepared as two layer mimics of native skin. A dense ‘dermal’ layer 
was developed by plastic compression of collagen gels seeded with human dermal 
fibroblasts (HDFs). Human keratinocytes were seeded onto the surface and 
constructs were submerged in media for 2 days before being raised to the air-liquid 
interface and cultured for an additional 12 days. One set of constructs was embossed 
with a regular pattern of grooves and ridges at the DE interface during the PC 
process, by embossing the putative interface of the HDF-seeded collagen gel with a 
pattern template of 36 or 53um diameter glass fibres (aligned parallel and 50-100µm 
apart) before keratinocyte seeding. The skin-like ECM construct formed rapidly, 
taking a maximum of 1 hour to fabricate and up to 14 days to culture keratinocytes to 
a multilayer. Histological analysis and immunofluorescence staining (anti-
cytokeratin AE1/AE3) indicated that in constructs with a smooth (non-paterned) DE 
interface a uniform, stratified and differentiated epidermis was formed by 2 weeks 
culture (Fig.7A, 9A). However, incorporating a micro-topography of grooves/ridges 
at the DE interface appeared to influence epidermal morphogenesis such that 
epidermal thickness increased at the grooves, while a thinner epidermis formed in 
the ridge/inter-groove regions. This pattern was consistent for both glass fibre 
diameters tested (36 or 53um) and for two sets of constructs, cultured over 2 and 3 
weeks (Fig. 7 C-F). 
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Fig.7 Incorporation of micro-topography at the dermo-epidermal (DE) interface 
influences keratinocyte stratification/differentiation. H&E-stained cross-sections of 
‘skin-like’collagen constructs seeded with HDFs and human keratinocytes and cultured 
for 2 (A, C, E) or 3 weeks (B, D, F). Constructs had either a smooth (non-patterned) 
DE interface (A,B) or were embossed with a regular pattern of grooves and ridges at 
the DE interface, by embossing the HDF-seeded ‘dermal’ layer with a template pattern 
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of 36um (C,D) or 53um (E,F) diameter glass fibres (50-100µm apart)  before 
keratinocyte seeding. Bars=100µm. 
 
In constructs with a smooth (non-patterned) DE interface, epidermal thickness was 
60±20µm after 2 weeks of culture (Fig.8). Constructs with a patterned DE interface 
showed a ~1.5 fold increase in epidermal thickness at the grooves (p>0.05) and a ~3 
fold reduction in thickness at the inter-groove regions (p<0.05) (Fig.8). For both 
fibre diameters tested epidermal thickness was significantly greater at the grooves 
than at the inter-groove regions at 2 weeks (p<0.05). Constructs cultured for 3 weeks 
showed an overall increase in epidermal thickness, regardless of the presence or 
absence of micro-topography at the DE interface. However, for patterned substrates 
the difference between epidermal thickness at the grooves and inter-groove regions 
continued to remain significant after 3 weeks of culture (p<0.05) (Fig.8).  
 
Fig.8 Effect of topography of the dermo-epidermal interface on epidermal thickness. 
Comparison of epidermal layer thickness in constructs with a smooth (non-patterned) 
DE interface or with a patterned DE interface, embossed with a template pattern of 
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36um or 53um diameter glass fibres, over 2 and 3 weeks of culture. Epidermal layer 
thickness at the groove and intergroove regions of constructs with a patterned DE 
interface was analysed separately. Three fields were analysed per H&E-stained cross-
section, with three sections per sample and three samples for each condition tested.  
Bars represent standard deviation of the mean, *p<0.05. 
 
Examination of cross-sections with a polarizing microscope showed that keratin was 
positively birefringent in all constructs tested, confirming formation of a cornified 
epidermis (Fig.9D-F). The optic axis of groove regions was parallel to the construct 
longitudinal axis, considered to be running perpendicular to the plane of construct 
cross-sections in the direction of the grooves, indicating that in groove areas keratin 
was oriented parallel to groove direction (Fig.9E, F). In contrast, keratin in smooth 
constructs and in ridge (inter-groove) regions appeared linearly oriented in the plane 
of construct cross-sections (Fig.9D, E), in the latter running perpendicular to groove 
direction, forming ‘cross-bands’ that connected adjacent grooves.  
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Fig.9 Analysis of epidermal differentiation and keratin structure in constructs with 
smooth and patterned dermo-epidermal interfaces. Immunofluorescence staining with 
anti-cytokeratin AE1/AE3 indicated that a stratified and differentiated epidermis was 
formed after 2 weeks culture for all conditions tested, i.e. constructs with a smooth 
(non-patterned) DE interface (A) or with a patterned DE interface, embossed with a 
template pattern of 36um (B) or 53um (C) diameter glass fibres (upper panel). Lower 
panel shows the positive birefringence of keratin in constructs with a smooth (non-
patterned) DE interface (D) or with a patterned DE interface, embossed with a 
template pattern of 36um (E) or 53um (F) diameter glass fibres. Dashed white lines in 
images D and E indicate the linear orientation of keratin in smooth and ridge (inter-
X-axis 
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groove) regions, respectively, while white circles in images E and F indicate the parallel 
orientation of keratin to the direction of the grooves, i.e. perpendicular to the plane of 
the image. 3D schematic shows the plane of cross-sections in grooved constructs, 
perpendicular to the direction of the grooves (X-axis denotes the longitudinal axis of 
the construct). 
 
4.2 DISCUSSION 
Original Hypothesis: Embossing a customised pattern template on the surface of 3D 
collagen hydrogel scaffolds will generate a permanent topography of controlled 
dimensions (width, depth, pitch). Surface topography will influence the attachment, 
morphology and orientation of endothelial cells cultured on acellular scaffolds (2D 
culture), while interface topography will influence the stratification of keratinocytes 
seeded on fibroblast-seeded scaffolds (3D culture).  
 
The purpose of this study was to develop a method for engineering topography in 3D 
collagen hydrogel scaffolds and to test its effect on epithelial cell function. Substrate 
topographic patterning is recognized as a powerful tool for regulating important cell 
functions such as cell alignment, proliferation and differentiation[73]. Topography 
could provide a biomimetic cell-stimulating cue because in vivo cells contact 
textured, not smooth interfaces[239]. Indeed, basement membranes of various tissues 
are composed of complex mixtures of nano-scale pits, pores, protrusions, striations, 
particulates, and fibers [101,239]. While current patterning techniques (e.g. 
lithography, micromachining) allow precise control of topographic pattern 
(anisotropic vs. isotropic) and scale (nano- vs. micro-topography), they are only 
applicable to 2D surface patterning, which inherently compromises their utility in 3D 
tissue engineering. Shifting the focus from flat surface (i.e. 2D) to interface (i.e. 3D) 
topographic patterning requires the ability to engineer the desired topography in 3D 
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scaffolds, which can be interstitially, as well as superficially, seeded with cells. The 
findings of this study indicate that it is possible to engineer topography in 3D 
plastically compressed collagen hydrogel scaffolds by incorporating an embossing 
stage during the compression process. While in this study we only engineered an 
anisotropic topographic pattern of grooves/ridges it would be possible, by pattern 
template customization, to produce any desired (e.g isotropic) topography. For 
example, a previous study by this group showed that it is possible to emboss an 
isotropic pattern of microgrooves on a collagen hydrogel’s surface by compressing it 
on a nylon mesh support with a fibrous structure ranging from <1 to >100µm[25]. 
Furthermore, application of uniaxial strain of 25% realigned this embossed 
topography into an anisotropic pattern of grooves parallel to the aligned strain [25]. 
Since the process is a plastic deformation, this restructuring of the surface was also 
plastic i.e. stable, suggesting that embossing and tension pre-alignment could be 
used in combination for converting initially isotropic into anisotropic topographies.   
 
The embossing method described here was successful in creating a regular pattern of 
grooves and ridges on the surface of collagen substrates, as shown by SEM and 
AFM. While it was possible to control groove width and periodicity with relative 
precision by controlling PBG fibre diameter and spacing, respectively, this was not 
the case for groove depth, where significant discrepancy was observed between 
expected and obtained values. The two proposed explanations for this effect are: 1) 
Pulling off the pattern template from the substrate surface following embossing 
could have resulted in some level of collagen recovery (elastic recoil), leading to the 
formation of shallower grooves. This is a likely possibility given the viscoelastic 
nature of collagen [44,215]. Indeed, we found that fixing the collagen substrate (in 
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glutaraldehyde solution for 1hr) prior to pattern template removal resulted in visually 
better retention of the embossed topography, as assessed by SEM (data not shown). 
This method, however, would compromise the ability to interstitially seed scaffolds 
with cells. 2)  The AFM method used to quantify groove depth required that the 
material was dehydrated prior testing, which must have affected the parameter being 
measured. It is therefore likely that both factors have contributed to some extent in 
this discrepancy. Future work should thus focus on developing fabrication, as well as 
quantification methods, for improving the precision of topographic depth control. 
For example, ongoing work by this group is investigating the effect of fluid flow 
direction during compression/embossing (i.e. embossing in the direction / against the 
direction of fluid outflow) on the stability of topographic features, while employing 
histological analysis for determination of feature depth.  
 
It is important to note that in the method described here the pattern template was 
compressed (for 2.5min) on a pre-compressed collagen gel i.e. a double compression 
process was employed (see Methods section). Fluid removal during the first 
compression stage (2.5min) resulted in an increase in average matrix stiffness 
modulus from 42.2kPa ±22 to 2240 kPa±846, as quantified previously using 
dynamic mechanical analysis [166] (note: the anisotropy of collagen density along 
the compression axis (Chapter 3) must have produced a higher stiffness at the FLS 
than the average matrix stiffness recorded by mechanical analysis). Therefore, 
embossing the pattern template on a stiff substrate resulted in faithful imprinting of 
the desired topography on the hydrogel’s surface. However, compressing the pattern 
template directly (for 5 min) onto uncompressed, compliant hydrogels only resulted 
in partial embossing of the intended pattern onto the surface (as assessed by SEM, 
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data not shown), suggesting that matrix stiffness modulus must exceed a given 
threshold for adequate retention of the embossed topography.  
The functionality of the engineered topography was first investigated using a 2D in 
vitro model, where endothelial cells were seeded on the surface of patterned or 
smooth collagen substrates.  We found that endothelial cells did not proliferate on 
either smooth or grooved collagen substrates, indicating that topography might not 
directly affect endothelial cell proliferation, as suggested by previous studies 
[240,241]. Endothelial cell adhesion was greater on substrates patterned with 36µm 
diameter fibres than on smooth substrates or substrates patterned with 53µm 
diameter fibres, suggesting that the dimensions of the engineered topography are also 
important. The increase in cell adhesion observed here when micro-groove 
dimensions (groove width) matched cell size, i.e. on substrates patterned with 36µm 
diameter fibres, was likely due to an increase in the level or strength of individual 
cell attachment zones[73]. Certainly, the micro-patterned surfaces present a greater 
surface area for cells to interact with or attach to the substrate, resulting in higher 
molecular interaction between the cells and the surface. Indeed, a previous study has 
shown that the dimensions of grooves/channels influence endothelial cell adhesion 
on nano-patterned surfaces under shear stress [241].  Endothelial cells cultured on 
substrates patterned with 36µm diameter fibres were also more elongated and 
showed greater alignment with groove direction than cells cultured on substrates 
patterned with 53µm diameter fibres. Since groove depth was not significantly 
different for the two fibre diameters tested (table 1), the observed difference in cell 
adhesion, morphology and orientation must have largely been mediated through the 
difference in groove width, which was significant (table 1). Indeed, it is well known 
that the scale of anisotropic topography plays an important role in deciding cell 
133 
 
behavior. Cell orientation generally increases with increasing groove depth [73,240], 
but decreases with increasing groove width or pitch. If pitch is large relative to cells 
(as was the case with substrates patterned with 53µm diameter fibres), cells may 
sense each ridge as an individual topographic feature to traverse [73].  Importantly, a 
previous study reported that maximum alignment of bovine aortic endothelial cells 
was observed for 1 µm deep channels [240], i.e. in the range tested in our study, 
suggesting that groove depth here was not a limiting factor for the observed cell 
behavior. Topographic scale has also been shown to affect whether cells bridge 
between ridges or conform to the grooves, through selective focal adhesion 
formation on ridge tops or down to groove floors [73,109]. At the microscale, with 
decreasing groove width and increasing groove depth, cells tend to bridge the ridges 
without descending into the grooves [73,109]. Investigation of such effects using the 
current method would require more precise control of the depth of topographic 
features. 
 
After establishing the functionality of the engineered topography in directing 
epithelial cell function on 2D surfaces, we further explored its potential in regulating 
cell behaviour in 3D interfaces, by reconstructing an in vitro model of the dermo-
epidermal (DE) junction. The ability to seed cells both interstitially and on the 
surface of micro-patterned collagen substrates, allowed  formation of a biomimetic 
interface, similar to the basal lamina found in native skin [239]. As with most 
tissues, the basal lamina in the skin is not a simple flat plane of connective tissue, 
rather it conforms to a series of ridges and invaginations known as rete ridges and 
papillary projections. In native skin, cellular microenvironments produced by the 
topographic features at the DE junction appear to regulate the spatial organization 
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and function of keratinocytes[242]. In skin with thin epidermis, such as foreskin, 
breast skin, and scalp, clusters of keratinocyte stem cells are found at the peaks of 
dermal papillae. Each stem cell divides to give rise to another stem cell and a 
transient amplifying cell that laterally migrates down into the rete ridges and 
undergoes 3–4 divisions producing postmitotic cells that migrate up from the basal 
layer to form differentiated features of the tissue. In contrast, skin with thicker 
epidermis, such as palmar epidermis, has longer dermal papillae and rete ridges 
which have clusters of epidermal stem cells at their bottom. Transient amplifying 
cells migrate up the basal layer as they produce postmitotic cells that, in turn, 
migrate to the surface of skin over a period of weeks, where they are eventually 
sloughed off. Although these cellular events are well characterized in native tissue, 
the underlying physiological or topographical mechanisms that mediate them remain 
unclear. In our study, immunohistological analyses showed that the epidermal layer 
in grooved substrates was composed of differentiated and stratified keratinocytes that 
conformed to the surface of the dermal layer, forming rete ridge-like structures 
comparable in dimensions to those observed in native skin. Moreover, stratification 
was enhanced in the groove regions, suggesting that epidermal organisation is 
critically influenced by the topography of the basal lamina. The topographical micro-
environment might influence keratinocyte differentiation/proliferation by affecting 
the spatial arrangement of cell–matrix contacts and/or cell-cell contacts [69], e.g. 
keratinocyte migration could be enhanced when cells have a non-attached dorsal 
surface. Indeed, it has previously been shown that expression of α2β1 integrin, a 
marker of epidermal stem cells, varies with topography such that high expression is 
found in patches of basal cells located on the tips of the dermal papillae (foreskin, 
scalp) or at the bottom of the deep rete ridges (palm) [243].  
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Previous studies have reported that keratinocyte stratification and differentiation 
increases as channel depth increases and channel width decreases[69,239]. However, 
in these studies photolithography and replica molding techniques were used to 
incorporate microtextured features into collagen membranes, preventing seeding of 
the membranes with fibroblasts. In our study, fibroblast-seeded collagen substrates 
were patterned using embossing micro-fabrication, which is a gentler method (plastic 
compression did not significantly reduce fibroblast viability[25]), enabling co-
culture of fibroblasts with keratinocytes. This is a key improvement from previous 
techniques, since it permits investigation of the effects of topography at a 3D cellular 
interface. Importantly, we found that culturing keratinocytes onto acellular (i.e. 
fibroblast-free) collagen substrates resulted in poor epidermal differentiation (data 
not shown), indicating that the presence of a fibroblast-seeded dermal layer is vital 
for normal epidermal morphogenesis. It has indeed been shown that activation of 
keratinocytes seeded on collagen matrices may depend, in part, on paracrine 
signaling from dermal fibroblasts[244]. In the presence of fibroblasts, keratinocyte 
proliferation is stimulated and epidermal morphology is improved. These 
interactions may be mediated through cytokines such as keratinocyte growth factor 
(KGF), a fibroblast-secreted growth factor that regulates epithelial cell growth. 
Ponec and colleagues found that in keratinocyte cultures on scaffolds, without 
fibroblasts, no proliferative cells were detectable in the epidermis after 2 weeks at 
the air/ liquid interface. Such epidermis consisted of only three or four viable cell 
layers[244]. These findings emphasise the principle that engineering truly 
biomimetic constructs will require development of micro-textured 3D scaffolds that 
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can be interstitially, as well as superficially, seeded with cells (i.e. on either side of 
the patterned topography).  
 
The 3D model of the DE junction presented here may also be useful for investigating 
the critical topographical features of skin that contribute to its mechanical stability. 
In areas of the skin exposed to high friction/loading (i.e. shear at the plantar and 
palmar surfaces), the dermal papillae and epidermal ridges are longer and more 
numerous, suggesting that the enhancement of the interface between the epidermis 
and dermis provides additional mechanical stability[245]. For example, it has been 
shown that thickened cornified epithelium such as the human callus contains surface  
ridges and grooves, and that the cross-bands between ridge and groove areas form a 
fairly regular lattice-like pattern [245]. This lattice-like pattern comprises an 
additional structural modification of the keratin in the submicroscopic dimension, as 
keratin is oriented in the direction of the grooves and ridges (Fig.10) [245]. This was 
indeed in agreement with the findings of our study (Fig.9E).  
 
 
Fig.10 Schematic showing oriented areas of keratin in human callus. Broken lines 
indicate the direction of orientation of keratin fibres in groove and inter-groove regions 
of the callus (Reproduced from Matoltsy et. al., 1955 [245]. 
 
137 
 
It is proposed that this lattice structure functionally increases the mechanical strength 
of the stratified squamous epithelium, as well as assuring iso-dimensional 
mechanical and physical responses to mechanical stress. A microfabricated basal 
lamina that creates a complex interdigitating interface between the epidermal and 
dermal layers might therefore be expected to improve the resistance of engineered 
skin substitutes to failure under shear forces. By testing the properties of skin 
equivalents incorporating rete ridges and dermal papillae of various geometries, it 
should be possible to establish a direct and quantitative correlation between 
topography and mechanical properties. Moreover, these studies can be extended to 
the molecular level by examining the distribution/numbers of known adhesive 
proteins such as integrins and hemidesmosomes.  
 
Engineering such complex interfaces might also facilitate improved mass transport 
of nutrients and growth factors to the epidermis (e.g. by providing a greater surface 
area for transport/ diffusion) [69], potentially aiding the surgical take of tissue 
engineered skin substitutes (i.e. integration to host tissue margins). Furthermore, 
since the embossing microfabrication technique presented here can be used to create 
more complex patterns, it should be possible to mimic the fine lines and pore 
structures of native skin (e.g. hair follicles, glands etc.), thus creating more ‘natural’ 
and perhaps cosmetically acceptable skin constructs. 
 
4.3 CONCLUSIONS 
This study presents a novel method for engineering topography on 3D collagen 
scaffolds. Pattern template embossing ensures rapid, faithful fabrication of a desired 
topography, while importantly maintaining the viability of cells seeded within the 
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collagen matrix. This effectively enables interstitial, as well as superficial cell 
seeding of patterned scaffolds, therefore fulfilling the pre-requisite for expanding 
topographic control of epithelial cell functions from 2D surfaces to 3D interfaces. 
This represents a new strategy for engineering in vitro 3D models of biomimetic 
tissue interfaces (e.g. basement membranes), to investigate the effects of topography 
on epithelial cell behaviour, with important implications for regulating cell function 
in engineered 3D tissue constructs.  
 
4.4 MATERIALS & METHODS 
Pattern template production 
Glass fibre production 
Glass for PBG preparation was obtained by using NaH2PO4, CaCO3, P2O5 and Fe2O3 
(BDH, UK) as starting materials. The precursors were weighed out and then placed 
into a 200 ml volume Pt/10% Rh crucible type 71040 (Johnson Matthey, Royston, 
UK). The crucible was then placed into a Carbolite furnace at between 950 
0
C and 
1050 
0
C for 1hr. The glass was poured into a graphite mould, which had been 
preheated to 350 
0
C. The mould was placed back into the furnace and left to slowly 
cool to room temperature, to remove any residual stress. The glass rods obtained 
from the mould, of final composition P50C30N15Fe5, were cut into disks of 15mm 
diameter, and 2mm thickness, using a Testbourne diamond saw. Glass fibres were 
obtained using a fibre drawing method, from a newly acquired Fibre-rig 
(Biomaterials Department, UCL). The fibre-rig consists of a top loading furnace 
(Lenton Furnaces) with a Pt/10% Rh crucible (Johnson Matthey, UK) consisting of a 
bushing with an approximate 1mm hole, and a tip approximately 15mm long. Glass 
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was placed into the crucible and left for an hour to melt and to homogenise. The 
temperature of the furnace was then dropped to achieve a viscosity suitable for 
fibrisation of the glass. Different fibre diameters were obtained by pulling the glass 
at different RPMs. To obtain fibres of ~35 µm diameter 300 RPMs were used, while 
for fibres of ~55 µm diameter 100 RPMs were used.  
 
Determination of glass fiber diameter 
To measure fiber diameter, a small bundle of parallel aligned fibres from each RPM 
were placed into a PTFE mould and covered with resin (Struers, UK). The resin was 
then polished and examined under a light microscope, which was attached to a 
CoolSnap Digital Image Analysis system (ISS Group Ltd, Manchester). Image Pro 
Plus software was used to measure the diameter of the fibres in microns. The mean 
values presented and the errors were calculated from measurements on 30 fibres. 
 
Pattern template preparation 
Unidirectional parallel aligned fibres (35 or 55 µm diameter) were arranged in 
bundles (~200 fibers) with a constant spacing of 50-100µm (Fig.11a,b). Bundles 
were held in place by fixing each edge of the bundle using cyanoacrylate glue. 
a)                                                           b) 
                  
Fig.11 Pattern template used for embossing. (a) Macroscopic view of a phosphate-
based glass (PBG) fibre pattern template, comprising of parallel aligned fibres.  (b) 
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Light microscope image of the same pattern template showing parallel aligned fibres 
(35µm diameter) with a constant spacing of 50-100 µm (bar=100µm). 
 
Microtextured topographic patterning of collagen constructs 
Pattern template embossing 
Collagen gels were prepared as previously described [210] (see Chapter 2). 
Following setting and incubation, gels were compacted for 2.5 min by a combination 
of compression and blotting, as shown in figure 12a. This led to formation of a flat 
collagen sheet (~100 µm thick) protected between two nylon meshes. (Note: for 
control smooth/non-patterned constructs the duration of this first stage of 
compression was 5 min, as they did not undergo a second stage of embossing 
compression - see below). Following plastic compression of collagen hydrogels 
(2.5min), the resulting dense collagen sheets underwent a second stage of 
compression, during which a pattern template of parallel aligned phosphate-based 
glass fibres (PBGs) was embossed onto their surface. After the first compression, the 
top nylon mesh was removed and constructs were turned over and placed onto the 
PBG pattern template, which was in turn placed on double layer absorbent Whatman 
paper. Note that in this arrangement the non-FLS was in contact with the pattern 
template. Constructs were compressed for 2.5 min using a 120g load (Fig. 12b). The 
pattern template was then removed and the constructs were fixed in 2.5% 
gluteraldehyde for 1 hr.  
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Fig.12 Schematic showing the two-step process used to create micro-topography on the 
surface of collagen scaffolds. During the first step of the process collagen hydrogels 
underwent compression under fixed mechanical loading over a porous (blotting paper) 
support to remove the majority (~98%) of their interstitial fluid, resulting in formation 
of ~100 µm thick collagen sheets. In the second step of the process, dense (~20% 
collagen w/w) collagen sheets underwent a second stage of compression, during which a 
pattern template of parallel aligned phosphate-based glass fibres was embossed onto 
their surface, resulting in the formation of a  topographic pattern of parallel 
grooves/ridges.   
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SEM analysis of engineered topography 
Conventional SEM (Philips CM12 electron microscope; Agar Scientific, UK) was 
used to study the micro-groove topographic pattern embossed on the surface of 
collagen constructs. After embossing constructs with a 35 or 55 µm diameter fiber 
pattern template, constructs were prepared for scanning electron microscopy as 
previously described (see Chapter 2). Five fields were randomly selected per 
construct, with 4 constructs used for each condition. SEM images were analysed for 
quantification of the width of patterned grooves, using an imaging software (Image J, 
NIH, USA).  
 
AFM analysis of engineered topography 
Atomic Force Microscopy (AFM) was used in this study to quantify the depth of 
grooves once the PBG pattern template was embossed on the collagen scaffold 
surface. 
Basic principles 
Atomic force microscopy, or scanning force microscopy, is a relatively new 
technique that was initially proposed in 1986 by Binnig et al [246]. Only in the 
1990s did it become widely used. AFM, unlike usual microscopy, creates an image 
by 'feeling' the surface of material and not by seeing it directly as in optical 
microscopy. Pictures are obtained by measuring small vertical displacements of the 
probe scanning along the surface. These deflections are caused by number of forces 
(chemical, capillary, Van der Waals, etc.) and can be measured using Hooke's law. 
Several approaches were suggested of how to detect the tip displacement (e.g. 
capacitive sensing, optical interferometry) but typically the laser spot displacement is 
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used. The laser beam is focused on the tip and reflected onto the quartered 
photodiode detector. When the tip is displaced it results in a change in the laser spot 
position on the quartered surface of the sensitive photodiode, that makes possible to 
measure either normal and lateral motions of the tip. This complex signal goes 
through a differential amplifier into a feedback loop which maintains a pre-
programmed parameter (deflection or amplitude) as a constant by manipulating with 
a piezo scanner (usually tubular type is used) (note: this is not the only possible 
design of the instrument but all of them consist of the same tip scanning deflection 
mechanism). 
 
AFM modes 
AFM can be used in several modes and conditions (liquid, air or vacuum), but in 
terms of this study tapping or contact AFM in air was used. Contact (in air) mode of 
AFM is performed by probe scanning along the surface in constant contact with it. 
Deflection of probe in each point, caused by surface features, is measured and 
maintained as a constant by feedback loop mechanism and after computer processing 
recorded as an image. Spring constant of probes used is in the range 0.01 - 1.0 N/m 
and typical interaction forces are of the order of 1nN. In contrast with contact, in 
tapping (air) mode stiffer probes are used within the range of 30 - 60 N/m and 
interaction forces of about 0.1 nN are applied. Here the tip is oscillated with a 
frequency close to the natural resonance and the amplitude is reduced as the tip 
approaches the surface. The reduced amplitude is measured and maintained at a 
constant level by feedback loop. 
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AFM limitations 
As well as many other techniques AFM has its limitations. There are some common 
problems of all modern electronic methods: thermal drift, stability of amplifiers, 
bandwidth etc. Due to high sensitivity of ultra small displacement measurements, it 
is very sensitive to background vibration, which should be eliminated. But there are 
some problems specific to AFM, which should be taken into account, such as tip 
effects. There are several tip effects that can be outlined: tip broadening (arising 
when the radius of probe curvature is comparable with the radius of the feature being 
measured), compression (some soft biological materials show dependence of width 
upon the pressure applied), tip convolution effects (which can be seen with a 
collagen sample, where the fibre appears as a hilly structure on the surface and not as 
a cylindrical object), multiple tip effects (the features observed on the image are 
multiplied). Importantly, in terms of this study, samples had to be dehydrated prior 
testing, which expectedly must have affected the parameter being measured (i.e. 
groove depth). This effect was likely a major contributing factor for obtaining a 
lower value for groove depth than expected from groove diameter measured by SEM 
(see results).  
 
AFM image analysis  
Five fields were randomly selected per construct, with 4 constructs used for each 
condition. Images were analysed for quantification of the depth of patterned grooves 
by measuring the distance from the bottom of each groove to the tip of the lowest of 
the two ridges, using an imaging software (WSxM 2.2., Nanotec Electronica S.L., 
Spain). 
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Endothelial cell cultures 
For cell attachement and orientation studies HUVECs were seeded on non-patterned 
or patterned collagen substrates (surface area=3.66cm
2
) at a seeding density of 2x10
4
 
cells/cm
2
. This seeding density ensured that there was no direct cell-cell contact. For 
quantification of cell attachment cells were allowed to attach for 4hrs before 
substrates were washed twice with PBS (5ml) to remove non-adherent cells. For 
quantification of cell orientation and elongation cells were cultured on substrates for 
48hrs before being washed with PBS and fixed in 100% ice-cold methanol and 
processed for SEM.  For analyses of cell proliferation HUVECs were seeded on non-
patterned or patterned collagen substrates (surface area=3.66cm
2
) at a seeding 
density of 5x10
3
 cells/cm
2 
and cultured for 24 or 48hrs. Medium was removed from 
all culture wells every 24hrs and 5ml alamar blue (Serotec, UK) solution (diluted 1 
in 10 with phenol-red free culture medium) was added. The collagen matrices were 
incubated in alamar blue solution at 37°C for 4 hrs. Alamar blue solution was then 
removed and 100 µl was sampled from each well. Samples were transferred into a 96 
multiwell plate and absorbance readings were taken at 510 and 590 nm using a 
microplate spectrophotometer (MR 700 microplate reader, Dynatech Laboratories). 
Readings were converted to cell number using a standard curve. The collagen 
matrices were washed in PBS (for 5 min, twice) before fresh medium (5ml) was 
replaced, allowing monitoring to continue. Four constructs were tested per condition. 
Quantitative morphometric analyses 
For quantification of HUVEC attachment, substrates were visualised using an 
Olympus BX41 light microscope and images were captured with an Olympus DP70 
CCD camera. The number of cells per x20 microscopic field was counted manually. 
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Five fields were randomly selected per substrate, with 4 constructs tested per 
condition. For quantification of HUVEC orientation SEM images were analysed 
using an imaging software (Image J, HIH, USA) to calculate the cell orientation 
angle. This was defined as the angle between the direction of the major axis in the 
cell and the direction of the groove and ranged between 0 and 90 degrees. Cells were 
considered to be aligned parallel to the ridges/grooves when cell orientation angles 
were less than 20° and non-aligned if angle was 20-90
o
. HUVEC elongation was 
quantified by calculating the ratio between the major and minor axes of each cell. 
The major and minor axes were defined by the long direction of the cell body and the 
direction perpendicular to the major axis, respectively. The ratio of cell major axis to 
cell minor axis was used to define an elongation index. At least 10 random fields 
were analysed per sample, with 4 constructs tested per condition.  
 
Development of skin equivalent 
Dermal layer 
The dermal layer of the skin equivalents was developed by Plastic Compression (PC) 
of collagen hydrogels seeded with 2x10
5
 human dermal fibroblasts (HDFs) (<10 
passages). Compressed HDF-seeded collagen matrices were peeled off the nylon 
meshes and placed in cell culture inserts (BD Falcon, Stockholm, Sweden). A 
topographic pattern of parallel 3D micro-ridges was embossed into the putative 
dermal-epidermal (DE) interface, by embossing the dermal layer with a pattern 
template of phosphate-based glass fibres (PBGs), as described above. For control 
constructs with a smooth DE interface, 5 min of conventional plastic compression 
was used.  
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Epidermal layer 
Human primary keratinocytes were seeded onto the surface of compressed collagen 
gels at seeding density 150 000 cells/cm
2
 and constructs were submerged in 5 ml 
KER- medium (80% DMEM, 20% HAM’s F12, 2% glutamine, 10% FCS, 0.2% 
hydrocortisone, 0.1% insulin, 0.1% T3/T, 0.1% choleratoxin, 2.5% adenine) for 2 
days before being raised to the air-liquid interface and cultured for an additional 12 
days (2 weeks culture) or 19 days (3 weeks culture) in KER+ (EGF 10 µg/ml added 
to the KER- medium).  
  
Histology and immunohistochemical staining 
Histological and quantitative morphometric analyses 
After 12 or 19 days of culture, the collagen constructs were fixed and processed for 
routine histology (see Chapter 2).  Cross sections were H&E stained and 
epithelialisation was determined with an Olympus BX41 microscope. Three fields 
were measured per section, three sections per sample and three samples for each 
condition were tested.   The thickness of the stratified epidermal layer in each 
channel and between channels was measured vertically from the lower surface of the 
stratum basale to the outer edge of the stratum corneum, using an imaging software 
(Image J, NIH, USA).  
Immunostaining for PAN-cytokeratin 
To verify differentiation of the epidermis in the skin equivalent, 
immunohistochemistry targeting human epidermal cytokeratin was performed. After 
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dewaxing and serum blocking, the sections were incubated with primary antibody 
(Mouse anti-cytokeratin AE1/AE3, Chemicon International, UK) for 30 minutes at 
room temperature, rinsed in PBS, and incubated with secondary antibody (Alexa 
Fluor 488, Molecular probes, Inc. OR, USA) for 30minutes (see Chapter 2). AE1 
reacts with the acidic keratins, while AE3 reacts with the basic keratins. After 
washing, bound antibody was localised using a fluorescence Olympus BX41 
microscope at approximate absorption 495 nm, and fluorescence emission 519 nm, 
and captured using a Olympus DP70 CCD camera. For each condition, at least three 
samples of collagen constructs were examined.  
 
Polarized light microscopy 
For the polarization optical studies an Olympus BX41 polarizing microscope was 
used. The sign of birefringence was determined by means of a first order red 
retardation plate. Birefringence was referred to the optic axis of a component 
structure, or to a characteristic structural feature, in the epidermal layer of H&E-
stained construct cross sections. Sections were cut perpendicular to the construct 
surface and to the direction grooves (in embossed constructs).  
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CHAPTER 5 
 
CONTROLLING COLLAGEN MATRIX STIFFNESS: A TOOL 
FOR REGULATING CELL PROLIFERATION 
 
Human dermal fibroblasts (HDFs) in free floating collagen matrices show minimal 
proliferation, though this may increase when the matrix is ‘under tension’. We have 
investigated the detailed mechanics underlying one of the possible controls of this 
important cell behavior, in particular the idea that this is a response to substrate 
stiffness. Hyper-hydrated collagen gels were plastically compressed to give a pre-
determined collagen density and stiffness, resulting in a series with increasing 
stiffness modulus. Using these physiologically relevant, biomimetic 3D ECMs we 
tested the hypothesis that matrix stiffness directly regulates the proliferation rate of 
resident adult HDFs. Mechanical properties were tested using a Dynamic mechanical 
analyser; and cell number by Alamar Blue assay (see Methods section). 
5.1  RESULTS 
Fibroblast proliferation in free floating and attached matrices 
Consistent with the previous literature [127,247] we found that fibroblasts cultured 
in free floating collagen matrices at an initial cell density of 4x10
4
 cells/ml showed 
no proliferation after 8 days of culture (Fig. 1). In contrast, fibroblasts cultured at the 
same initial cell density and in the same matrices, but attached (i.e. matrices were 
allowed to develop isometric tension), showed some proliferation (doubling time of 
6 days) after an initial lag period of 4 days (Fig 1). 
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Fig. 1. Proliferation of adult human dermal fibroblasts cultured in attached and free 
floating (FF) collagen matrices.  Fibroblasts were cultured for eight days. Proliferation 
was assessed using the alamar blue assay. Initial cell density was 4x10
4
 cells/ml for both 
conditions. 
 
Similar patterns of growth were also seen at a higher initial seeding density (1x10
5 
cells/ml: data not shown). This agrees with previous findings and indicates that the 
alamar blue technique is an effective method for quantification of cell growth in 
collagen gels.   
Correlation of matrix collagen density with stiffness modulus 
Since the objective here was to test the effect of matrix stiffness on cell proliferation, 
we measured the change in Young’s modulus for collagen gels compressed to three 
different levels of fluid loss (50, 75 or 99% fluid removal). This process produced 
collagen matrices with 0.4, 0.7 and 20% (w/w) collagen density, respectively (see 
methods). Dynamic mechanical analysis established that increasing the collagen 
matrix density resulted in proportionately higher matrix stiffness (Young’s modulus) 
(Fig.2). There was a more than fifty fold increase in the modulus between the 20% 
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collagen gels (2240 ±846 kPa) compared to 0.4% gels ( 42.2 ±22 kPa) (P<0.05), 
which interestingly corresponded with an almost identical (50 fold)  increase in 
collagen density.  
 
 
Fig. 2. Correlation between matrix collagen density and stiffness modulus. Mean 
Young’s moduli as measured by dynamic mechanical analysis (DMA) for collagen 
matrices compressed to 50, 75 and 99% fluid removal, corresponding to 0.4, 0.7 and 20 
% (w/w) collagen density. Three collagen constructs were tested for each level of 
compression (n=3), *p<0.05.   
 
Effect of increasing matrix stiffness of fibroblast proliferation 
Fibroblasts cultured in compressed matrices with a collagen density of 20% w/w 
(modulus of 2240 ±846 kPa), at an initial seeding density of 1x10
6 
cells/ml, showed 
rapid proliferation without any lag period. Doubling time was 48hrs (p<0.05) (Fig 
3a). Proliferation rate was seeding-density dependent (though never showed a lag 
152 
 
phase) with a doubling time of 96 hrs at an initial seeding density of 4x10
6 
cells/ml 
(Fig 3b) and zero net growth in matrices seeded with 20x10
6 
cells/ml, indicating that 
this was the cell density at which cell-cell contact inhibition occurred in this 3D 
system (Fig 3c). Indeed, at this high seeding cell density, cell number showed a 
cyclical pattern over the first 6 days, indicating that growth is initiated once cell 
density (i.e. cell-cell contact inhibition) is reduced. However, a negative trend in cell 
number seemed to be established, such that by 8 days cell number was 50% lower 
than at the beginning of culture (p<0.05). Cell death, in this case, could be the result 
of apoptosis or necrosis.  
 
 
Fig. 3. Proliferation of adult human dermal fibroblasts in PC collagen gels. 5ml 
collagen gels were plastically compressed with a 120g load for 5min resulting in >99% 
fluid removal and 20% (w/w) collagen density. Initial cell densities immediately after 
compression were (a) 1x10
6 
cells/ml, (b) 4x10
6 
cells/ml and (c)20x10
6 
cells/ml. Asterisk 
indicates significant increase in cell number from day 0 to day 2 (a) and significant 
decrease from day 0 to day 8 (c) (*p<0.05).  
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Having established that collagen matrix stiffness correlates directly with fibroblast 
proliferation in three-dimensional culture, we tested the hypothesis that there was a 
continuous, graded relation between proliferative response and stiffness rather than 
the effect of a threshold stiffness, above which fibroblast division is initiated. 
Fibroblasts were cultured in collagen matrices of 0.2, 0.4 or 0.7 % collagen density 
at the same initial cell density of 4x10
4
 cells/ml. Figure 4a shows that greater 
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proliferation (87% increase in cell number) was observed in matrices of 0.7% 
collagen compared to matrices of 0.4 % collagen (25% increase in cell number), 
after 2 days of culture. As expected, no proliferation was observed in matrices of 0.2 
% collagen (uncompressed free floating). A similar pattern of growth was observed 
after 6 days of culture (Fig 4b).  These results indicate not only that cell proliferation 
responds in a graded manner to matrix stiffness but that it is also highly sensitive to 
relatively small absolute changes in matrix stiffness (note: collagen densities of 0.4% 
and 0.7% resulting in matrix stiffness of 42 kPa and 143 kPa, respectively, are within 
the physiological range[248]).  
 
 Fig. 4. Effect of increasing matrix stiffness on fibroblast proliferarion. Proliferation of 
adult human dermal fibroblasts in collagen matrices of 0.2, 0.4 and 0.7% collagen 
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density (w/w). Initial cell densities immediately after compression were 4x10
4
cells/ml 
for all three conditions. Mean percentage increase in cell number over (a) a two day 
(day 0 to day 2) or (b) a 6 day (day 0 to day 6) culture period.  
 
Reversal of fibroblast quiescence  
These results provide evidence that fibroblast proliferation is directly regulated by 
the stiffness of the matrix in which the cells reside. However, in the previous 
experiments, fibroblasts were seeded within matrices that were compressed at day 0 
of culture, and thus any signaling relating to extracellular matrix stiffness was 
present at the initial stage of the growth response. Previous studies indicated that 
quiescent fibroblasts in free floating gels are in a distinct state (they become arrested 
in the Go phase of the growth cycle) and that their lack of growth is not due to cell-
cell contact inhibition or deficiency of growth factors [249]. To examine whether 
this represents a permanent change in cell behaviour or an example of dynamic (i.e. 
reversible) cell regulation, we examined the proliferation of fibroblasts where matrix 
stiffness was increased in situ at specific time points in the culture period. 
Fibroblasts were seeded at 4x10
4
 cells/ml and cultured in free floating matrices. As 
expected, no proliferation was observed after 24 hours (Fig 5). The first set of 
matrices was then compressed in situ (after 24 hours) to give a collagen density of 
20% (w/w) and returned to culture (we have previously shown that the Plastic 
Compression process does not cause any cell death [25]). Within the next 24hrs (day 
2 of culture), fibroblast proliferation was significantly increased (by 62%, p<0.05) in 
in situ compressed but not in uncompressed matrices. Similarly, in situ compression 
of free floating matrices on day 5 initiated proliferation within 24hrs. It is important 
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to note that while matrix compression itself inevitably increases cell density, this did 
not block proliferation, as might have been expected if cell-cell contact inhibition 
was a limiting factor. This indicates that fibroblast quiescence in free floating 
matrices cannot be a consequence of the increased cell density due to cell-mediated 
matrix contraction, as sometimes suggested. 
 
 
Fig. 5. In situ plastic compression of free floating matrices reverses human dermal 
fibroblast quiescence.  Fibroblasts were seeded in free floating matrices at an initial cell 
density of 4x10
4
 cells/ml. Collagen matrices were taken out of culture and compressed 
on day 1 or day 5 (arrow) before being returned to culture. A set of gels was left in 
culture for 8 days, without compression at any point (for each condition three gels were 
tested). Asterisk indicates significant difference in cell number between compressed 
and uncompressed matrices (*p<0.05) at day 1 and day5.    
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5.2 DISCUSSION 
Original Hypothesis: The stiffness of collagen hydrogels will be directly related to 
their collagen density and therefore to their hydration level. The proliferation rate of 
human dermal fibroblasts (HDFs) will be closely related to collagen matrix stiffness 
such that stiffer matrices will support higher proliferation rates. 
 
The purpose of this study was to investigate whether cell proliferation is directly 
regulated by matrix stiffness. It has already been established that fibroblasts cultured 
in free floating matrices divide very little and undergo apoptosis[128]. In contrast, 
cells cultured in attached matrices begin to divide after a lag period of approximately 
four days. While this observation indicates that mechanical loading stimulates cell 
division, and inversely that loss of mechanical tension inhibits proliferation and 
induces apoptosis, the effects of matrix stiffness on cell proliferation have yet to be 
isolated. Using plastic compression to rapidly remove fluid out of collagen 
hydrogels, we have been able to precisely control matrix stiffness. Fibroblasts seeded 
within matrices of high stiffness began to divide rapidly with a doubling time of two 
days. Expansion was seeding density-dependent with inhibition of cell proliferation 
been observed at 1x10
6
 cells/ml.  At such high seeding density, cell-cell contact 
inhibition likely becomes significant. HDF proliferation was related to matrix 
stiffness such that increasing matrix stiffness lead to increasing proliferation rates 
from 5 to 3 days doubling time, and this in turn related to increasing matrix stiffness 
modulus. Since there was a 50 fold difference between the stiffness of the most 
compliant and stiffest substrates, this indicates that cells respond to a wide range of 
stiffness levels, as it has previously been suggested[125]. 
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Previous studies employing two dimensional substrates have indeed implicated 
matrix stiffness as a significant factor influencing cell proliferation [125,250]. Direct 
regulation of cell proliferation by matrix stiffness within a biomimetic, three-
dimensional environment has not previously been tested. It is important to note that 
compression of collagen matrices, as a means of controlling stiffness, does not alter 
the tension within the matrix, thus enabling the isolation of any effects of stiffness on 
cell behaviour.  It has been proposed that the magnitude of tractional forces 
fibroblasts exert on their substrate may influence cell proliferation, and that 
fibroblast quiescence in compliant hydrogels is related to their failure to exert strong 
tractional forces[125]. It has also been previously shown that fibroblasts which have 
lost contact with their surrounding extracellular matrix, undergo reversible growth 
arrest [251]. On the other hand, Niland et al have demonstrated that fibroblasts 
display a marked reduction of apoptosis in mechanically relaxed (i.e. contractile) 
collagen matrices in the presence of adhesion-blocking antibodies against α1β1 or 
α2β1 integrins, while cells lacking alpha2 integrin displayed no apoptosis [252], 
suggesting that cell-matrix interactions are important for cell survival/growth in 
natural ECMs. In our system, increasing stiffness by increasing matrix collagen 
density, inevitably resulted in alterations in the number of binding sites and thus in 
cell-matrix interactions. This would ultimately lead to changes in the expression of 
genes related to cell division [253].  
Previous studies indicated that quiescent fibroblasts in free floating gels are in a 
distinct state, as they become arrested in the Go phase of the growth cycle[254] and 
that their lack of growth is not due to cell-cell contact inhibition or deficiency of 
growth factors [249]. In addition, PDGF receptor desensitization and disruption of 
the ERK signalling pathway have been observed in quiescent fibroblasts in free 
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floating matrices[137,138,255-257]. Here we show that increasing matrix stiffness at 
specific points during the culture period initiates cell proliferation. This finding 
indicates that fibroblast quiescence in free floating matrices, and presumably the 
mechanism(s) that facilitates this,  represents an example of dynamic (i.e. reversible) 
feedback regulation. Since matrix compression itself inevitably increases cell 
density, but does not block growth, this also provides supportive evidence against 
the idea that fibroblast quiescence in free floating matrices is a consequence of the 
increased cell density due to cell-mediated matrix contraction[249].  
Regulation of cell proliferation by matrix stiffness could have important implications 
in our erstanding of the mechanisms mediating wound healing. Unlike fibroblasts of 
dermis that are quiescent and stationary, fibroblasts of granulation tissue are 
proliferative and motile[258]. During repair, tensile forces develop within the matrix 
of the wound bed. Fibroblasts in a mechanically loaded (attached) matrix resemble 
proliferating cells of granulation tissue, and the isometric tension that develops is 
equivalent to that found in skin wounds. In this study, we have shown that matrix 
stiffness, rather than tension, can itself directly regulate cell division, thus potentially 
providing an additional mechanism for controlling cell proliferation within the 
wound bed. As normal repair progresses, tensional force is normally relieved 
through a combination of biosynthetic activity and wound contraction and the cells 
of granulation tissue disappear over a period of weeks. This removal of cells happens 
at least in part via apoptosis[133,134]. In skin tissues, the development of 
hypertrophic scars after burns or other skin trauma is characterized by a non-
disappearance of myofibroblasts [259] and an overproduction of extracellular 
matrix[260]. A lack of apoptotic induction is thus thought to be a prominent factor in 
this phenomenon [261]. Our findings indicate that increasing matrix stiffness during 
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hypertrophic scarring could also induce excessive cell proliferation and, together 
with the lack of apoptosis could contribute to the excessive cellularity and 
contraction associated with hypertrophic scars. This hypothesis is consistent with the 
finding that fibroblast proliferation in vivo is increased in keloid scars which are 
characterized by excessive collagen synthesis within the wound, and thus higher 
matrix stiffness [262,263].  
 
5.3 CONCLUSIONS 
The ability to control the hydration level of a collagen hydrogel scaffold provides a 
means for controlling its collagen density which is directly related to matrix stiffness 
modulus. In this study we have shown that adult HDFs cultured within 3D collagen 
matrices proliferate preferentially within stiffer matrices, while the quiescence of 
HDFs observed in compliant matrices is reversible by increasing matrix stiffness. 
These findings represent an important advance in our ability to test regulated cell 
proliferation with important implications for improving our understanding of the 
mechanisms governing wound healing and designing engineered connective tissues 
based on collagen and other hydrogel-based scaffolds. 
 
5.4 MATERIALS & METHODS 
Collagen matrix models 
HDF-seeded collagen gels (5ml) were prepared as previously described [210] (see 
Chapter 2). The collagen-cell suspension was poured into a rectangular mould (size: 
4×3x1 cm) made from Derlin blocks (Intertech, UK) and incubated at 37°C in a 5% 
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CO2 humidified incubator for 20 min. Finally, the set gel was covered with 5ml 
complete culture medium and 50 mg/ml ascorbic acid. 
Attached matrices   
After setting, collagen matrices were left attached to their culture wells. Within 
24hrs, the matrices underwent isometric compaction. The matrices were cultured at 
37°C for the times indicated in the experiments.  
Free Floating matrices  
Attached matrices were gently released from the underlying culture well with a 
spatula to initiate mechanical unloading. Within 24hrs, the matrices underwent cell-
mediated isotonic contraction. The matrices were incubated at 37°C for the times 
indicated in the experiments.  
Plastic compressed matrices  
Following setting and incubation, gels were compacted by a combination of 
compression and blotting [25], as shown in Fig 6(a) (also see Chapter 2). 
Compressed collagen matrices were peeled off the nylon meshes and placed in 
culture wells containing 5 ml complete culture medium. In order to produce collagen 
matrices of a desired level of hydration, and thus (average) collagen density, 
collagen gels were allowed to compress under their own weight (no application of 
load) on blotting paper for a given period of time, determined by the fluid loss vs. 
time standard curve (Fig 6b). This was obtained by measuring gel weight at one 
minute intervals during compression and indirectly calculating the %fluid loss from 
the gel. For a given level of fluid loss, it was possible to calculate the resulting 
matrix % collagen density (wet/weight, w/w), as shown in Fig 6c. 
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(a) 
 
Fig. 6. Controlling fluid loss and matrix collagen density by plastic compression. (a) 
Schematic showing the plastic compression fabrication process. Collagen gels are 
compressed with an applied mechanical load and rapid fluid removal (99% fluid loss 
within 5 min) is achieved by a combination of compression and blotting. 
 
 
(b) Relation between %fluid loss vs. time during compression of collagen matrices 
(5ml) under their own weight. 
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(c) Relation between %fluid loss vs. matrix %collagen density for the same 
compression. This is a mathematical calculation assuming a pre-compression collagen 
density of 0.2% (w/w). By varying the duration of compression it was possible to 
control fluid loss and matrix collagen density to produce a collagen density/stiffness 
series.  
 
Quantification of fibroblast proliferation 
Alamar blue is a redox indicator that both fluoresces and changes colour in response 
to the chemical reduction of culture medium which results from cell proliferation and 
division[264]. Alamar blue (10x concentrate, Serotec) was diluted 1 in 10 with 
phenol-red free culture medium. Medium was removed from all culture wells every 
24hrs and alamar blue solution (5ml) was added. The collagen matrices were 
incubated in alamar blue solution at 37°C for 4 hrs. Alamar blue solution was then 
removed and 100 µl was sampled from each well. Samples were transferred into a 96 
multiwell plate and absorbance readings were taken at 510 and 590 nm using a 
microplate spectrophotometer (MR 700 microplate reader, Dynatech Laboratories). 
Readings were converted to cell number using a standard curve. The collagen 
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matrices were washed in PBS (for 5 min, twice) before fresh medium (5ml) was 
replaced, allowing monitoring to continue.  
Measurement of collagen  matrix Young’s modulus 
Mechanical properties of plastic compressed collagen matrices were measured using 
a dynamic mechanical analyser (Perkin Elmer, UK)[25]. Collagen sheets (1 mm 
wide, 1 cm long) of three different levels of compression (50, 75, 99% fluid loss) 
were uniaxially deformed along their longest axis with the amount of tension 
required to produce a 5–30% strain.  Samples were perfused with PBS between 
measurements. The stress–strain relationships were linear for the tested samples. 
Young’s modulus was calculated using the formula: E = (F/A) x (L/ΔL), where 
F=force applied on the sample, A=unstressed cross sectional area through which the 
force is applied, L= unstressed length, and ΔL=change in length. The values reported 
are the averages of at least three samples for each compression level.  
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CHAPTER 6 
A COLLAGEN MATRIX WITH GRADED DIRECTIONAL 
STIFFNESS: GUIDING CELL MIGRATION IN 3D 
 
Matrix stiffness has been implicated in the mechano-biological control of a range of 
cell behaviours such as cell adhesion, proliferation (Chapter 5) and migration. In 
particular, cells have been shown to preferentially migrate towards areas of greater 
stiffness, a phenomenon termed durotaxis. However, most studies of mechano-taxis 
have focused on the effects of substrate stiffness in 2D. This part of the work 
describes a novel model of a continous stiffness gradient engineered within 3D 
collagen scaffolds and tests the hypothesis that cell migration will be guided by such 
a gradient. Wedge-shaped collagen scaffolds were compressed to produce sheets of a 
desired (0.1mm) uniform thickness, but with increasing collagen density along the 
length of the sheet, while the number of growth-arested HDFs in compliant, middle 
and stiff areas was quantified as a measure of cell migration. 
6.1 RESULTS 
Generation of stiffness gradient in 3D collagen matrices 
We hypothesised that vertical compression of collagen gels with a wedge-shaped 
cross section, by a horizontal/level plate (zero tilt), must leave more collagen 
material at one end (thick end of the wedge) than the other and so produce an 
increasing density along the length of the construct. Production of a gel with a flat 
wedge surface will produce a linear gradient (rate of change proportional to the angle 
of that surface). However, non linear (e.g. exponential) density gradients could be 
formed by casting the gel surface in a curved profile.  
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In order to quantify this stiffness gradient we measured the elastic modulus at the 
two extreme ends and in the middle of the compressed sheet. This was measured by 
loading 1 mm wide strips of these 3 construct regions, perpendicular to the axis of 
the density gradient, using Dynamic Mechanical Analysis (DMA) (see Methods 
section). The Young’s modulus increased from 1057±487 KPa at the soft end to 
2305±693KPa at the stiff end (p<0.05) and was 1835±31 KPa in the middle. This 
represented a near linear increase in modulus along the construct (Fig 1). 
 
 Fig. 1 Engineered stiffness gradient analysis. Young’s moduli for the compliant (soft), 
middle and stiff regions of the construct, as measured by dynamic mechanical analysis. 
The >2 fold increase between the compliant and stiff ends was significant (* p<0.05).  
 
Density gradient analysis 
Uncompressed constructs were seeded with agarose marker beads in order to 
quantify the density gradient which generated this stiffness gradient. Seeding the 
constructs with marker beads also aimed to mimic the cellular density gradient that 
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would form if the constructs were cell-seeded. The use of agarose beads, instead of 
cells, eliminated any complications due to changes in cell morphology, cell 
movement during processing or cell-mediated collagen contraction. Mean agarose 
bead density along this gradient rose from 10±1 to 71±12 from the soft to stiff ends, 
respectively, and was 19±5 in the middle (Fig 2a, b). This indicated successful 
engineering of a density gradient that partly corresponded to the stiffness gradient 
measured. The non-linear rise in bead density (contrast with linear increase in 
modulus) is likely to be a result of beads tending to settle under gravity and 
accumulate towards the thick lower end of the wedge during the short gelation 
period. A comparable non-linear shift would be expected for cell seeded gels, though 
its magnitude would probably be less and dependent on cell type and gelling 
conditions.  
 
Fig. 2 Density gradient analysis. (a) Agarose marker beads in the soft, middle and stiff 
areas of the construct, as a measure of the density gradient. Readings are average 
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number of beads per x10 photographic field, 5 fields per area per construct, 3 
constructs tested. (b) Phase contrast images (x10) of the soft, middle and stiff areas of 
the construct. Arrows show agarose beads.   
 
Fibroblast guidance by durotaxis in 3D collagen matrices  
To test the hypothesis that such 3D gradients could direct cell migration, cells were 
seeded in constructs with a stiffness gradient of 1057±487 KPa to 2305±693KPa, 
from the soft to the stiff end respectively (over 40 mm length), and cultured over 3 
and 6 days.  Human dermal fibroblasts, treated with mitomycin C to block 
proliferation[265,266], were seeded at low density (2 000 cells/cm
2
) in wedge-
shaped collagen constructs, using a 2 stage casting process (see methods), so that cell 
density was uniform along the gradient at the beginning of culture. Importantly, at 
this low seeding density, cell-cell contact was seen to be minimal. Average cell 
density was measured in the compliant, middle and stiff regions of the construct at 3 
and 6 days of culture. Although there was a trend for preferential accumulation of 
cells towards the stiff region of the gradient at 3 days of culture, this only reached 
statistical significance after 6 days (p<0.05) (Fig. 3a, b). 
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Fig. 3 Fibroblasts seeded in collagen matrices with a built-in stiffness gradient exhibit 
durotactic migration. (a) Measurements of the number of cells in the soft, middle and 
stiff regions of the construct at 0, 3 and 6 days of culture. Contructs were stained with 
calcein to visualise live cells. Readings are averages of 5 fields per region per construct 
with 3 constructs per time point (*p<0.05). The average cell density within each 
construct did not significantly differ between day 0 and 3 or 6 days of culture (p>0.05). 
(b) Fluorescence microscopy images (x10 field) at day 0 (A-C) and day 6 (D-F) of 
culture, at the soft (A, D), middle (B, E) and stiff regions of the construct (C, F).  
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Arrows in image E show bipolar, elongate fibroblasts migrating along the gradient 
axis, Bars=10µm. 
 
This system produced a final difference in cell density along the gradient of 3 fold. 
This relatively slow rate of cell re-positioning is likely to be due to the high substrate 
density at the extreme which would retard cell locomotion. It is important to note 
that the increase in the average cell density in the stiff region was accompanied by a 
decrease in the compliant region, implying that cells migrated out of the soft and into 
the stiffer regions.  Since the cells were growth-arrested, migration and not 
proliferation must have been responsible for this directional accumulation. Indeed, 
the average cell density within each construct did not significantly differ between 
day 0, 3 and 6 days of culture (p>0.05), confirming that the fall in cell density in the 
soft region was not a result of cell death.  
 
6.2 DISCUSSION 
Original Hypothesis: HDFs seeded within a 3D collagen matrix containing a 
stiffness gradient will preferentially migrate towards the stiff end of this gradient. 
 
In this study we successfully engineered a model of a continuous stiffness gradient 
within a three dimensional collagen scaffold. Previous studies of mechanotaxis have 
focused on culturing cells on two dimensional patterned substrates [68,125]. In 
addition to their obvious limitation as biomimetic models of cell function, the use of 
polyacrylamide as scaffold material is also poorly biomimetic.  Here the choice of 
collagen, the most abundant protein component of the ECM, enabled the 
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development of a truly 3D, biomimetic environment in which the phenomenon of 
durotaxis could be tested.  
In this model, casting preparation of the collagen gel scaffold is an one-step process, 
in contrast to that for synthetic polymer surfaces [68], with rapid fabrication of a 
density gradient.  The density gradient nature of this model also has the advantage of 
exposing cells to a continuous stiffness gradient, in contrast to sharp boundaries of 
changing material stiffness  as in previous studies [68]. This allows development of 
native-like durotactic gradients, which like chemical gradients, are characterised by 
long-range continuity[3]. 
It was possible to quantify this stiffness gradient by measuring the stiffness modulus 
in the compliant, middle and stiff regions of the construct. This gave a >2 fold 
increase in modulus for a 5 fold increase in collagen density. The range of matrix 
stiffness (1 to 2 MPa) tested here was in the native tissue range (e.g. skin, tendon). 
Varying the final construct thickness by adjusting the degree of compression can 
predictably change the magnitude of the collagen density gradient and thus the 
stiffness gradient. For example, matrix stiffness in the range of 20 to 50 KPa could 
be used to model granulation to scar tissue formation during wound healing [267]. In 
addition, the angle of inclination of the casting well will determine the rate of change 
of stiffness in the gradient. Indeed, the linearity or non-linearity of the gradient will 
be determined by the slope of the inclined surface of the gel (flat or curved). 
Furthermore, controlling the 3D spatial organisation of collagen sheets containing a 
stiffness gradient could provide a tool for engineering gradients with a specific 
spatial configuration within 3D scaffolds (e.g. longitudical vs. radial gradients) 
(Fig.4). This could have important implications for precise guidance of cells within 
3D tissue constructs. For example, constructs containing a longitudinal gradient 
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could be used to model axon guidance in a nerve conduit, while constructs 
containing radial gradients could be useful for modelling cell migration in vascular 
wall structures. In addition, bi-axial gradients could be applied to guide cells to a 
desired point within a 3D complex tissue. It is important to note that the high end of 
the stiffness range tested here was the same as that previously reported for plastically 
compressed cell-seeded collagen gels, with no significant cell damage [25]. 
Therefore, there is presently no reason to expect that cells in different parts of this 
gradient have been significantly (or differentially) affected by the initial 
compression. Indeed, previous studies have found preservation of cell viability even 
after double compression, which raises the matrix stiffness dramatically [268]. 
A                                                                    B                  
              
 
Fig.4 Schematic showing three possible 3D spatial arrangements of rectangular 
collagen sheets containing a stiffness gradient. A collagen sheet could be spiraled along 
its long axis (A) producing a longitudinal gradient or along its short axis (B) producing 
a radial gradient. In the latter, the direction of spiraling will determine the final 
direction of the gradient (i.e. stiff-to-compliant or compliant-to-stiff).                                                       
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C 
 
Layering two collagen sheets and spiraling along the longitudinal axis (C) would 
produce a construct with a bi-axial gradient. The order of layering and the direction of 
spiraling will determine the final direction of the bi-axial gradient. 
 
We also demonstrated the preferential accumulation of cells towards the stiffer 
regions of the gradient. During cell seeding we employed a two step casting process, 
in order to produce a uniform cell density along the length of the construct. This 
allowed relative changes in cell density to be quantified.  Had we seeded the whole 
wedge-shape construct with cells, a cell density gradient would have been formed 
from the start, as shown by the agarose bead experiment. The ability to observe 
mechanotaxis on a large population over a long period enables a statistical approach 
to studying the phenomenon in three dimensions and complements the cell by-cell, 
time-lapse observations that first reported durotaxis[145]. Early studies of durotaxis 
found that isolated cells were able to migrate only from compliant to stiff regions, 
but that cells with neighbours were able to migrate from stiff to compliant regions as 
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well[145]. This is not surprising as the measured migration is likely to be an average 
of movement events in all directions. The short time scale of these studies and the 
lack of population data did not enable the clarification of what the net effect would 
be on the whole population. Our findings are in agreement with that of a previous 
study that investigated the durotactic migration of larger cell populations in two 
dimensions [68], and show that over a sufficiently long time span, and averaged over 
many cells, a net migration into stiff regions occurs.     
 In this model the stiffness gradient corresponded to a collagen density gradient, 
from the compliant to the stiff end of the scaffold. This suggests that an integrin-
binding ligand density gradient accompanied the formation of the rigidity gradient, 
leading to a concurrent gradient adhesiveness, which can also lead to a directed cell 
motility response (i.e., haptotaxis) [148,150]. This would imply that preferential 
accumulation of cells towards the stiff regions of the construct was not entirely 
caused by durotaxis. However, it has recently been suggested that,  physiologically, 
matrix compliance and ligand density are not mutually exclusive, but highly coupled 
(orthogonal) variables that determine mean cell responses ranging from cell 
spreading to cell shape and molecular organization [269,270].  Sensing the stiffness 
of the substrate is associated with the binding of integrin receptors with ECM 
proteins that provide anchors to the cytoskeletal network via cytoplasmic scaffolding 
proteins [271]. Using the integrin-mediated mechanosensor, cells can probe the 
stiffness of the substrate to simply move or pull on their microenvironment. Indeed, 
it has been shown that smooth muscle cell spreading is driven by intracellular 
processes such as actin filament growth but modulated by external cues that include 
substrate stiffness as well as ligand density [272].  
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It has been shown that substrate stiffness can have profound effects on cell 
proliferation [125,154]. In Chapter 5 we showed that fibroblasts proliferated faster 
when seeded within stiffer 3D collagen gels [166]. In order to isolate the migratory 
response of cells, it was important to exclude these proliferative effects and this was 
done by treating cells with mitomycin C. Although trends were apparent at 3 days, 
accumulation of cells in stiff regions only became significant after 6 days of culture. 
This rate of migration seems to be comparable to the findings of a previous study 
where significant accumulation was observed after 5 days[68]. It is important, 
however, to note that in our model cells were seeded within a 3D matrix whereas in 
the previous study they were cultured on a 2D surface, and that matrix remodeling 
during cell locomotion in three dimensions has been shown to have a significant 
effect on the rate of migration [125]. In addition to matrix molecular composition 
and rigidity, the topography of a three-deimnsional matrix affects the formation of 
cellular adhesions [269]. This is a key point, as physiologically, stromal cells must 
also migrate through the 3D ECM. Furthermore, the 3D matrix stiffness in this 
model was in the range of 1-2 MPa, compared to previously described 2D substrates, 
typically in the range of 1-40 KPa [68,125]. Increasing density/stiffness of the ECM 
(and with it durotactic migration) is accompanied, however, by greater ‘matrix drag’, 
as cells must penetrate more dense fibril networks with increasing overall cell 
adhesiveness and decreasing progression between fibrils. This dimension is key to 
physiological stromal cell migration as net progression is a balance of these two 
opposing factors, modified by the ability of the cell type in question to secrete matrix 
proteases, such as MMPs, and so degrade a pathway or modify a section of ECM. 
This is supported by the finding that a biphasic dependence of migration speed on 
ECM stiffness exists, with an optimal substrate stiffness capable of supporting 
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maximal migration[273]. As a result, the ability of cells to optimise migration rate, 
towards the ideal (durotaxis only) rate will depend on their ability to generate 
controlled, local proteolytic activity capable of reducing ‘matrix drag’ (Fig.5).  
Indeed, it has previously been shown that collagen matrix stiffness regulates MMP 
production by fibroblasts cultured within collagen constructs i.e. MMP secretion is 
mechanosensitive [165].  
 
Fig. 5 
Theoretical, predicted plot of the dual antagonistic effects of increasing matrix density 
on overall average cell speed. Increasing migration rate is predicted with increasing 
substrate stiffness (durotaxis) due to simple Newtonian mechanics and translation of 
cell force into motion. However in 3D, this must be balanced against the increase in 
‘matrix drag’ as cells must penetrate more dense fibril networks with increasing 
overall cell adhesiveness and decreasing progression between fibrils. The net effect of 
these opposing factors (dashed line) is likely to give a maximal migration rate at an 
intermediate substrate density where ‘matrix drag’ is just becoming limiting. However 
, over longer periods (3-6 days) these cells would be expected to produce matrix 
degrading/modifying  proteases, such as MMPs , capable of opening up pathways, so 
increasing cell motion above this relatively simple prediction.  
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The current model is based on progression through largely homogeneous, random 
(isotropic) collagen fibril meshes, as plastic compression of collagen hydrogels does 
not result in any significant fibril alignment [24].  However, these are almost never 
found in native ECMs, rather local or long-range fibre alignments produce matrix 
anisotropies[39]. The presence of fibril alignment on a directional stiffness/density 
gradient would be expected to generate the highest cell speeds (and so net migration 
velocities), parallel to fibril alignment or between fibril bundles where ‘matrix drag’ 
will be minimal and durotactic advantage maximal. Interestingly, this is consistent 
with common fibroblast behaviour to migrate between existing tissue planes. In this 
model it is possible that, after extended culture periods, such cell-mediated 
differential collagen matrix organization [25] could have a significant effect on the 
rate and direction of cell migration. Any such effect would be expected to gradually 
enhance the initial matrix gradient/anisotropy over extended periods (see Chapter 
10). 
Using this model, it will be possible to better understand factors governing the rate 
and direction of cell migration in tissues where spatio-temporal changes in ECM 
stiffness occur e.g. during embryonic development or wound healing and tissue 
repair[267].  The ability to guide cells in 3D using matrix stiffness gradients could 
also have important implications for engineering constructs with controlled tissue 
architecture and function. Matrix stiffness is indeed increasingly recognized as an 
important regulator of cell proliferation, adhesion and collagen deposition [125,166], 
cellular functions that are critical for biomimetic and functional tissue growth.  As 
discussed above, the current meodel allows stiffness gradients of variable magnitude 
to be produced, matching the stiffness of the target tissue e.g. stiffer in bone tissue, 
elastic in cardiovascular or muscle tissue, and relatively softer in brain or skin tissue. 
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This model could thus be an important tool for designing and engineering tissue 
implants with a built-in ability to direct cell in growth, accumulation and transit.  
 
6.3 CONCLUSIONS 
We have developed a model of a 3D stiffness gradient within a collagen scaffold that 
will be valuable for investigation of cellular locomotion in 3D tissues where ECM 
stiffness is an important factor, such as embryogenesis, wound healing and tissue 
growth, remodeling or aging. Durotactic control of cell migration rate and direction 
may also be an important tool for engineering biomimetic structure and function into 
tissue implants or models for screening and research. 
 
6.4 MATERIALS & METHODS 
Fabrication of collagen constructs with graded stiffness 
Collagen gels were prepared as previously described[25]. Collagen constructs with a 
gradient of biomaterial matrix stiffness were prepared by casting 7 ml of collagen 
solution  in moulds (4x2.5x1.1cm), made from Derlin blocks (Intertech, UK), which 
were cast at an incline of 15º (Fig 6a).  Collagen gels were incubated at 37°C in a 5% 
CO2 humidified incubator for 20 min. After setting, the resulting wedge-shaped 
collagen constructs were compressed vertically by a horizontal/level plate, moved by 
a computer controlled motor (Dartec, UK) to produce sheets of 0.1mm uniform 
thickness (Fig 6b). This compressing stage used the same method as described for 
plastic compression fabrication of collagen-cell constructs [25]. It is important to 
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note that values of final collagen density were calculated based on the final construct 
thickness, in this case 100µm, as shown in Figure 7.  
 
 
Fig. 6 
Fabrication of collagen constructs with a gradient of biomaterial matrix stiffness.  
Collagen solution (light grey area) was cast in moulds (dark grey area) set at an incline 
of 15º, resulting in formation of wedge-shaped collagen constructs (a). After setting, the 
wedge-shaped collagen constructs were compressed vertically by a horizontal/level 
plate, moved by a computer-controlled motor, to produce sheets of 0.1mm uniform 
thickness (b). Cell-seeded constructs were fabricated by first pouring 5 ml of acellular 
collagen solution and after 1 min casting a second layer of cell-containing collagen 
solution (2ml). This ensured even distribution of cells, resulting in a uniform cell 
density along the construct after compression (c).  
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Fig. 7 (a) Schematic showing how the % fluid loss and % collagen density at the two 
ends and middle region of a construct can be calculated. Angle of inclination of the 
mould used to set the collagen gel was 15º. Compression was to a controlled final 
thickness of 0.1mm. (b) Plot of % fluid loss against % collagen density during 
compression of a collagen gel with initial collagen density of 2mg/ml (0.2%). Note that 
this is a mathematical calculation (i.e. collagen density is calculated based on wet gel 
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weight). (c) Plot showing how % collagen density varies with distance along a collagen 
sheet compressed to 0.1mm.  
 
Measurement of collagen matrix Young’s modulus 
Compressed collagen constructs with a gradient of collagen density were divided 
equally into three regions, from less to more dense zones. Dynamic mechanical 
analysis (Perkin Elmer, UK) was carried out on 1 mm wide strips obtained from each 
region to measure the elastic modulus and thus the rigidity gradient that formed from 
the compliant to the stiff end of the construct [25]. Strips were uniaxially deformed 
along their longest axis with the amount of tension required to produce a 5–30% 
strain.  Samples were perfused with PBS between measurements. The stress–strain 
relationships were linear for the tested samples.Young’s modulus was calculated 
using the formula: E = (F/A) x (L/ΔL), where A =unstressed cross sectional area, F 
=force, L = unstressed length, and ΔL =change in length. The values reported are the 
averages of at least three samples from each region.  
Quantification of density gradient 
As a measure of the density gradient resulting after compression, collagen gels were 
seeded with agarose marker beads (Sigma, UK) (0.15 ml of 0.2g/ml stock solution) 
before setting. After compression, each construct was divided in 3 equal areas, 
corresponding to the soft, middle and stiff parts of the gradient. The number of beads 
per x10 photographic field was manually counted in each of the three areas, using a 
phase contrast microscope. Averages based on five fields per area, per construct. 
Three constructs were analysed. 
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Cell-seeded constructs to test migration 
HDF-seeded collagen constructs were prepared by first casting 5 ml of acellular 
collagen solution and after 1 min, before the collagen had fully set, casting a second 
layer of collagen solution (2ml) containing a total of 20, 000 fibroblasts (Fig 6c). 
The short duration between casting the first 5 ml and final cell-seeded 2ml of 
collagen solution ensured adequate integration across the interface of the two layers 
[274] so that after setting, a single collagen construct was obtained with no obvious 
line of separation. This method resulted in collagen constructs having a uniform 
fibroblast density (2000 cells/cm
2
) after compression. Seeding the whole collagen 
construct with cells was avoided, since this also generated a cell density gradient, 
due to accumulation of cells towards the thick end of the wedge.  After casting, 
wedge-shaped cell-seeded constructs were compressed to produce sheets of (0.1mm) 
uniform thickness, as described above. Cells were growth arrested by 10 µg/mL of 
mitomycin C (Sigma, UK), which was left in the culture media for 2 h after cell 
seeding and removed by three washes of PBS. Collagen constructs were cultured at  
37°C  for up to 6 days, with replacement of culture media(5ml) every second day.  
Quantification of cell accumulation 
Collagen constructs were taken out of culture after 0, 3 and 6 days of culture and 
incubated for 1hr in phosphate-buffered saline (PBS) plus 5 µM calcein AM 
(Molecular Probes, Invitrogen) at 37°C. Samples were subsequently washed in PBS 
and viewed with a fluorescence microscope. Cells were counted manually. Each 
construct was divided into 3 equal regions (stiff, middle, soft) and cell density within 
each region was calculated as the average number of cells per x10 photographic 
field. Since cells had moved across a 3D space within the construct, the plane of 
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focus was manually set and kept constant during counting.  Reported values are 
averages of 5 fields per region per construct with 3 constructs per time point.  
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CHAPTER 7 
LAYERED COLLAGEN SCAFFOLDS WITH DEFINED 
MATRIX STIFFNESS: REGULATION OF CELL-MEDIATED 
INTERFACE INTEGRATION 
 
In Chapter 3 we showed how Plastic Compression fabrication can be employed to 
rapidly engineer biomimetic collagen sheets with precise control of matrix collagen 
density and mesoscale structure. However, utilisation of compressed collagen sheets 
as bio-functional units (i.e. basic building blocks) for complex tissue reconstruction 
critically relies on the ability to assemble them in 3D (e.g. by layering). Indeed, 
optimal integration of construct components is a primary prerequisite for successful 
application of this and other types of sheet-based engineering (e.g. cell-sheet 
engineering[86]) in development of biomimetic (e.g. heterogeneous/complex) tissue 
constructs. As we have shown in the last two chapters, an important regulator of the 
cellular responses (migration, proliferation, collagen deposition) mediating interface 
integration is matrix stiffness. The aim of this study was to develop a sheet-based 3D 
model that would allow control of interface matrix stiffness, in order to investigate 
its effect on cell-mediated interface integration of sheet-based collagen constructs. A 
previous study by this group focused on engineering a collagen-based 3D interface 
model for assessing cell-dependent mechanical integration of tissue surfaces [158]. 
This construct, consisting of a fibroblast-seeded pre-contracted collagen gel 
embedded within a cell-free collagen hydrogel lattice, enabled solid interface 
formation in vitro with a well-defined geometry and the possibility of measuring 
mechanical linkage. In this study we have adapted this model by layering compliant 
collagen hydrogels, seeded with human dermal fibroblasts (HDFs), and then 
compressing them to obtain layered collagen sheets. We tested the hypothesis that 
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such bilayer-sheet scaffolds can undergo cell-mediated enhancement of interface 
integration. We also investigated the role of matrix stiffness in cell-mediated 
interface integration by measuring the interface adhesive strength of constructs 
compressed at the beginning (compressed culture; high stiffness) or the end 
(compliant-compressed culture; low stiffness) of the culture period. As a measurable 
outcome of cellular responses to varying matrix stiffness, interface integration was 
quantitatively correlated to cell migration across high and low stiffness interfaces.  
 
7.1 RESULTS 
The interface model used in this study, comprising two layered collagen hydrogels 
that were compressed to produce bilayer collagen-sheet scaffolds (see Methods), was 
effective in forming reliable and reproducible interfaces with known dimensions 
(bilayer construct thickness ~ 200 µm).  Under these conditions, the pull-out force 
was proportional to the contact surface area, which was measurable (2cm
2
) and 
reproducible between experiments. The interface adhesive strength was assessed by 
placing the bilayer construct on the t-CFM and pulling at a constant rate to give 
displacement and eventual fracture of the interface (see Methods). 
 
Finite Element Analysis of interface stresses 
In order to analyse the distribution of predicted stresses, acting on the interface 
during mechanical loading, we constructed an FE model of the interface system .The 
highest stresses were predicted in the xy plane perpendicular to the interface, parallel 
to the direction of loading (Fig.1a). Figure 1b shows that the predicted stress acting 
in the xy plane rises sharply at the interface, with higher stresses at the top part of the 
interface than in the middle, indicating that failure of the interface would start in this 
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region.  A rise of normal stress at the interface was also observed in a collagen-based 
hydrogel interface construct, previously described by this group [158]. Debonding at 
any one point of the region of highest stress (top region) would lead to an increase in 
the stress throughout the remaining intact interface and rapid failure.  
 
Fig. 1 
Analysis of interface stresses by Finite Element Analysis. (a) Computer illustration of 
the finite element model of the interface construct (cross-sectional view) and the stress 
distribution predicted in the xy plane parallel to the direction of loading, as the 
interface was pulled apart. Dashed line represents the interface between the two layers. 
The scale of the coloured bar indicates the magnitude of the stresses (dark blue lowest, 
red highest). (b) Graph showing the predicted stress in the xy plane, in the top and 
middle regions of the construct, from the fixed bar to the distal end. The interface was 
at 100 µm distance (each layer was 100µm thick).  Insert schematic shows the cross-
sectional view of the construct. 
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Interface integration of acellular vs. cellular matrices 
In order to establish a baseline of interface adhesive strength, we characterized the 
integration of acellular bilayer constructs by varying the casting period (i.e. the time 
period the bottom gel was allowed to set before casting the top gel) from 5 to 2.5 
min. Importantly, the bottom gel was observed to set (i.e. it was not in a liquid state) 
within the shortest (2.5 min) casting period tested. Upon mechanical testing, the 
interface was characterized by a clear maximum force required for fracture, followed 
by rapid failure (Fig.2a). This was in agreement with the FE model’s prediction. The 
results showed that there was a more than 2 fold increase in peak force from 3.2±1 to 
8.6±0.5 mN before interface fracture when the casting period was reduced from 5 to 
2.5 min respectively (p<0.05) (Fig.2a), indicating that a near inverse-linear relation 
exists between casting period and interface adhesive strength. The time required for 
interface fracture was also increased by more than 2 fold when the casting period 
was reduced to 2.5 min, implying that a greater number of bonds had formed 
between the two layers, in addition to individual bonds being stronger. These results 
indicate that the casting period, which determines the degree of gel stabilization 
during setting, is a critical factor controlling the integration of acellular collagen 
hydrogels.   
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Fig. 2 
Interface intergration of acellular and cell-seeded bi-layer collagen constructs. Plot of 
force developed during interface mechanical testing versus time, for (a) acellular 
constructs with a casting period of 2.5 or 5 min and (b) cell-seeded (compressed at day 
0) versus acellular constructs with a casting period of 5 min after 1 week culture.  
 
Cell-seeded constructs were cultured for 1 week, as our previously established model 
showed significant enhancement of  interface integration after 1 week of culture 
[158]. Cell-seeded constructs with a 5 min casting period were used for assessing 
cell-mediated effects on interface integration, as these had the lowest baseline 
(without cells) adhesive strength (Fig. 2a). It is important to note that the baseline 
adhesive strength of  acellular constructs was unaltered by prolonged culture (up to 7 
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days, data not shown), indicating that the collagen-collagen interaction alone did not 
play a significant role in any enhancement of interface integration with culture time. 
This was in agreement with data obtained from our previous model [158].  Figure 2b 
shows that cell-seeded constructs (compressed at day 0), cultured for 1 week, 
showed a more than six-fold increase in peak force before interface fracture (20±5 
mN) compared to acellular constructs (3±1 mN). This was statistically significant 
(p<0.05). The time required for interface fracture was also increased by 3 fold for 
cell-seeded constructs.  
 
Effect of matrix stiffness on cell-mediated interface integration 
Once it was established that this bilayer collagen model could undergo cell-mediated 
enhancement of interface integration, we investigated the effect of matrix stiffness 
on interface adhesive strength, by comparing the integration of constructs 
compressed at the beginning (compressed culture; stiff) or the end (compliant-
compressed culture; compliant) of the 7 day culture period. As a means of 
controlling matrix stiffness, fluid was removed from constructs using plastic 
compression to increase collagen density and thus matrix stiffness (see Chapter 5). 
Compression typically resulted in an increase in collagen density from 0.2% 
(collagen hydrogels) to ~15% (collagen sheets), relating to ~99% fluid removal [25]. 
Matrix stiffness, previously quantified using dynamic mechanical analysis, was 
42.2kPa ±22 and 2240 kPa±846 for compliant and stiff matrices, respectively [166]. 
We observed an increase in maximum interface adhesive strength from 16±6 Pa for 
acellular constructs to 95±26Pa for stiff constructs (compressed cultures) and 
129±38 Pa for compliant constructs (compliant-compressed cultures) (Fig 3). While 
there was a trend for compliant matrices to show greater strengthening of the 
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interface compared to stiff matrices, this difference was not statistically significant 
(p>0.05). This suggests that within 1 week cells were capable of forming bonds of 
comparable strength between both stiff and compliant matrices.  
 
 
Fig.3 Comparison of cell-mediated interface integration of stiff vs. compliant bi-layer 
matrices. Histogram comparing the adhesive strength of acellular constructs with that 
of compressed (high stiffness) and compliant-compressed (low stiffness) 1 week 
cultures, *p<0.05. The peak force before failure was used to determine interface 
adhesive strength. 
 
Dependence of cell-mediated interface integration on cell migration 
Previous studies have showed that cell-mediated interface integration is dependent 
on cell  migration across adjacent surfaces [158,160]. We thus quantified cell 
migration across the interface using a modification of the ‘nested collagen matrix’ 
model developed by Grinnell et al, where cells migrate out of a cell-seeded matrix 
into an acellular matrix [143] (see methods), and correlated this to interfacial matrix 
stiffness. Figure 4 shows that within 24hrs of culture, cells had migrated out of low 
stiffness (uncompressed) matrices, while minimal migration was observed out of 
stiff (compressed) matrices (p<0.05).  In such stiff matrices cells were seen to align 
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along the boundary between inner and outer gel and maintain a longitudinal 
morphology (Fig 4b). However, after 7 days of culture there was no significant 
difference between the number of cells that had migrated out of stiff or compliant 
matrices (Fig.4a). Given that cell migration plays a critical role in the integration 
process, this finding seems to be supportive of our data showing that stiff 
(compressed) and compliant (compliant-compressed) cultures had similar interface 
adhesive strengths after 1 week.  
 
 
Fig.4 
Comparison of cell migration across the interface in compliant and stiff collagen 
matrices. (a) Histogram showing the number of cells migrating out of cell-seeded 
matrices per x10 photographic field, for compliant (uncompressed) and compressed 
(high stiffness) cultures at 24hrs or 1 week,  *p<0.05. 
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(b) Phase-contrast micrographs of the interface between cell-seeded and acellular 
matrix showing cells (arrowed) migrating across the interface in compliant (A, C) or 
compressed (B, D) cultures at 24hrs and 1 week. Bars=10µm. 
 
Interface structural analysis 
Visualization of the interface of acellular constructs, using SEM, showed that there 
was a well defined fusion line at the interface of the two collagen layers, after 
compression (fig 5). This was also observed in stiff (compressed culture) constructs 
cultured for 1 week, but was absent from 1 week compliant (compliant-compressed) 
constructs, indicating that fibroblasts cultured in compliant matrices had managed to 
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fuse the two collagen layers. Fusion of the two layers could imply a greater degree of 
interface integration in compliant constructs which, while not significant, could be 
measured after 1 week (Fig.3).  
 
Fig.5 
Interface structural analysis for acellular, stiff and compliant cell-seeded bi-layer 
contructs. SEM images of transverse cross sections of the interface for acellular bilayer 
constructs (a), compressed (high stiffness) 1 week cultures (b) and compliant-
compressed (low stiffness) 1 week cultures (c). Arrows show fusion line at the interface.  
 
 
7.2 DISCUSSION 
Original Hypothesis: Layered collagen matrices can undergo cell-mediated 
integration, while interface adhesive strength will depend on matrix stiffness at the 
interface. 
 
 
This study investigated the interface integration of layered collagen-sheet scaffolds. 
We previously showed that plastic compression of collagen hydrogels (~0.2% 
collagen w/w) produces dense (up to 15-20% collagen w/w), mechanically strong 
(stiffness modulus ~2240 KPa) collagen sheets (~100µm thick) that can support a 
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high cell viability [25]. Plastic compression of collagen constructs results in 
irreversible water loss from the matrix, however, as we discussed in Chapter 6 the 
fluid loss vs. collagen density curve is not linear. For example, while 50% fluid loss 
roughly doubles the collagen density, removing 99% of the gel’s fluid results in a 
~75 fold increase in collagen density. This enables rapid, as well as predictable, 
control of the gel (average) collagen density and matrix stiffness. Here we show that 
the interface between such layered collagen sheets with defined matrix stiffness can 
undergo cell-mediated integration.  
 
The simple geometry of this model enabled the application of the FE method to 
predict and locate the maximal stresses along the interface during mechanical 
loading. The ability to precisely predict stress distribution within a heterogeneous 
construct, and thus the regions where failure of the interface is likely to occur, would 
be invaluable when engineering multilayer structures (e.g. blood vessels [95]) or 
where material properties vary from one layer to the next e.g. hybrid constructs of 
two biomaterials [275].  
 
This model allowed reproducible quantification of the mechanical strength of the 
interface. The baseline adhesive strength could be modified by changing the total 
contact surface area (data not shown) and the casting period. We found that there 
was a near inverse-linear relation between interface integration strength and casting 
period, indicating that bond strength/number of bonds between two adjacent collagen 
gels is reduced with increasing gel stabilization during setting. However, increasing 
the casting period beyond 5 min did not significantly alter (reduce) adhesive strength 
(data not shown). This suggests that there is a threshold in the degree of stabilization 
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of the bottom gel, above which interface integration is not time dependent. An 
important feature that might relate to this threshold behaviour was the formation of a 
‘skin-like’ layer on the surface of the bottom gel, within 5 min of setting [44], which 
coincided with the lowest level of adhesive strength. This ‘skin-like’ layer occurring 
at the gel-air casting interface represents a thin but ordered (packed fibrillar) 
structure at the gel’s surface that is different from the homogeneous, random fibril 
centre of the gel [44].  
 
Culturing cell-seeded bilayer constructs for 1 week resulted in increased interface 
integration compared to acellular constructs. Such cell-mediated enhancement of 
interface integration has been previously reported by this group, using a hydrogel-
based interface construct [158]. Interestingly, we found no significant difference in 
interface adhesive strength between stiff (compressed) and compliant (compliant-
compressed) constructs after 1 week. This suggests that cells are equally capable of 
forming functional bonds between stiff, as well as between compliant matrices. 
Indeed, compressed collagen scaffolds have been shown to undergo functional 
cellular remodelling (and change in material properties) in vitro [25], as previously 
reported for compliant collagen hydrogels [126]. This could have important 
implications for engineering heterogeneous constructs that require a greater initial 
matrix stiffness and mechanical strength [276]. On the other hand, this finding could 
perhaps explain why engineered tissues based on cell-sheets, that contain relatively 
little ECM, and are thus compliant, can rapidly integrate with host tissues [86]. 
However, the above findings do not exclude the possibility that matrix stiffness 
could be a critical determinant of the strength of mechanical linkages formed at an 
interface, over longer culture periods. 
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It has previously been shown that cell migration across an interface is partly 
responsible for cell-mediated integration of adjacent surfaces [158,160]. A possible 
mechanism by which single cells could build up collagen bridges while migrating 
could depend on their ability to drag and bend collagen fibres during locomotion 
within 3D collagen matrices [277]. We found that while a greater number of cells 
had migrated across the interface in compliant matrices compared to stiff matrices at 
24hrs, no significant difference was observed after 1 week of culture. This lag phase 
exhibited by fibroblasts cultured within stiff matrices is likely to be due to lower 
initial migratory speeds, as cells migrated through a denser ECM. Previous studies 
have indeed shown that when fibroblasts were cultured on substrates of increasing 
stiffness, migration speed decreased noticeably with increasing substrate mechanics 
[125]. However, within a 3D ECM cells can optimise their migration rate, a process 
that depends on their ability to generate controlled, local proteolytic activity (e.g. 
MMPs) capable of reducing matrix resistance/drag. Indeed, increasing matrix 
stiffness has been shown to upregulate MMP expression by HDFs [140,165].  While 
cell migration speed within stiff matrices would be expected to increase with time, 
the opposite would occur for cells migrating through compliant matrices, as cell-
mediated matrix contraction would gradually result in increased matrix density (and 
stiffness), thus slowing down cell locomotion. This would imply that at some point 
in time the two migration rates would become comparable. We did observe similar 
rates of cell migration between stiff and compliant matrices after 1 week. This could, 
at least partly, explain the lack of any significant difference in interface adhesive 
strength between stiff (compressed) and compliant (compliant-compressed) cultures. 
The above findings also suggest that regulation of matrix density/stiffness could 
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enable the formation of selectively permeable migration barriers to cells within 
interfaced (e.g. layered) 3D ECMs, to provide spatial cues that can influence cell 
behaviour [278].  
 
Collagen deposition has also been implicated in the mechanical integration of tissue 
surfaces cultured in partial apposition [91]. In fact, it has been suggested that pre-
existing collagen at an interface is responsible for the assembly of new collagen 
fibres at the boundary [279]. Importatnly, collagen gene expression and collagen 
synthesis have been shown to depend on matrix stiffness [165], implying that the 
two culture conditions examined with this model (compressed versus compliant-
compressed) could have differed with respect to the amount of collagen deposited at 
the interface. While such differences might be difficult to quantify in the short term, 
by assessing interface adhesive strength, they could potentially have a significant 
effect on the degree of interface integration over longer culture periods. The ability 
to quantitatively correlate matrix stiffness with the extent of interface integration  
could have important implications for modelling the behaviour of heterogeneous 
constructs cultured in loading bioreactors, where mechanical stimulation of cells to 
improve ECM (mainly collagen) synthesis is inevitably accompanied by an increase 
in matrix stiffness [280]. Indeed, a study by Hoerstrup et al showed that tubular co-
polymer constructs exposed to shear and cyclic distension achieved  higher  burst 
pressures after 4 weeks in culture and that increased integration of construct 
components was accompanied by a significant increase in collagen deposition [281]. 
Furthermore, the biodegradable behaviour of collagen scaffolds and their ability to 
undergo functional (and quantifiable) cellular remodelling makes the current model a 
useful tool for modelling host integration of tissue-engineered constructs in vivo. For 
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example, a previous study by this group showed that when plastic compressed 
cellular and acellular constructs were implanted in vivo in a lapine model, cell-
seeded constructs underwent remodelling up to 5 weeks and had a higher matrix 
stiffness compared to acellular constructs, implying that cell seeding contributed to 
this process post-implantation[54]. 
 
Visualization of the interface showed that cells cultured within compliant matrices 
had managed to completely fuse the two collagen layers, while cells cultured within 
stiff matrices had failed to do so, after 1 week. While it has been shown that 
fibroblasts cultured within compliant collagen matrices contract and remodel the 
matrix within 24hrs [126], stiff  matrices undergo a much lesser degree of 
remodelling. Indeed, increased matrix stiffness has previously been shown to reduce 
generation of quantifiable cellular force (by HDFs)  over 24 hrs  and delayed the 
onset of matrix contraction [165]. Cell-mediated matrix contraction in compliant 
matrices presumably played a role in increasing the displacement of fluid (water) 
from one collagen layer to the other. This movement, in turn, probably dragged 
collagen fibrils across the interface, resulting in fusion of the two layers [158]. 
Translation of such micro-structural differences between the interface of compliant 
and stiff matrices into measurable differences in adhesive strength may, however, 
require longer periods of culture. Nevertheless, the ability to control cellular force 
generation, by regulating matrix stiffness, could provide an additional tool for 
forming stable interfaces between hydrogel matrices, against cell contraction [282]. 
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7.3 CONCLUSIONS 
We have successfully engineered a sheet-based 3D model of interface integration 
based on layered, biomimetic collagen-sheet scaffolds and showed that such 
constructs are able to undergo cell-mediated enhancement of interface integration. 
The ability to regulate cellular behaviour (proliferation, migration and collagen 
deposition) at an interface, by controlling matrix stiffness, could provide an 
important tool for modelling the integration of sheet-based (cell-sheets, biomaterial 
sheets or hybrids) constructs in vitro or in vivo. This could have important 
implications for the design of sheet-based bioengineered tissues and their application 
to complex tissue reconstruction.  
 
  
7.4. MATERIALS & METHODS 
Bilayer collagen scaffold development 
Cell-seeded collagen gels were prepared as previously described [210] . The collagen 
gel or collagen-cell suspension (containing 5x10
5
 human dermal fibroblasts) was 
then poured into a rectangular mould (size: 4×3x1 cm) made from Derlin blocks 
(Intertech, UK) and incubated at 37°C in a 5% CO2 humidified incubator for either 
2.5 min (acellular gels) or 5 min (acellular and cell-seeded gels) . At the end of the 
incubation period, the gel was removed from the incubator and two spacers (1x3cm) 
were placed on its top surface, at each end. A second acellular gel or collagen-cell 
suspension containing 5x10
5
 fibroblasts, was then poured on top of the first gel (Fig. 
6a). The bilayer collagen gel was incubated at 37°C in a 5% CO2 humidified 
incubator for 30 min.  
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Interface models 
Acellular bilayer collagen constructs 
Following setting and incubation, bilayer collagen gels were compacted by plastic 
compression for 5 min (Fig. 6a), using a combination of compression and blotting, to 
remove ~99% of the fluid (water) [25]. This lead to formation of a flat, dehydrated 
bilayer collagen sheet (200 µm thick) protected between two nylon meshes. 
Compressed matrices were peeled off the nylon meshes and underwent mechanical 
testing. Note that plastic compression typically results in an increase in collagen 
density from 0.2% (collagen hydrogels) to ~15% (collagen sheets) [25].  
Compressed matrix culture (high stiffness)  
Following setting and incubation, bilayer cell-seeded gels were compacted at day 0 
by a combination of compression and blotting, as described above (plastic 
compression of cell-seeded collagen gels has previously been shown not to reduce 
cell viability [25]). Compressed matrices were peeled off the nylon meshes and 
placed in culture wells containing 5 ml complete culture medium and cultured for 7 
days (Fig.6a). At the end of the culture period matrices underwent mechanical 
testing.  
Compliant-compressed matrix culture (low stiffness)  
Following setting and incubation, uncompressed bilayer cell-seeded gels were placed 
in culture wells containing 5 ml complete culture medium and cultured free-floating 
for 7 days. While the gels underwent some isometric (vertical) compaction (~30%, 
data not shown) over 1 week, the spacers placed between the two collagen layers 
prevented any significant cell-mediated contraction (data not shown). On day 7 
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matrices were taken out of culture and were compacted by a combination of 
compression and blotting as described above (Fig.6a). Compressed matrices were 
peeled off the nylon meshes and underwent mechanical testing.  
 
Fig.6  
Experimental setup for measuring interface integration in bi-layer collagen constructs. 
(a) Schematic of development of bilayer collagen constructs. Collagen gels were cast on 
top of each other with spacers placed at the two edges of the interface. Constructs 
underwent plastic compression for 5 min using a 120g load to obtain a 200µm thick 
bilayer sheet. The three models tested were acellular constructs (A), compressed 
cultures (high stiffness) (B) and compliant-compressed cultures (low stiffness) (C). (b) 
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Schematic showing the process for measuring interface adhesive strength. After 
compression, spacers were removed and the free ends of each sheet were attached to 
floatation bars, which were connected to the t-CFM through metal wire. 
 
(c) Photograph of the full assembly placed in a culture well filled with culture medium 
(A). Desktop representation of bilayer construct before (B) and after (C) being 
subjected to mechanical loading, showing failure at the interface.   
 
 
Finite Element Analysis 
 
In order to analyse the distribution of predicted stresses acting throughout the bilayer 
construct during mechanical loading, a solid model of the interface construct was 
created in the FE package LISA (Finite element technologies, USA). The model 
consisted of two 8 node hexahendron elements joined at an interface. This model 
was then meshed by using 864 8-noded hexahedron 3D solid elements. Compressed 
collagen sheets were given a Young’s Modulus of 2240 KPa, based on previous data 
[166]. Sheets were modelled as homogeneous isotropic linear elastic materials to 
keep calculations feasible [283]. This assumption was reasonable as long as the load 
rates were slow. The back end of the fixed collagen sheet was restrained in all 
directions with respect to the contact surface of the bar. The sheets were assumed to 
be completely and uniformly bonded at the interface. A load that was representative 
of the force magnitude applied by the t-CFM. was applied perpendicular to the face 
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of one collagen sheet to pull it off the fixed sheet. The distribution of stresses along 
the interface was then computed. 
 
 
 
Assessment of mechanical integration of interfaces 
 
 
The mechanical integration of  bilayer collagen constructs was assessed by 
subjecting them to a single-lap test to failure by using the tensioning culture force 
monitor (t-CFM), a  previously described computer driven tensional loading device 
[158].  After compression of bilayer collagen constructs (acellular and cell-seeded), 
the engineered interfaces were attached onto floatation bars through their free ends 
(after spacers were removed) and connected to the t-CFM by surgical metal wire 
(0.35 mm in diameter), as shown in figure 6b, c. The t-CFM consisted of a stress-
strain measuring system composed of an x-y stage placed on a linear table moved by 
a stepper-motor (SY561T, Parker, Germany) attached to a microdrive (XL25i, 
Parker). The force sensor, composed of a copper beryllium beam (0.15 mm thick) 
coupled with a strain gauge (Measurement Group UK, UK), was mounted vertically 
onto a static reference point to the moving x-y. Shear stresses developing from the 
floatation bars were avoided by connecting and suspending the whole assembly in 
culture medium before applying strain. Unidirectional tensile loads were 
programmed into the computer-based software X150 (Parker Automation, City, 
USA) and applied to the interface. Signal from the force transducer was acquired by 
a data acquisition card (National Instruments, USA), displayed in real time and 
recorded by LabVIEW 6.0 software (National Instruments, USA). Data were 
recorded at a rate of 1 point/second. Each data point was the average of 1,000 points 
(acquisition rate: 1,000 points/s) giving a good signal to noise ratio. For each 
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measurement, the x-y stage was moved at a constant velocity of 4.8 mm/min until 
interface fracture was achieved, as indicated by a force drop after a steady rise to the 
peak adhesive strength. The movement of the stage was maintained until full 
separation was observed. The interface surface area (2 cm
2
) was used to normalize 
peak force values and to obtain adhesive strength values. 
 
Assessment of cell migration 
In order to quantify cell migration we used the ‘nested collagen matrix’ model, 
described by Grinnell et al [143]. The experimental setup is shown in figure 7. 
Nested collagen matrices were prepared by embedding cell-seeded collagen matrices 
(1ml) into cell-free matrices (5ml). For compressed cultures (high stiffness), the 
nested matrices were compressed at day 0, while for compliant cultures (low 
stiffness), nested matrices were left uncompressed and free-floating during the 
culture period. For both conditions, inner gel final cell density was 2x10
6
 cells/ml. 
Nested matrices were cultured for 1 or 7 days in 5ml complete medium and then 
removed from culture, fixed  in 2.5% gluteraldehyde in 0.1M phosphate buffer, pH 
7.5, at 4
0
C for 1 h, followed by washing in PBS. The gels were then stained with 1ml 
1% toludine blue. They were then destained through a series of 30 min washes in 
PBS. Migration across the interface was quantified with a phase-contrast 
microscope. Since cells had moved across a 3D space within the construct, the plane 
of focus was manually set and kept constant during counting. The number of cells 
migrating across the interface per x10 field was counted. Reported numbers are the 
average of 5 fields per sample, with 3 samples per condition.  
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Fig. 7 
Assessment of cell migration out of cell-seeded collagen matrices using the ‘nested 
collagen matrix’ model.  Schematic showing model development. HDF-seeded collagen 
gels were placed into acellular gels and either compressed at day 0 and cultured for 
24hrs or 1 week (compressed culture; high stiffness) or cultured uncompressed for 
24hrs or 1 week (compliant culture; low stiffness). For both conditions, inner gel final 
cell density was 2x10
6
 cells/ml. 
 
SEM interface analysis  
Conventional SEM (Philips CM12 electron microscope; Agar Scientific, UK) was 
used to study the morphology of collagen fibrils at the interface following 
compression. Acellular or cell-seeded bilayer constructs cultured for 7 days were 
routinely processed for SEM as described in Chapter 2. Air-dried constructs were 
sectioned transversely to expose the interface. They were mounted vertically onto 
stubs, sputter coated, and examined with SEM. 
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CHAPTER 8 
IDENTIFICATION OF KEY FACTORS IN DEEP CELL O2 
PERFUSION 
 
Cell behaviour is inherently linked to the prevailing O2 micro-environement, as this 
critically directs the most basic cellular activities (i.e. metabolic and synthetic 
functions). Identification of the factors that determine deep cell O2 perfusion is 
therefore a key pre-requisite to regulating cell behaviour in 3D engineered tissues. In 
this study we have quantified O2 consumption by Pulmonary Artery Smooth Muscle 
Cells (PASMCs), seeded under a range of conditions in dense collagen 3D tubular 
constructs, to establish a working experimental model of the system. We hypothesize 
that O2 consumption by resident cells, rather than matrix density/diffusion 
coefficient or diffusion path length, is the primary determinant of prevailing local O2 
tension in a 3D nanofibrillar collagen construct. In particular, we tested the 
hypothesis that cellular O2 consumption will generate natural (i.e. biomimetic) radial 
O2 gradients from the outer surface of the construct to the core (lumen), while such 
gradients will not form in acellular constructs.  In this study we have dissociated the 
effects of matrix density/diffusion coefficient, diffusion path length and cellular O2 
consumption on deep O2 perfusion, and have correlated O2 consumption gradients 
with cell density to test if exposure of core cells to lower O2 tension reduces cell 
survival (measured as cell viability along the radial consumption gradient), under 
both static and dynamic perfusion culture conditions. Furthermore, to show how 
different cell types behave in terms of O2 consumption, we compared PASMC 
responses to those of human dermal fibroblasts (HDFs), cultured under identical 
conditions in the same 3D model [173] up to 6 days in culture. 
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8.1 RESULTS 
Correlation of core O2 tension with construct cell density 
We first measured O2 diffusion into the core of cell-free plastically compressed 
collagen tubular constructs (~1.5 mm radial wall thickness).  Such validation and 
calibration studies without cells (Fig. 1a) provided a steady-state base level O2 
tension at the core and surface over 24 hrs (note that the fluctuations in core O2 
tension over 24hrs were not statistically significant, p>0.05). The core O2 level was 
not significantly different from that on the surface (~148mmHg), indicating a ‘zero’ 
gradient with free radial O2 diffusion through the nano-fibrillar collagen matrix of 
the wall. This concurs with our previous work showing a high O2 diffusion 
coefficient through this dense collagen. In contrast, cellular constructs (~1.5 mm 
radial thickness) exhibited time-dependent O2 depletion in their core over a period of 
24 hrs (Fig. 1a). O2 tension fell rapidly over 0-5 hrs depending on cell density and 
reaching 10±6.2 mmHg for high cell density constructs (23.2x10
6 
cells/ml) and 
80±11.7 mmHg at the low cell density (11.6x10
6 
cells/ml). The 2 and 8 fold decrease 
in O2 tension at low and high cell densities, respectively, was significant (p<0.05) 
indicating that cell O2 consumption (i.e. the number of cells consuming O2 along the 
diffusion path) was a central determinant of core O2 tension in the system over 
24hrs. Importantly, core O2 tension was found to be inversely proportional to cell 
density. Figure 1b illustrates the relationship between cell density and O2 
consumption rate, with constructs seeded at twice the cell density having a 2 fold 
greater O2 consumption rate over the 12 to 24hrs period of culture. The initial 
consumption rate (0-5hrs) was 3 fold higher at the high cell density, perhaps due to 
pre-adaptational differences in core cell metabolism at different O2 tensions (going 
from culture hypoxia to tissue-like normoxia).   Core O2 tension was found to be 
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stable over extended periods, from 24-72hrs, at ~20mmHg (Fig.1c). This contrasts 
with the same system previously established using HDFs, which adapted over the 
24-72 hr period to reduce O2 consumption such that core O2 tension rose to 65mmHg 
by 30hrs [173]. This 3-fold difference between the PASMC and HDF O2 level 
became statistically significant at 40 hrs (fig. 1c).  
 
Fig.1 Correlation O2 tension in the core of 3D collagen constructs  with cell density and 
cell type. (a) O2 tension in the centre of acellular and PASMC-seeded spiral constructs 
cultured for 24hrs. Two different cell densities were measured, 11.6 million cells/ml 
and 23.2 million cells/ml (average of n = 5 for each data set is presented here). Time-
zero is taken as the time point when the probe was positioned in the construct.(b) Rate 
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of O2 consumption within constructs seeded with 11.6 million cells/ml and 23.2 million 
cells/ml and cultured for 24hrs. 
 
(c) O2 tension in the centre of spiral constructs seeded with 23.2 million cells/ml  and 
cultured for 3days (n=3). Comparative HDF data has been derived from Cheema et al 
[173], *p<0.05.  
 
Correlation of core O2 tension with consumption path length 
We also tested the effect of increasing diffusion distance on core O2 tension within 
the lower cell density (11.6x10
6 
cells/ml) constructs. This compared the effects of 
increasing the diffusion distance (i.e. construct wall radial thickness) from ~1.5 mm 
to ~2 mm.  This not only resulted in increased wall thickness, but also increased the 
total number of cells along that diffusion path (i.e. consumption gradient increased 
with distance). To dissociate between the effects of cell O2 consumption from that of 
dissusion path length, acellular constructs of each radial wall thickness were also 
compared. Figure 2 shows that for acellular constructs, increasing the diffusion 
distance had no significant effect on core O2 tension. For cell-seeded constructs an 
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increase in diffusion and consumption path-length of 33% resulted in an increase in 
O2 consumption and a ~30% reduction in core O2 tension (marked here as significant 
after 12hrs, p<0.05). Importantly, even though the increase in diffusion/consumption 
path-length generated a proportionately lower core O2 tension this difference 
emerged as a new basal value of core O2 tension post 12hrs, rather than an altered 
initial rate of consumption (0-10 hr slope).   
 
Fig. 2 Effect of increasing consumption path length on core O2 tension. O2 tension in 
the centre of acellular spiral constructs and constructs  seeded with 11.6 million 
cells/ml and cultured for 24hrs. Constructs had a radial thickness of 1.5mm (15 layers 
spiral) or 2 mm (20 layers spiral), * p<0.05.  
 
Comparison of PASMC vs HDF viability in static cultures 
We have previously established that human dermal fibroblasts (HDFs) seeded at 
23.2x10
6 
cells/ml within 3D compressed collagen constructs retained high (80%) 
core cell viability for up to 5 days in culture [173]. To compare the effect of 
physiological (1-10% O2 or 7.6-76 mmHg) hypoxia on HDF and PASMC viability 
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we measured the difference in PASMC viability between core and surface cells (high 
cell density cultures) over 0-6 days. Exposure of PASMCs to the lowest levels of O2 
(~10 mmHg) in the core had no significant effect on 24 hr cell viability (Fig 3a, b), 
which was over 95% in both the core and surface regions of the construct, indicating 
that this cell type is not significantly susceptible to short term hypoxia.  However, 
after 6 days of static culture, there was a significant reduction in cell viability both at 
the construct core (55%) and surface (75%) (p<0.05) (fig. 3a, b). This decrease in 
cell viability was accompanied by a gradual increase in core O2 tension from 20 
mmHg at 72hrs to 100 mmHg at day 6, as overall O2 consumption was reduced 
apparently due to reduced cell number (fig. 3c). It is important to note, however, that 
this increase in core cell death, at low O2 tension, was accompanied by a smaller but 
still significant level of cell death at the surface, where O2 was not depleted.   
 
 
Fig. 3 Comparison of PASMC core and surface viability over a 6 day culture period. 
(a) Cell viability measured at time zero and then at 1, 3 and 6 days in static cultures 
(23.2 million cells/ml), *p<0.05. 
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(b) Fluorescent images of the central (core; I, III, V, VII) and outer (surface; II, IV, VI, 
VIII) region of constructs seeded with 23.2 million cells/ml and cultured for up to 6 
days under static conditions. Green (calcein) and red (ethidium homodimer) 
fluorescence indicate live and dead fibroblasts, respectively. 
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(c) O2 tension in the centre of spiral constructs seeded with 23.2 million PASMCs/ml 
and cultured for 6 days. 
 
Effect of dynamic perfusion on PASMC viabiliy 
We hypothesized that introduction of forced flow of medium to this static system 
would reduce O2 gradient formation and improve cell viability. Constructs were thus 
cultured under dynamic perfusion. Dynamic perfusion culture of high cell density 
constructs for 6 days significantly improved core cell viability at day 6 (from 55% in 
static culture to 70% in dynamic perfusion culture, p<0.05) (Fig. 4). 6 day surface 
cell viability (88%) was also increased relative to static conditions (75%) but this 
was not statistically significant, being effectively the same as short-term (day 1) with 
minimal cell death (Fig. 4).  Dynamic perfusion culture, however, did not abolish the 
difference in cell viability between core and surface, observed with static culture, 
which remained statistically significant after 6 days (p<0.05). The observed increase 
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in long term core cell viability under dynamic perfusion culture (which presumably 
increased O2 perfusion to the construct core) was in agreement with our previous 
finding that cellular O2 consumption imposed a limitation in core O2 availability and 
compromised cell survival.  
 
Fig.4 Dynamic perfusion increases PASMC viabililty. Cell viability, as measured by 
live/dead assay for constructs seeded with 23.2 million PASMCs/ml and cultured for 1 
and 6 days under static and dynamic perfusion culture conditions,  * p<0.05.  
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8.2 DISCUSSION 
Original Hypothesis: O2 consumption by resident cells (pulmonary artery smooth 
muscle cells), rather than matrix density/diffusion coefficient or diffusion path 
length, is the predominant factor controlling O2 tension in the core of 3D nano-
fibrillar collagen scaffolds. 
 
The findings of this study indicated that the major limiting factor resulting in O2 
depletion in the core of 3D nano-fibrillar collagen constructs was cell consumption 
of O2 and not a limitation of O2 diffusion caused by extended diffusion path-length 
through ECM (up to 1.5-2 mm, as tested in this model). Indeed, previous research 
carried out on thick fibrin matrices has indicated that gel thickness, in the order of 
centimetres, was not a limiting factor for O2 diffusion[94]. Such components of 
native ECM (i.e. collagen, fibrin) have already been used in direct applications as 
biomimetic tissue engineering scaffolds[9].  Differentiating between diffusional and 
cell consumption limitations, in terms of nutrient supply to the scaffold core, is 
critical for the design of bioreactors (where constructs are cultured prior to 
implantation) that aim to improve deep cell perfusion until functional scaffold 
vascularisation is established. In effect, the extent of limitations in nutrient perfusion 
to the scaffold core will ultimately govern its maximum size/thickness, and therefore 
its utility as a tissue repair/regeneration tool. 
It is important to note that while the current model’s tubular geometry mimics ‘3D 
vascular tissue geometry’, it effectively creates radial O2 gradients (surface-to-core) 
which are reverse to the natural gradients (core-to-surface). The use of a tubular 
model in this case did not aim to reproduce the directional anisotropy of in vivo 
gradients, but made it feasible to engineer a 3D model tissue where cell density and 
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radial thickness could be easily and predictably controlled[25], in order to examine 
their effects on spatio-temporal changes in O2 tension. 
There was a direct linear relation between cell density and O2 consumption by 24 
hours, however the initial (0-5 hrs) rate of O2 consumption was not directly 
proportional to cell density. In fact, for the higher cell density (double that of the 
lower cell density) initial O2 consumption was 3 fold higher. This finding seems to 
be in agreement with the well established principle that rates of energy metabolism 
are dependent not only on a single substrate but on the entire nutrient–metabolite 
milieu . For instance, oxygen uptake is enhanced at low glucose concentrations (the 
Crabtree effect, [284]). Oxygen consumption rate also varies with oxygen 
concentration and pH [285]. The linear relationship which develops within 24 hours 
may represent an adaptive response by cells to the surrounding O2 environment. 
There is likely to be an iterative feedback response with regards to O2 consumed and 
O2 available, which in turn will regulate the cellular metabolic response and other 
changes in gene expression, primarily extracellular matrix production and up-
regulation of angiogenic signals (as discussed in Chapter 9) [286,287]. It is 
important to note that smooth muscle cell densities in the present study are 
comparable to those used in previous (vascular engineering) studies (40-100 x 10
6 
cells/ml)[288]. 
Cheema et al. have previously measured O2 consumption by HDFs, cultured in the 
same 3D system. When HDFs were seeded at 23.2x10
6 
cells/ml O2 tension was not 
significantly different  compared to that observed with PASMCs, after 24hrs [173]. 
However, while core O2 tension  (~20mmHg) was found to be stable over extended 
periods, between 24-72hrs for PASMCs, this was not the case with HDF cultures 
where core O2 tension rose back to 65mmHg by 30 hrs (Fig. 1c).  As mentioned 
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above, this is likely to be due to differences in cell metabolism and O2 utilization 
between the two cell types, with HDFs appearing to adapt to hypoxia by reducing 
their O2 consumption (note that the higher O2 tension in HDF cultures was not due to 
cell death, as core HDF viability was not significantly reduced for upto 5 days in this 
system). These findings suggest that PASMCs are high consumers of O2 and that cell 
phenotype, as well as cell density, is an important determinant of O2 consumption.  
Constructs of varying radial wall thickness (15 vs. 20 layers, corresponding to ~1.5 
vs. ~2 mm thickness), and thus of varying diffusion and consumption path length, 
exhibited different plateau values of O2 tension. This response, however, was 
characterized by a 12 hr lag phase. Given the high diffusion coefficient of O2 
through acellular collagen (note: O2 diffusion coefficient in compressed collagen is 
4.5 x 10
-6
 cm
2
/s
-1 
, which is in the range of native intestinal submucosa[289]
 
), the 
33% increase in material thickness (i.e. diffusion path length) must have minimally 
limited O2 diffusion, which was in agreement with experimental data (shown by the 
lack of significant difference in O2 tension in the core of acellular contructs of 1.5 
and 2 mm radial thickness). This indicates that the 12hr lag phase observed here was 
a function of the cell O2 consumption gradient established in this system. Controlling 
construct thickness (i.e. the number of cell-seeded layers/consumption path length), 
as well as cell density (i.e. the number of cells per layer/unit area), could thus 
provide an additional means for controlling the rate of O2 consumption through a 
construct (Fig.5).  This ability to selectively and predictably ‘tune’ O2 distribution 
and local tissue perfusion within a 3D construct  could have important implications 
for the layer-by-layer assembly (e.g. cell-sheet and matrix-sheet engineering) 
approach which has been pursued by a number of groups due to its architectural 
relevance to native tissue (e.g. blood vessel) structure [86,290,291].  
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Fig.5 Schematic showing how O2 tension could be ‘tuned’ within a 3D layer/sheet-based 
scaffold. Cell O2 consumption generates an O2 gradient from the surface to the core 
region of the scaffold. By controlling (A) the cell density (i.e. number of cells per 
layer/unit area), (B) the number of cell-seeded layers (i.e. consumption path length) 
and (C) the type of seeded cells (and their spatial position), it is theoretically possible to 
predictably define the local O2 microenvironement at any chosen point in 3D. This is 
key for optimising deep cell O2 perfusion and engineering correct, biomimetic O2 
gradients where they are functionally important. 
 
While our data suggest that in cell-seeded collagen constructs the formation of O2 
gradients was the result of cell consumption, it is possible that changes in material 
properties through cell-mediated matrix remodelling could have also contributed at 
later stages to changes in O2 diffusion[292]. Indeed, cell-seeded constructs cultured 
for 2 days had a 2.5 fold higher stiffness modulus compared to day 0 cell-seeded 
constructs (data not shown). Within such a short time period, however, and given the 
high initial stiffness (1.8 MPa [25] ) of acellular compressed collagen matrix (~50 
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fold higher than the stiffness of uncompressed collagen hydrogels, 40 KPa [166], 
which undergo cellular remodelling within 24hrs), this  increase in stiffness was 
likely contributed by cytoskeletal elements (cytoskeletal stiffness) which act 
additively to matrix stiffness [293]. Nonetheless, it is possible that over longer 
periods of culture, cell-mediated matrix remodelling (increase in density of collagen 
filaments or cross-linking between collagen fibrils i.e. change in the porosity of the 
material), could have a significant effect on O2 diffusion[294].    
Viability of PASMC in the core of high cell density constructs exposed to levels 
<10mmHg of O2, remained high (~80%) up to 3 days, however by day 6 this level 
decreased to 58%.  We have established then that PASMCs can survive 
physiological hypoxic conditions for at least 24hrs. While PASMC exposure to 
hypoxia did not result in rapid cell death, continued exposure did kill cells, probably 
until the core O2 rose again, sparing the remaining cells.  It is important to note that 
while plastic compression has previously been shown not to significantly reduce cell 
viability [25], at such  high seeding cell densities no cell proliferation occurred 
[166]. This implies that there was a net reduction in cell number within constructs at 
6 days. Not surprisingly, this was accompanied by a gradual increase in core O2 
tension, in agreement with reduced overall O2 consumption, representing a natural 
feedback mechanism, likely to mirror that found in vivo. A previous study has shown 
that the micro-environment within polymer scaffolds containing transplanted 
hepatocytes was hypoxic (pO2 < 10 mmHg) after 5 days in vivo[295], indicating that 
the detrimental effect of hypoxia on long term cell survival is not limited to in vitro 
culture. However, this study highlights that the reported effect of hypoxia on cell 
viability has to be treated with caution, as different cell types show different 
consumption and sensitivity to reduced O2 tension. As discussed above, HDFs can 
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adapt to hypoxia by reducing their O2 consumption resulting in preservation of long 
term viability (Fig. 6). This has important implications for controlling deep cell O2 
perfusion in engineered complex/heterogeneous tissues where two or more cell types 
are present (such as blood vessels) (Fig.5).  
 
 
Fig.6 Comparison of core and surface cell viability for 3D collagen constructs seeded 
with HDFs or PASMCs at high density over 6 days static culture. Cell viability, as 
measured by live/dead assay for constructs seeded with HDFs and PASMCs at 23.2 
million cells/ml and cultured for 1 and 6 days under static culture conditions, 
*p<0.05.Comparative HDF data has been derived from Cheema et al [296].  
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In our 3D model, in addition to O2 availability, the diffusion of key higher molecular 
weight nutrients (e.g. glucose) could be a limiting factor for cell survival. Glucose 
diffusion coefficients have previously been established and this was not found to be 
limiting for cells in the same 3D model [297]. While glucose diffusion might not be 
a limiting factor, static culture of cells within this 3D model does produce a glucose 
consumption gradient from the construct surface to its core within 24hrs [297], 
implying that low core glucose levels could have contributed to decreased core cell 
viability. However, previous work has shown that fibroblasts exposed to hypoxia 
become tolerant to glucose starvation as they switch to amino acids as an energy 
source [298]. Whether PASMCs respond in a similar manner remains to be 
examined. It is also important to consider the possibility that cells cultured statically 
(without circulation of culture medium) were exposed to increased levels of toxic 
metabolic products (such as lactic acid, not measured here), diffusing away from the 
core cells. This could explain the observed reduction in surface cell viability (25% 
by day 6) which could not easily be explained by any limitations in O2 or glucose 
availability. Indeed, a previous study has shown that effective pH buffering reduces 
cell death by attenuating the acidosis that accompanies anaerobic metabolism [299]. 
The above findings suggest that when engineering functional tissues, a trade-off 
needs to be established  between the high cell density required and O2 
availability[300]. It has thus been suggested that in diffusion-limited (i.e. large) 
tissue constructs, a more sophisticated transport system must be employed 
[199,294,300]. Compared to static culture, dynamic perfusion culture has previously 
been shown to increase gas transport and maintain normoxic levels of O2 tension 
within 3D constructs [301,302]. Here we showed that dynamic perfusion culture 
(over the outer construct surface) significantly improved core cell viability at day 6, 
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although this remained significantly lower than surface cell viability.  These findings 
are in agreement with previous studies that showed that perfusion culture increases 
cell viability within a construct and improves the spatial uniformity of cell 
distribution [303-306].  Since we have shown that O2 availability became limiting 
and impacted on core cell survival in static cultures, the improvement in core cell 
viability observed by medium perfusion was presumably due to an increase in O2 
transport. However, this does not preclude involvement of additional mechanisms 
such as prevention of nutrient depletion at the surface of the construct, as well as 
effective removal of harmful metabolic products released by core cells. 
 
8.3 CONCLUSIONS 
We have determined parameters for the successful culturing of PASMC’s within 
dense collagen tubular constructs resulting in prolonged cell survival. The current 
model establishes that O2 perfusion is primarily dependent on cellular O2 
consumption, therefore being cell-phenotype and density specific. Our findings 
suggest that it could be possible to spatially organize cells within 3D constructs to 
control O2 distribution throughout the construct, as well as to limit/control O2 
perfusion to certain well-defined construct areas. These controls could potentially act 
as effectors of metabolic or angiogenic cell signalling, as discussed in Chapter 9. 
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8.4. MATERIALS & METHODS 
Preparation of 3D Plastic Compressed collagen gel constructs  
Once detached, PASMCs were counted and embedded in 3D collagen type I gels 
(see Chapter 2). Collagen gels were set in a mould with dimensions 2.2 (width) x 3.3 
(length) x 1 cm (height). Gels were then removed from the mold and routinely 
compacted by a combination of compression and blotting between layers of 
supporting nylon mesh and filter paper sheets [25] (see Chapter 2). Plastic 
compression produced flat collagen sheets (96.4±8.7µm thick [25]) protected 
between two nylon meshes. This did not significantly reduce cell viability[25]. These 
dense, dehydrated collagen sheets were then rolled around a 1mm external diameter 
hollow mandrel (0.8mm internal diameter) to produce tight spirally wound tubular 
constructs, ~4 mm in external diameter, 21 mm in length (Fig 7a). Use of a tubular 
construct model in this case enabled rapid and precise layering of collagen sheets 
which would be technically difficult with a planar model. Construct radial (wall) 
thickness was varied between ~1.5 mm and ~2 mm by controlling the starting sheet 
length of the collagen sheet, hence the number of spiral layers; PC collagen sheets of 
3cm in length produced 15 layer spiral constructs, corresponding to 1.446±0.13mm 
radial wall thickness (each layer was 96.4±8.7µm thick), while sheets of 4.5cm long 
produced 20 spiral layers and 1.93±0.17mm radial wall thickness. There was no 
significant change in radial wall thickness of cell-seeded constructs over a 3 day 
culture period (data not shown).  Required cell densities were calculated in direct 
proportion to the initial cell seeding density and fluid loss during plastic 
compression. Final cell density was calculated as: initial cell density x fold volume 
change during PC. Hence for a typical initial gel volume of 5 ml, and collagen 
concentration of 0.2%, this increased to 11% following compression (measured by 
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dry/wet weight ratio), corresponding to a 58-fold increase. Since all seeded cells 
remain within the PC collagen gel, final cell density increased in proportion from 
200,000 cells/ml (or 1 million cells/construct) to 11.6 million cells/ml, and from 
400,000 cells/ml (or 2 million cells/ construct) to 23.2 million cells/ml [173].   
 
Oxygen monitoring  
Fibre-optic O2 probes (Oxford Optronix, Oxford, UK) were inserted into the lumen 
of acellular and cell-seeded 3D tubular constructs by first inserting the probe into the 
mandrel, positioning it halfway along the long axis of the construct and withdrawing 
the mandrel to leave the sensor probe (280 μm diameter)  in the construct lumen 
(1mm diameter) (Fig. 7a). The constructs were then sealed at both ends using 
cyanoacrylate glue. In addition to preventing O2 diffusing longitudinally into the 
construct from the two ends, sealing the ends also ensured that spiral constructs were 
kept from unwinding in culture and that the O2 probe was secured in place to prevent 
its longitudinal and radial movement during the experiment. Hence, a diffusion 
length of >1 mm was dominant throughout the construct, radially across the tube 
wall from lumen to surface. The 3D monitoring set-up is shown schematically in 
figure 7b. 3D samples were cultured statically in standard 100ml universal tubes. 
Constructs attached to O2 probes were bathed in 50 ml complete medium composed 
of F12 Ham’s media supplemented with 10% (v/v) fetal calf serum (FCS, First 
Link,UK), 2 mmol/l glutamine (Gibco Life Technologies, UK), 1,000 U/ml 
penicillin and 100 mg/ml streptomycin (both from Gibco Life Technologies, UK). 
There was no change of medium during each experiment. The tip of the sensor probe 
incorporates an O2-sensitive luminescent compound within an O2-permeable matrix. 
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Quenching of the luminescence by molecular O2 allows the luminescence emission 
lifetime to be used as a read-out of O2 tension in immediate surroundings. The 
calibration of the optical O2 probe is accurate to 0.7mmHg, with exceptional stability 
over 6 days at the slowest sampling rate [173]. Readings were taken continuously in 
real-time. O2 tension in the construct core refers to measurements recorded within 
the construct lumen, while O2 tension at the construct surface refers to O2 tension 
recorded in the surrounding media. After each experiment, the probe reading was 
taken in the external medium to confirm minimal drift in response. Fibre-optic 
probes were used in conjunction with an OxyLab pO2ETM system (Oxford Optronix 
Ltd, Didcot, UK) coupled to an A/D converter (12 bit) with data collection to 
Labview (National Instruments, Texas, USA). Results are presented as partial 
pressure values (i.e. pO2) in mmHg (e.g., 7.6mmHg corresponds to 1% O2). To 
calculate O2 consumption rate (mmHg O2/hr) in cell-seeded constructs, the hourly O2 
tension in cell-seeded constructs was subtracted from the 24hr average O2 tension in 
acellular constructs. 
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Fig.7 Experimental setup used for monitoring O2 tension in the core of 3D collagen 
constructs. (a) Schematic of development of tubular spiral collagen constructs. 
Compressed collagen sheets were spiraled round a mandrel and an O2 probe was 
inserted into the mandrel before the mandrel was withdrawn, leaving the probe in the 
centre of the construct. Constructs were then sealed at both ends using cyanoacrylate 
glue, which also ensured that spiral constructs were kept from unwinding in culture. 
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(b) Schematic of the experimental set up, with the O2 probe in the centre of a spiraled 
plastic compression construct. Constructs were cultured in 50 ml media. (c) Assessment 
of cell viability involved unrolling 3D constructs and dissecting 2 regions corresponding 
to the core and surface of the spiral constructs. 
 
Quantification of cell viability 
Cell viability was qualitatively assessed using the Live/ Dead Viability/Cytotoxicity 
Kit (Molecular Probes, L-3224, Oregon, USA) based on the simultaneous staining of 
live and dead cells with calcein AM and ethidium homodimer (EthD-1), 
respectively. Quantitative analyses were carried out with Live/Dead Reduced 
Biohazard Viability/Cytotoxicity Kit (Molecular Probes, L-7013, Oregon, USA) 
according to the manufacturer’s protocol. SYTO-10, a green fluorescent nucleic acid 
stain and Dead Red (ethidium homodimer-2) were used, and, after capturing images, 
live/dead nuclei were counted to give % cell viability.  Spiral constructs were first 
unrolled and then cut into 2 sections, corresponding to core and surface regions and 
stained (fig.7c). Viability of cells in each construct was performed independently 
from the O2 measurements. Representative areas were chosen in two regions (core 
and surface) of PC constructs and were visualized using confocal microscopy (Bio-
Rad Radiance 2100, Carl Zeiss Ltd, Hertfordshire, UK).  Five or more random fields 
were viewed per section with at least 3 samples for each experimental condition.  
Dynamic perfusion cell culture 
Collagen spiral constructs were produced by rolling PC cell-seeded collagen sheets 
round a solid mandrel (1mm diameter) and sealing the ends of each construct using 
cyanoacrylate glue. The mandrel supporting the constructs was then inserted into a 
silicone tube (8 mm internal diameter, 80cm length)  connected at one end to a 
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peristaltic pump (Masterflex,, Cole Parmer) and at the other end to a 500 ml media 
reservoir. The flow rate was adjusted so that the constructs were perfused with 
medium, round the outer construct surface (i.e. no medium flow through the lumen), 
at a constant rate of 1 ml/min throughout the culture periods of 24hrs or 6 days 
(Fig.8). 500 ml complete medium was re-circulated during the culture period.  
 
Fig.8 Schematic showing setup used for dynamic perfusion culture of constructs. 
Constructs were perfused with medium at a constant flow rate of 1ml/min in a re-
circulating bioreactor and were cultured for 1 or 6 days. Note that this model produced 
reverse flow, i.e. flow occurred round the outer construct surface and not through the 
construct lumen.   
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CHAPTER 9 
CONTROLLING PHYSIOLOGICAL ANGIOGENESIS BY 
HYPOXIA-INDUCED SIGNALLING 
 
The full sequence of signals leading to new blood vessel formation is a physiological 
response to tissue hypoxia, mediated by upregulation of a cascade of angiogenic 
factors.  Controlled initiation of this mechanism for therapeutic/engineered 
angiogenesis must rely on precisely localised hypoxia. In Chapter 8 we showed that 
by controlling the seeding cell type,  density and position, therefore cell-depot O2 
consumption, it is possible to define accurately where the hypoxia will develop 
within a 3D construct (i.e. core O2 < surface O2). In this study we have designed a 
3D in vitro model able to test the effect and predictability of spatially positioned 
local hypoxic stimuli using defined cell depots in different locations within a 3D 
collagen matrix. Cell-mediated hypoxia was engineered using human dermal 
fibroblasts (HDFs), to generate a local population of Hypoxia-Induced Signaling 
(HIS) cells. We tested the hypothesis that 3D co-culture of a HIS cell population 
(HDFs) with endothelial cells (ECs), would rapidly induce a physiological 
angiogenic response. In this 3D in vitro model the directing HIS cells (hypoxic 
HDFs) and the responding ECs could be spatially positioned to prevent initial direct 
cell contact. HDFs were either exposed to normoxia (incubator levels) or localized 
physiological hypoxia to up-regulate critical angiogenic factors (HIF-1α, VEGF). In 
vitro bioresponse was monitored in terms of EC migration and tube formation 
towards the angiogenic factor source (HIS cells).  The practical effectiveness of 
spatially controlled hypoxia-induced signaling to promote and direct vascularisation 
in vivo was then tested by implanting collagen constructs, incorporating HIS cell 
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depots in their core, subcutaneously and intramuscularly in rabbits.  The effect of 
pre-conditioning constructs prior to implantation, to optimize up-regulation of 
angiogenic signaling, was assessed using specific EC staining, while the 
functionality of newly formed vessels was assessed by extended real-time O2 
monitoring.  
9.1 RESULTS 
In vitro induction of angiogenesis by hypoxia-induced signaling  
HDFs and human umbilical vein endothelial cells (HUVECs) were spatially 
positioned within sheet or spiral collagen constructs such that the two cell 
populations were separated by an acellular region (Fig. 1A, also see methods). HDFs 
were seeded at high density (23.2x10
6
 cells/ml) such that in the spiral constructs 
(axial and radial models) cell O2 consumption rapidly (within 24h) generated 
physiological hypoxia (~25mmHg /3.2% O2) in the HDF compartment’s core [173]. 
In contrast, HDFs within sheet constructs (~200µm thick) were constantly exposed 
to near culture medium O2 levels, i.e. non-hypoxia (140-160mmHg/ 18.4-21% O2,) 
[173].  
We tested the hypothesis that co-culturing hypoxia-induced signaling HDFs (HIS-
HDFs) with ECs (HUVECs), within 3D spiral constructs, would result in a 
physiological angiogenic response.  In such HIS-HDF/EC co-cultures ECs formed 
CD31 and vWF positive clusters and capillary-like structures (CLSs) with lumens 
after 1 week in vitro culture (Fig.1A). CLS formation in the HIS-HDF compartment 
indicated that ECs had migrated through the acellular region and invaded the HIS-
HDF compartment by 1 week, suggesting that a functional angiogenic factor gradient 
was established from the HIS-HDFs towards the EC zone. In addition, CLSs in the 
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EC compartment stained positively for integrin αvβ3(Fig.1A), typical of migrating 
endothelial cells [307].  
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Fig.1  
Induction of in vitro angiogenesis by hypoxia-induced signalling (HIS). (A) Capillary-
like structures (CLSs) and endothelial cell clusters (ECCs) in (I) core of HIS-HDF/EC 
axial co-cultures, (II) surface of HIS-HDF/EC axial co-cultures, (III) HIS-HDF/EC 
radial co-cultures, (IV) HDF/EC sheet co-cultures and (V) EC only-cultures at 1 and 2 
weeks; visualised with  human anti-CD31, anti-vWF, anti-integrin αvβ3 (green) and 
DAPI nuclear staining (blue) (bars=200µm). H&E staining of HIS-HDF/EC axial co-
cultures (cross-sections) showed CLS lumens (arrowed, bars=100µm). Note the 
increase in the number of lumens in the core of axial co-cultures from 1 to 2 weeks. 
Schematic indicates the region in the construct where images where taken for the three 
different co-cultures. 
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(B) Quantification of CD31+ve CLSs (in HDF compartment) of HIS-HDF/EC axial co-
cultures (core and surface analysed separately), HIS-HDF/EC radial co-cultures, 
HDF/EC sheet co-cultures and EC-only cultures (1 & 2 weeks). (C) Comparison of core 
and surface total lumen area (H&E stained sections as % total section area) for HIS-
HDF/EC axial co-cultures (1 & 2 weeks). 
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(D) Comparison of CD31+ve CLSs in HIS-HDF and EC compartments of axial co-
cultures (core & surface; 2 weeks). (E) Mean length of CD31+ve CLSs in HIS-HDF and 
EC compartments of axial co-cultures (core & surface) and radial co-cultures at 2 
weeks. 
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(F) Mean CD31+ve endothelial cell clusters (ECCs) in the HDF compartment of HIS-
HDF/EC axial and radial co-cultures, HDF/EC sheet co-cultures and EC-only cultures 
(1 & 2 weeks). (G) Mean ECC area for each condition (1 & 2 weeks). Note ECCs were 
absent in the core of axial co-cultures at 2 weeks. For plots B, D, E, F, G bars 
correspond +/-se of means, for plot C bars correspond +/-sd of means, *p<0.05. Four 
constructs were tested for each condition per time point. 
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At 1 week all 3D spiral co-cultures (axial and radial models) had significantly 
greater CLS scores than non-hypoxic sheet co-cultures or EC-only culture controls 
(p<0.05) (Fig.1B). After 2 weeks only the core of axial co-cultures had significantly 
greater CLS density, though this was by a factor of 5 to 10 fold depending on which 
zones/models were compared. Specifically, CLS density was ~6 fold higher in the 
core of axial co-cultures compared to the surface (p<0.05) (Fig.1B).  
In HIS-HDF/EC co-cultures the spatial positioning of the two cell populations had a 
direct effect on the pattern of angiogenesis. In axial model co-cultures there was a 
significant increase in the number of CLSs, within the HIS-HDF compartment, in the 
core, but not on the surface, from 1 to 2 weeks (Fig.1B). A similar response was also 
seen for total lumen area, which increased from 1 to 2 weeks only in the core of axial 
co-cultures, in this case by ~2 fold (Fig.1C). The number of CLSs in the HIS-HDF 
and EC compartments of axial co-cultures was the same at the construct surface, but 
~3 fold greater within the core HIS-HDF compartment than in the core EC 
compartment, at 2 weeks (p<0.05) (Fig.1D). In contrast, radial model co-cultures 
produced a small CLS response at 1 week (same as axial model) but no increase in 
core CLS score was seen in the radial model from 1 to 2 weeks (Fig.1B), consistent 
with the idea that the 3D growth factor diffusion barrier is also important.  
Mean CLS length within the HIS-HDF compartment (both axial and radial models) 
did not significantly change between weeks 1 and 2 (data not shown). However, the 
3D positioning of the HIS-HDF and EC populations did significantly influence CLS 
length at 2 weeks. In axial model co-cultures, CLS length was over 2 fold greater in 
the EC compartment compared to the HIS-HDF compartment, both in the core and 
on the surface (p<0.05) (Fig.1E). In complete contrast, CLS length in the radial co-
culture model was 5 fold greater in the HIS-HDF compartment (p<0.05). 
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Importantly, CLS elongation index (ratio of straight line separation of CLS ends / 
total CLS length) in the HIS-HDF and EC compartments was in the range of 0.8-1for 
both culture models, indicating that longer CLSs were straight and directional, rather 
than tortuous (i.e. guided).  
Endothelial cell clusters (ECCs) formed in all culture models by 1 week (Fig. 1F),  
but while ECC density showed a near-linear increase over 1 to 2 weeks in radial co-
cultures, sheet co-cultures and EC-only cultures, it fell by at least a half in axial co-
cultures , both in the core and surface regions (Fig.1F). Mean ECC area was 
inversely correlated to ECC number, showing an increase on the surface of axial co-
cultures (no ECCs were detectable in the core of axial co-cultures at 2 weeks) and a 
reduction (or no significant change) in all other conditions tested, from 1 to 2 weeks 
(Fig.1G). In combination, these findings would suggest that in axial co-cultures 
ECCs progressively fused to form larger aggregates or CLSs (in the core), while in 
all other conditions tested endothelial cells continued to form clusters with no 
significant change in cluster size.  
 
Hypoxia-induced generation of angiogenic factors 
Previous work by this group has shown a dramatic upregulation of VEGF gene 
expression under physiological hypoxia in the core of 3D HDF-collagen constructs, 
over 8 days [173]. Figure 2 shows the expression of key angiogenic factors at the 
protein level over the 5-10 day period of culture. 3D constructs of EC-only cultures 
(1.16 x10
6 
HUVECS/ml) and HIS-HDF/EC axial co-cultures (23.2 x10
6
 HDFs/ml 
and 1.16 x10
6 
HUVECs/ml in the HIS-HDF and EC compartments, respectively) 
were compared. ELISA was used to quantify HIF1α and VEGF165 protein secreted in 
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the media or retained within the constructs. As expected no HIF1α (a nuclear 
transcription factor) was detected in any of the media. HIF1α was present within 
HIS-HDF/EC co-culture constructs, but there was no significant difference in HIF1α 
levels between 5 and 10 days, indicating that HIF1α expression had peaked early on 
during culture (Fig. 2A). This was in agreement with previous data that showed that 
HDFs were exposed to hypoxia within 24hrs in this system[173]. Importantly, 
HIF1α was not detectable within EC-only culture constructs, indicating that ECs in 
co-cultures were not exposed to hypoxia (EC density was identical in EC-only 
cultures and co-cultures) (Fig.2A). VEGF165 was found both in the media and within 
the constructs of HIS-HDF/EC co-cultures, at 5 and 10 days, indicating that VEGF 
was partially retained within these nano-porous collagen scaffolds (Fig.2B). VEGF 
retention: release ratio was approx. 3:1 (construct : medium) at 10 days. While 
VEGF protein levels showed an increase from 5 to 10 days culture, both in the media 
and within constructs, this increase was statistically significant only for constructs, 
with VEGF levels increasing by 7 fold (p<0.05) . This was consistent with increasing 
VEGF gene expression over 8 days [173]. No VEGF was detectable in either the 
media or within constructs of EC-only cultures, at both 5 and 10 days (Fig. 2B), 
which was in agreement with the absence of HIF1α expression. 
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Fig.2 
Localised exposure of HDFs to physiological hypoxia resulted in up-regulation of 
angiogenic factor protein expression in vitro. ELISA was used to analyse protein levels 
of HIF-1α (A) and VEGF165 (B) secreted in the media or retained within collagen 
constructs of either EC-only cultures (1.16x10
6 
/ml) or HIS-HDF/EC axial co-cultures 
(23.2 x10
6
 HDFs/ml and 1.16 x10
6 
HUVECs/ml) at 5 and 10 days . Plot (A) shows HIF-
1α within collagen constructs only as no HIF-1α could be detected in the media.  VEGF 
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was produced into both collagen constructs and media, though not by ECs.  Basal 
(zero) control medium was DMEM supplemented with 5% FCS. Bars correspond +/-sd 
of means, *p<0.05. For each factor three samples were analysed per time point, per 
condition tested.  
 
Reversal of angiogenic response to hypoxia-induced signaling 
The basic hypothesis here suggests that blocking the function of one of the key 
angiogenic factors (e.g. VEGF) would reverse the cellular angiogenic response to 
hypoxia-induced signaling  in this 3D system. Ability to block the HIS angiogenic 
response was tested in HIS-HDF/EC axial co-cultures pre-incubated with either non-
specific IgG or anti-VEGF neutralizing IgG. Anti-VEGF blockade did not affect the 
previous response in terms of number of CLSs formed within the HIS-HDF 
compartment, either in the core or on the surface at 1 week (data not shown). 
However, figure 3 shows that anti-VEGF blockade did reduce the mean length of 
CLSs formed within the HIS-HDF compartment. While this inhibition of function 
was seen in both the core and surface zones compared to non-specific IgG controls, 
at 1 week, the difference was only significant on the surface (p<0.05). This could be 
due to partial diffusion of antibody through the construct. Indeed, measurement of 
IgG permeability through compressed collagen membranes (by filtration test) 
showed that at least 7% of IgG was retained per collagen layer of the spiral (each 
spiral comprising 5 layers). The significant, but partial, abolition of function seen at 
the surface, where VEGF blockade was not limited (constructs incubated at 
saturating concentration of anti-VEGF IgG) indicated that anti-VEGF treatment was 
only partially effective in blocking the HIS mediated angiogenic response. 
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Fig.3 
Blocking the function of VEGF only partially abolished the angiogenic response to 
hypoxia-induced signalling. HIS-HDF/EC axial co-cultures were incubated with either 
non-specific IgG or anti-VEGF IgG, at saturating concentration (10µg/ml), for 1 week 
and the length of CD31+ve CLSs  within the HDF compartment was analysed for the 
core and surface zones  separately. Bars correspond +/-se of means, *p<0.05. Four 
constructs were tested for each condition.  
 
Matrix remodelling during angiogenic induction 
It is well documented that during the early stages of vessel growth, controlled local 
dissolution of the ECM by proteolytic enzymes, including the matrix 
metalloproteinases (MMPs), is important not only for the coordinated movement of 
endothelial cells, but also for the release of sequestered angiogenic molecules [308]. 
We therefore investigated the expression of two angiogenic factor-regulated MMPs, 
MMP-2 and MMP-9[308], during angiogenic induction in this 3D system. ELISA 
was used to analyse protein levels of MMP-2 and MMP-9 secreted in the media or 
retained within collagen constructs of HUVEC only-cultures and HIS-HDF/EC axial 
242 
 
co-cultures over the 5-10 day period of culture. For both culture conditions MMP-2 
was present in the media and within collagen constructs, at 5 and 10 days, indicating 
that MMP-2 was partially retained within collagen scaffolds (Fig.4A). No significant 
difference in MMP-2 levels was observed, either in the media or within collagen 
constructs, from 5 to 10 days culture for either culture condition (Fig.4A).  However, 
HIS-HDF/HUVEC co-cultures produced significantly higher levels of MMP-2 than 
HUVEC only-cultures at both 5 and 10 days (~2 and 10 fold difference in media and 
collagen construct levels, respectively), suggesting additional production of MMP-2 
by HIS fibroblasts and/or differences in the regulation of MMP-2 expression by 
hypoxia-induced angiogenic factors [308,309]. Compared to levels of MMP-2, the 
amount of MMP-9 protein secreted in media or retained within collagen contructs 
was significantly lower (Fig.4A, B). While MMP-9 was detected in the media and 
collagen constructs of HIS-HDF/HUVEC co-cultures, at 5 and 10 days, no 
significant amounts were detected in HUVEC only-cultures (Fig.4B). As with the 
expression of MMP-2, the length of the culture period did not have any significant 
effect on the levels of MMP-9 protein. The expression of MMP-2 and MMP-9 in this 
system confirms that the hypoxia-induced angiogenic response observed in HIS-
HDF/HUVEC co-cultures was accompanied by active matrix remodelling.  
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Fig.4 Localised exposure of HDFs to physiological hypoxia results in up-regulation of 
angiogenic factor-regulated MMPs in vitro. ELISA was used to analyse protein levels of 
MMP-2 (A) and MMP-9 (B) secreted in the media or retained within collagen 
constructs of HUVEC only-cultures and HIS-HDF/HUVEC co-cultures at 5 and 10 
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days in vitro culture. Bars correspond +/-sd of means, *p<0.05. Three samples per time 
point were analysed for each MMP, per condition tested. 
 
In vivo vascularization of constructs by hypoxia-induced signaling  
We previously found that vascular in-growth into 3D spiral collagen constructs  in 
vivo, without insertion of angiogenic signaling, was typically seen 3 weeks post-
implantation [54]. We therefore tested if 3D constructs containing HIS fibroblasts 
would become vascularized earlier. The ability to further accelerate construct 
vascularisation by speeding up angiogenic factor expression through in vitro pre-
conditioning was also tested. Acellular or rabbit dermal fibroblast (RDF)-seeded 
collagen constructs were implanted subcutaneously into the back of rabbits. All cell-
seeded constructs comprised of a HIS-RDF core and an outer acellular wrap (Fig.5, 
also see methods). Cellular constructs were: (i) low density (5.8 x10
6
 RDFs/ml) pre-
conditioned (LDPC), (ii) high density (23.2 x10
6
 RDFs/ml) pre-conditioned (HDPC) 
and (iii) high density (23.2 x10
6
 RDFs/ml) non-pre-conditioned (HD) constructs.  
Total white blood cell count in rabbits implanted with cell-seeded constructs was 8.2, 
15.5, 9.1, 5.5 x 10
9 
cells/L on day 0, 1, 7 and 14 respectively, indicating that the 
inflammatory response had subsided by 7 days. 
In contrast to acellular constructs, which showed no visible vascularisation at 1 
week, LDPC, HDPC and HD constructs were all visibly vascularised by 1 week in 
vivo (Fig.5A). Importantly, host vessels that had invaded the engineered collagen 
constructs at 1 week contained intra-luminal red blood cells (RBCs), suggesting that 
these vessels were perfused by 1 week (Fig.5B). Furthermore, permeating host blood 
vessels stained positively with anti-CD31 (Fig.5B). 
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Fig.5 
Hypoxia-induced signalling in vivo promoted rapid vascularization of cellular 
constructs. (A) Collagen constructs +/- RDF seeding were sutured subcutaneously into 
the back of rabbits for 1 or 2 weeks. Cell-seeded constructs were low density (5.8 x10
6
 
RDFs/ml) pre-conditioned (LDPC), high density (23.2 x10
6
 RDFs/ml) pre-conditioned 
(HDPC) and high density (23.2 x10
6
 RDFs/ml) non-pre-conditioned (HD) constructs. 
Pre-conditioning involved 5 days static culture of constructs prior implantation. 
Macroscopic images were taken directly after suture removal and implant recovery. 
Arrows indicate host vessels that had infiltrated the implants (bars=0.5cm). (B) (i) Co-
localisation of H&E staining (left panel, showing a red blood cell-filled vessel lumen) 
with CD31 (right panel, showing endothelial cells lining the lumen) in a 2 week HDPC 
construct. H&E staining, arrows indicate areas which have been magnified: (ii) 
Transverse section of 1 week HDPC construct with magnification image. Schematic 
indicates the corresponding plane within the construct. (iii) Transverse section of 2 
week HDPC construct with magnification image. Long arrow indicates penetration of 
cells towards the construct core. CD31 staining counterstained with haemotoxylin, 
arrows indicate CD31+ve endothelial cells lining vessel lumens: (iv) Positive control- 
muscle from rabbit. (v) 1 week LDPC construct. (vi) 1 week HDPC construct. (vii)  2 
week LDPC construct. All magnification bars are 100µm.   
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 (C) Quantification of the total area of RBC-containing lumens (total area of all RBC-
containing lumens in H&E stained sections as percentage of total section area) in 
subcutaneously implanted acellular, LDPC, HDPC and HD constructs, at 1 and 2 
weeks implantation. (D) Quantification of host blood vessel radial invasion distance 
(average radial distance of RBC-containing lumens (H&E stained) from construct 
edge) for all conditions tested, at 1 and 2 weeks implantation. Dashed line indicates the 
distance (0.77mm) from the constructs’ surface to the cellular core. Bars correspond to 
+/-sd of means, *p<0.05. Six constructs were tested for each condition, for 1 and 2 
weeks implantation.   
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LDPC constructs had the largest total area of invading RBC-containing host vessels, 
being 10 fold greater than acellular controls (p<0.05), and HDPC constructs the 
least, after 1 week (Fig. 5C). Although differences between cellular constructs were 
not statistically significant (p>0.05) due to high variance, the pattern was identical in 
2 sets of constructs, harvested at 1 and 2 weeks, suggesting that these trends were 
real . There was an overall increase in the total area of RBC-containing host vessels 
in all implanted constructs, including acellular constructs, by 2 weeks post-
implantation, consistent with the anti-CD31 staining (Fig. 5B). While all cellular 
constructs showed greater vascularisation than acellular constructs at 2 weeks, this 
difference was smaller than at 1 week and not statistically significant (p>0.05) 
(Fig.5C). Radial invasion distance of host blood vessels into the collagen spirals was 
approx. 2 fold higher for cellular constructs compared to acellular constructs at 1 
week (Fig. 5D), though blood vessels had only penetrated into the acellular wrap 
(~0.77mm thickness) in cell-seeded constructs, without reaching the cellular core, at 
1 week (Fig. 5D). Acellular construct vascularisation had caught up by 2 weeks, 
though by this stage some host blood vessels had penetrated into the core of LDPC 
and HD constructs (Fig. 5D).  
In vivo vessel functionality was assessed by real-time monitoring of core O2 levels in 
acellular or RDF-seeded spiral constructs, implanted intramuscularly in the back of 
rabbits, over 2 weeks (Fig.6A). In this case, cellular constructs were seeded at low 
density (LD: 5.8 x10
6
 RDFs/ml) or high density (HD: 23.2 x10
6
 RDFs/ml) and 
implanted directly without any in vitro pre-conditioning. As before, by 2 weeks host 
vessels containing intra-luminal RBCs were present in acellular, LD and HD 
constructs, although both types of cellular constructs were more profoundly perfused 
than acellular conctructs (Fig.6B). Not surprisingly, initial (day 0, immediately post 
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surgery) core O2 levels of LD and HD constructs were approx. 30% (p>0.05) and 
90% (p<0.001) less compared to acellular constructs, respectively (Fig.6C). 
However, while core O2 levels of acellular constructs continued to drop over the 
whole 2 weeks (due to inflammatory and connective tissue host cell infiltration [54])  
core O2 levels of LD constructs leveled off at a min (5-10 mmHg) by day 3. 2 week 
core O2 levels in LD constructs were 4 fold higher than in acellular constructs. This 
correlated with a 2 fold greater area of RBC-containing vessels in LD constructs 
compared to acellular constructs (Fig. 6D). Core O2 levels in HD constructs 
remained low in the first 5 days (due to their seeded cell O2 consumption), but rose 
by 5 fold by 1 week. This high level of core O2 (12-15 mmHg) was maintained over 
the second week, leaving the HD construct core O2 2 and 10 fold higher than LD and 
acellular constructs, respectively, at 2 weeks. The difference between total area of 
RBC-containing vessels in HD and acellular constructs was not significant (Fig.6D), 
despite the significant difference in core O2 levels at 2 weeks (p<0.05) (Fig.6C).  
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Fig.6 
Assessment of the functionality of invading host blood vessels into implanted constructs 
by real-time monitoring of O2 levels in vivo. (A) (a) Schematic of the setup used to 
monitor O2 levels in the core of intramuscularly implanted acellular or cellular 
collagen constructs. (b)  Collagen construct attached to a cannula ready to be 
implanted. (c) A fibre-optic O2 probe being inserted into the cannula of a rabbit during 
real-time monitoring. (B) Vascularization of intramuscularly implanted constructs; 
acellular, low density (LD; 5.8x10
6
 RDFs/ml), high density (HD; 23.2x10
6
 RDFs/ml) 
after 2 weeks implantation. Construct tissue sections  stained with H&E show clear 
increase in RBC-filled vessel lumens in both types of cellular constructs (bars=100µm). 
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(C) O2 tension in the core of intramuscularly implanted acellular, LD and HD 
constructs over 2 weeks implantation. Results are presented as partial pressure values 
(pO2) in mmHg (7.6mmHg corresponds to 1% O2). Time zero values represent 
readings taken in constructs immediately after implantation.  Bars correspond +/-se of 
means, *p<0.01 (HD vs. LD at day 0), **p<0.001 (HD vs. acellular at day 0), ***p<0.05 
(HD vs. acellular at day 14). Three constructs were tested for each condition (one 
construct per rabbit). (D) Quantification of the total area of RBC-containing lumens 
(H&E stained cross sections, as percentage of total section area) in acellular, LD and 
HD constructs after 2 weeks implantation. Bars correspond to +/-sd of means).  Three 
constructs (n=3) were tested for each condition. 
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9.2 DISCUSSION 
Original Hypothesis: Spatially controlled hypoxia-induced angiogenic factor 
signalling by fibroblast populations, exposed to local cell-mediated hypoxia in 3D 
collagen matrices, will promote directed endothelial cell migration and tubule 
formation in vitro and in vivo. 
 
The well recognized principle of complex spatio-temporal/chemical co-ordination in 
angiogenesis [196,310,311] was highlighted here in the finding that functional 
blocking of VEGF only partially abolished the HIS angiogenic response in vitro. 
This has important implications for engineering angiogenesis. Indeed, trying to 
mimic the necessary physiological complexity using bottom-up engineering of 
angiogenic cocktails appears to be near insurmountable at our current level of 
understanding [310,312,313].  A clear alternative is to engineer the onset of the 
process by producing local hypoxia (which is easier to control) in engineered cell 
populations to upregulate hypoxia-induced signaling (i.e. a physiological angiogenic 
cascade). The problem then shifts from trying to mimic a complex chemical 
language to engineering a predictable local cell-hypoxia.  
Exposure of  cells to physiological hypoxia has been shown to be effective in 
activating the production of cell-generated angiogenic factors [173,192,314]. In this 
study we have demonstrated that O2 consumption by a high density depot of normal  
HDFs generated a self-sustaining HIS cell response leading to the production of a 
functional sequence of critical angiogenic factor proteins. While physiological 
regulation of the O2 microenvironment in this system maintained a high cell viability 
(>80%) up to 5 days, some level of HIS cell damage or death is expected over longer 
culture periods[173]. It is important to note, however, that metabolic products 
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released from hypoxic tissues (e.g. lactate, pyruvate, adenosine, malate) have been 
reported to be intermediate effectors of angiogenesis[315], rather than inhibit the 
process.  In vitro this resulted in EC migration and tubule formation towards the 
source of angiogenic factors (HIS cells) by 1 week. In contrast to other co-cultured  
(2D) models with mixed cell populations [207,316,317], this model enables the 
spatial segregation of distinct directing and responder cell populations to test the 
effect of contact-independent cell signalling i.e., endothelial cell migration/tubule 
formation along an angiogenic growth factor gradient (note: the stability of cell 
segregation in this model was achieved by the large separation distance (1.5cm) 
between the cell compartments and the retardation of fibroblast migration in 
compressed/dense collagen matrix (see Chapter 7). The ability to spatially position 
HIS cells within a 3D construct also means that exposure of endothelial cells to cell-
generated hypoxia (and its negative impact on cell viability[318]) is avoided, which 
would not be possible with mixed co-culture. Importantly, this novel seeding 
technique lays the foundation for developing endothelial cell-free angiogenic 
implants (tested here in vivo), eliminating cell source limitations and ethical 
considerations. The absence of angiogenic responses in both EC-only cultures and 
sheet co-cultures (no hypoxia) demonstrates the need for hypoxia-induced signaling, 
rather than simple presence of HDFs. Although readily available HDFs were used 
for HIS generation, for simplicity, work from this group and others has shown that 
multiple cell types (e.g. bone marrow-derived stromal cells, vascular smooth muscle 
cells) respond to physiological hypoxia by upregulating angiogenic signaling 
[55,201,204,319,320], suggesting that different cell types could be used as the source 
of HIS cells, provided that cells are exposed to optimum (i.e. cell-type specific) 
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levels of physiological hypoxia [173,204]. It is likely then that this mechanism of 
engineered angiogenesis can be adapted to many tissues.  
The target of this study was to test and evaluate the ability of HIS cells, controlled 
using a model engineered tissue, to induce effective vascularisation. Importantly, a 
collagen type I support material was used to ensure a biomimetic tissue 
microenvironment [25]. The predictive importance of the 3D collagen model for 
practical, precise operation of the engineered angiogenesis cannot be 
overemphasized.  It is clearly possible to use the demonstration of hypoxia-induced 
angiogenesis by simply packing a large number of cells deep into any 3D construct.  
However, while this is eventually likely to generate some form of angiogenic growth 
factor cascade, it is actually of very limited practical significance without the 
precision and control.  The key new element here is that it is possible in principle, 
not only to predict and tune when the angiogenic burst is released, but to what 
extent, how long for and most importantly, where from.  The anisotropy of the 3D 
collagen model reflects the anisotropy found in almost all native tissues.  There are 
two levels of important anisotropy.  The first and least obvious, lies in the ability for 
small molecules (e.g. oxygen, glucose, lactate) to diffuse rapidly in most directions 
through the collagen nano-fibre mesh, even at high collagen densities [173,297]. 
Therefore, in spiral constructs O2 tension is almost entirely determined by cell O2 
consumption (as discussed in Chapter 8)  [55]. Importantly, work from this group 
previously showed that the generated  O2 consumption gradient (core O2<surface O2) 
correlates with greater VEGF gene expression in the core compared to the surface 
[173]. A functional output of this anisotropic effect was the stronger angiogenic 
response observed in the core vs. the surface of HIS-HDF/EC axial co-cultures at 2 
weeks. The second level of anisotropy relates to the diffusion of macromolecules.  
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Since these have longer transit times through the nano-porous collagen mesh, the 
direction and magnitude of macromolecular (e.g. angiogenic factor protein) gradients 
will mainly be determined by the diffusive properties of the matrix [237]. In spiral 
collagen constructs macromolecule diffusion would predominantly occur along the 
path of least resistance i.e. primarily between collagen matrix layers, with slower 
diffusion through layers.  In axial model co-cultures this would generate a strong 
axial angiogenic factor gradient from the HIS-HDFs to the ECs, while in radial 
model co-cultures the presence of this diffusion barrier would reduce the radial 
angiogenic factor gradient established between the two cell populations (Fig.7). This 
could explain why a greater CLS score was obtained in axial model co-cultures 
(core) than in radial model co-cultures at 2 weeks.  
 
Fig.7 Schematic showing the proposed 3D spatial organisation of angiogenic factor 
gradients in the in vitro model used to investigate the induction of angiogenesis by 
hypoxia-induced signalling. In spiral collagen constructs, diffusion of macromolecules 
(i.e. angiogenic factor proteins), produced by HIS cells (HDFs), is predicted to follow 
predominantly the path of least resistance, primarily between collagen matrix layers.  
Diffusion will be far slower through the layers (i.e. across the thickness of the dense 
collagen layers). Based on this analysis, in HIS-HDF/EC axial co-cultures (left panel) a 
strong axial angiogenic factor gradient would be generated from the HIS cells at one 
end to the ECs at the other (i.e. between the spiral layers).  However, in HIS-HDF/EC 
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radial co-cultures (right panel) a much smaller diffusion gradient would be expected to 
develop between the two cell populations, limited by the reduced protein diffusion rate 
through the dense collagen layers.  This prediction, tested here, suggests that spatially-
defined, biomimetic depot-release can be achieved, making it possible to direct the 
angiogenic gradient to a required 3D tissue position.   
 
EC migration has previously been observed in response to gradients of VEGFA 165 
[195]. In the present system far more HIF-1α and VEGF was generated in the HIS-
HDF compartment than the EC compartment, where growth factor proteins were 
undetectable (as demonstrated in the EC-only cultures). This expression correlated 
closely with the larger number of CLSs formed in the HIS-HDF compartment than in 
the EC compartment at 2 weeks (core of axial co-cultures). In contrast, CLS length 
was influenced primarily by the spatial position of ECs relative to HIS cells in the 
spiral. In axial model co-cultures, where ECs were aligned with the axial angiogenic 
factor gradient (Fig.7), longer CLSs formed in the EC compartment than in the HIS-
HDF compartment, i.e. furthest away from the growth factor source, at 2 weeks. This 
is consistent with ECs forming tubular structures back along a gradient, towards its 
source. Importantly, in radial model co-cultures, where protein growth factors had to 
cross the low permeability collagen layers (i.e. a diffusion barrier) to reach the 
responder ECs, CLSs in the EC compartment were shorter. The proposed generation 
of angiogenic factor gradients in this system, then, seems to recapitulate the native 
tissue in that the effects of protein factors are superimposed (sometimes dominated) 
by the ECM 3D structure and its enabling or restricting effects on growth factor 
diffusion [321]. This was further highlighted by the finding that  HIS-HDF/EC co-
cultures produced higher levels of angiogenic-factor regulated MMPs (MMP-2 and -
9) [308] than EC-only cultures, which supports the idea that the HIS angiogenic 
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response may also mediate ECM remodeling, a critical component of physiological 
angiogenesis[308].  
In contrast to CLS formation ‘clustering’appeared to be an intrinsic EC behavior 
rather than a response to hypoxia and angiogenic protein generation [316]. While 
there was minimal or no HIF-1α and VEGF accumulation in EC-only cultures up to 
10 days, this did not prevent EC clustering. However, CLS formation only occurred 
where a HIS-HDF population was present, suggesting that whilst there may be a 
cluster-to-CLS transition, it critically depends on the presence of angiogenic factors 
to progress all the way to CLS formation. Importantly, cluster formation did precede 
CLS formation, suggesting that it is a prerequisite step.  
HIS cell-generated in vivo angiogenesis was achieved within 1 week compared to 
studies where scaffold vascularisation by exogenous delivery of growth factor 
cocktails takes a minimum of 2 weeks [310,312,313]. This time delay is critical for 
implanted tissues, inevitably governing their dimensions and success rate [94]. HIS 
cell-generated growth factor production, in the present study, successfully 
accelerated the formation of functional vessels in vivo by 1 week. The proposed 
mechanism is recapitulation of angiogenic sprouting from the host, as it is known 
that sprouts are formed from existing vasculature in response to gradients of 
angiogenic proteins from avascular (as in this model) or ischaemic tissue [202]. As 
discussed above, the HIS approach  to engineered angiogenesis removes the need to 
seed constructs with  endothelial cells [317], eliminating cell source limitations and 
ethical considerations. A previous study by this group showed that a minimum of 3 
weeks is required for functional vascularisation of low cell density implants [54]. 
The present study showed that even these low cell density constructs have enhanced 
vascularisation (by 1 week) when pre-conditioned for 5 days in vitro, to optimally 
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up-regulate angiogenic signaling [173]. Other groups have reported that hypoxic pre-
conditioning of implanted bone marrow cells increases their angiogenic potency 
through up-regulation of VEGF expression [319,322,323]. This might have 
important implications for use of hypoxic pre-conditioning as an additional strategy 
to vascularise HIS cell-seeded constructs post-implantation.  In our model there was 
no histomorphometric improvement of angiogenesis in vivo using high cell density 
constructs, suggesting that an angiogenic factor cascade is generated at threshold O2 
levels or that in vivo there is a maximum speed of response, independent of growth 
factor levels. This has practical, bio-processing importance where cell availability is 
a limiting factor.  
Real time measurement of changing in vivo local O2 levels, deep inside the implant, 
is probably the most effective/relevant functional outcome of angiogenic engineering 
currently available.   This provides direct readout of the integration and likely 
survival of constructs [324], making close analysis of the core O2 data particularly 
important.  While core O2 tension was initially determined by resident (seeded) cell 
consumption, competition for O2 (and likely other nutrients, not measured here) 
between implant and native tissue became increasingly dominated by 
surrounding/in-growing host cell consumption, as shown by the acellular construct 
baseline which dropped below that of cellular constructs by 5-7 days. Furthermore, 
since there was clear histological evidence of greater infiltration of RBC filled 
vessels in 14 day LD and HD constructs than in acellular constructs, it is probable 
that the 4 and 10 fold difference in core O2 at day 14, respectively, was due to 
increased vascular perfusion. Histological analysis demonstrated that there was some 
level of cell death within LD and HD constructs, indicated by the presence of cell 
sparse areas (especially in the core, data not shown),  by 2 weeks implantation. 
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However, since cell death is hypoxia-driven, it cannot have exceeded the acellular 
construct baseline, confirming the histological data which suggest that the higher 14 
day O2 levels measured within cell-seeded constructs were a result of increased 
vascularisation and not reduced cell O2 consumption. These results further indicate 
that the HIS response was sustained long enough for effective angiogenic induction. 
While it is intended that rapid vascularization of native tissue surrounding the 
implant will also rescue the HIS cell depot, maintaining angiogenic signaling, further 
in vivo work is required to identify the precise effect of initial nutrient deprivation on 
HIS cell viability.  Importantly, the O2 level obtained in HD implants at 14 days 
(~15mmHg / 2%) was near the range reported for normal muscle (20-30mmHg / 2.6-
3.9%) [325], indicating that the implants had at least partially integrated with the 
host tissue. 
 
9.3 CONCLUSIONS 
While it is widely accepted that long-term exposure of cells to hypoxia can be 
detrimental to cell viability, the results of this study demonstrate for the first time 
that spatially controlled, cell-mediated hypoxia can be employed as a stimulus to 
trigger the complete angiogenic factor cascade for induction of a rapid, physiological 
angiogenic response in vitro and in vivo. The control and predictability of this system 
means that this can genuinely claim to be engineered angiogenesis. Indeed, the 
system not only allows the timed switching ‘on’ of local angiogenesis, but also its 
spatial location and even direction. Our findings suggest that while it might not yet 
be possible to contain the extent of engineered ‘on-off’ angiogenesis in vivo (as 
assessed by histological appearance), this system can be used to successfully 
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engineer early functional vascular perfusion of implants, as seen by deep tissue 
oxygenation. The ability to spatially localize HIS cells within a 3D tissue construct 
provides a powerful tool for tissue modeling in vitro (e.g. tumour angiogenesis 
[326,327], drug testing [207]), as well as pre-vascularization or pre-conditioning of 
engineered constructs for improving perfusion post-implantation [294,328]. 
Furthermore, the system is sufficiently flexible and robust to form the platform for a 
range of practical angiogenic therapies. A key strength of this study is the correlation 
of engineered angiogenesis with in vivo O2 monitoring.  This is a powerful indicator 
of successful construct vascularization, survival and integration. Assessment of O2 
and nutrient delivery to any implanted tissue forms the ultimate test of the ability of 
an engineered vasculature to function effectively.  
 
 
9.4 MATERIALS & METHODS 
Scaffold fabrication and culture 
HDF-, HUVEC- and RDF-seeded rat-tail type I collagen gels were prepared as 
previously described [25] (see Chapter 2). For preparing HDF/HUVEC co-seeded 
gels, separately pre-cast collagen gels (size:1.5(L) x 1.5(W) x 1(H) cm) containing 
2x10
6 
HDFs or 1x10
5 
HUVECs were co-transferred into rectangular moulds (size: 
4.5(L) x 1.5(W) x 1(H) cm), maintaining a 1.5cm separation distance between them 
and bathed in 2.25ml acellular collagen solution. The acellular collagen was allowed 
to set and integrate between the 2 other cellular gels in a 37°C, 5% CO2 humidified 
incubator for 30min (Fig.8A) prior to plastic compression (see Chapter 2). For 
preparing RDF-seeded gels, collagen gels (size:1.5(L) x 1.5(W) x1(H) cm) 
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containing 5x10
5
 or 2x10
6
 RDFs were transferred into one end of rectangular moulds 
(size:4.5(L) x 1.5(W) x 1(H) cm), 4.5ml acellular collagen solution was poured into 
the mould (to fill the other end) and allowed to set and integrate at 37°C for 30min 
(Fig.8B). Following 30 min setting gels were compacted by plastic compression, 
which did not significantly reduce cell viability [25]. Cell densities increased 
proportionally to the reduction in gel volume by fixed mass loading over a porous 
filter paper support [25]. Post-compression cell densities (calculated based on fluid 
loss) were 1.16x10
6 
HUVECs/ml in HUVEC-seeded constructs; 23.2x10
6
 HDFs/ml 
and 1.16x10
6 
HUVECs/ml in the HDF and HUVEC compartments of HDF/HUVEC 
co-seeded constructs, respectively; 5.8x10
6
 or 23.2x10
6
 RDFs/ml in the RDF 
compartment of RDF-seeded constructs. Compressed collagen sheets were 
immediately rolled either along their long or short axis, to produce tightly wound 
spirals of 45mm length, 1mm diameter or 15mm length, 2.3mm diameter, 
respectively. HUVEC-only seeded and RDF-only seeded constructs were spiraled 
along their short axis. RDF-seeded spiral constructs comprised of a cellular core and 
an acellular wrap (Fig.8B). HDF/HUVEC co-seeded constructs were either not 
spiralled, i.e. cultured as flat sheets (sheet co-culture) or spiralled before culture. 
Spiralling along the long axis axially aligned the HDF and HUVEC compartments 
(axial co-culture), while spiralling along the short axis positioned the HDF 
compartment in the core and the HUVEC compartment on the surface (radial co-
culture) (Fig.8A). HDFs and RDFs in spiral constructs were referred to as HIS-HDFs 
and HIS-RDFs, respectively, to indicate their function as hypoxia-induced signaling 
(HIS) cells.   
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Fig.8 Experimental design for development of constructs used for in vitro and in vivo 
testing. (A) Schematic of the fabrication process for HDF/HUVEC co-seeded collagen 
constructs. Collagen hydrogels (size: 4.5x1.5x1cm) were cast to give  three equal sized 
(1.5x1.5x1cm) compartments;  (i) HDF compartment (2x10
6
 HDFs), (ii) middle 
acellular compartment, (iii) HUVEC compartment (1x10
5
 HUVECs) . Once set, all 
were compacted together by plastic compression (A) to a ~200µm thick sheet, without 
significant reduction in cell viability. Post-compression HDF and HUVEC cell densities 
were 23.2x10
6
 and 1.16x10
6 
cells/ml, respectively. Compressed constructs were cultured 
as flat sheets (sheet co-culture) or rolled along their short (B) or long (C) axis into tight 
wound spirals, 15mm x 2.3mm or 45mm x 1mm (length x diameter), respectively. The 
axial co-culture model (C) gave axial alignment of HDF and HUVEC compartments 
whilst the radial co-culture model (B) had an HDF compartment at the core and 
HUVECs on the surface. Cells in non-spiral, sheet co-cultures were always ≤100µm 
from medium O2 levels, i.e. exposed to normoxia. In spiral constructs, core HDFs 
produced physiological hypoxia zones (measured[173]) and so were referred to as HIS-
HDFs, reflecting their function as hypoxia-induced signalling (HIS) cells. 
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(B) Schematic showing fabrication of the implanted collagen constructs. Gels (size: 
4.5x1.5x1cm) were cast as before but with a rabbit dermal fibroblast (RDF) 
compartment (size: 1.5x1.5x1cm) containing 5x10
5
 or 2x10
6
 RDFs next to an acellular 
compartment (size: 3x1.5x1cm). Following setting, plastic compression (A)  gave a 
~200µm thick sheet with post-compression RDF densities  of 5.8x10
6
 or 23.2x10
6
 
RDFs/ml. Compressed collagen sheets were rolled along their short axis (B) into  
spirals of 15mm length, 2.3mm diameter.  Spiralling along the short axis positioned the 
RDF compartment in the spiral core, forming a hypoxia-induced signalling RDF (HIS-
RDF) core, and the acellular compartment on the spiral surface (acellular wrap), 
radius (r) 0.77mm. 
 
For in vitro experiments, constructs were cultured statically in 5ml medium (50% 
DMEM, 50% endothelial growth medium) in a 37°C, 5% CO2 humidified incubator 
for the time indicated. Axial HDF/HUVEC co-cultures were also cultured in the 
presence of anti-VEGF neutralizing IgG (R&D, USA) at saturating concentration 
(10µg/ml) [208] or control goat IgG (10µg/ml) (Sigma, UK) for 1 week. For in vivo 
experiments, RDF-seeded constructs were either cultured in vitro in 5ml fully 
supplemented DMEM for 5 days prior to implantation (pre-conditioning) or 
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implanted immediately (no pre-conditioning). A minimum of three replicate 
constructs was used to test each condition. 
 
Quantification of IgG permeability through compressed collagen  
Since blockade of VEGF function was tested here by incubating spiral collagen 
constructs in the presence of anti-VEGF neutralizing IgG, it was important to assess 
the permeability of IgG through compressed collagen matrix. A stirred cell 
ultrafiltration unit was used (see Fig. 13, Chapter 3) to deliver an IgG-FITC 
containing PBS feed (IgG-FITC concentration= 50µg/ml) through collagen 
membranes by applying a transmembrane pressure of 9.8KPa. The collagen 
membrane to be tested was assembled in a 16.9 ml stirred cell, with a membrane area 
(A) of 5cm
2
. To measure the portion of fluorescently-labeled antibody retained by 
the collagen membrane, the membrane was washed with 5ml PBS after testing and 
diggested with 1 ml collagenase-PBS solution (1mg/ml). 100 µl were sampled from 
the digested membrane solution and permeate and tested with a fluoremeter. A 
standard curve of known IgG-FITC concentrations vs. fluorescence was used to 
calculate the concentration of IgG-FITC in the digested collagen membrane solution 
and permeate.  
 
ELISA  
VEGF165, MMP-2 and MMP-9 concentrations were measured using Quantikine 
ELISA kits, while total HIF-1α concentrations were measured using Surveyor IC 
ELISA kit (all from R&D). Triplicates of each sample were analyzed using a 
MicroPlate reader (Biorad, UK). Readings were taken at 450nm with 570nm λ 
correction. Two culture conditions were tested for each marker protein; HUVEC-
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only cultures and HDF/HUVEC axial co-cultures. Constructs were cultured for 5 or 
10 days in 50% DMEM –50% endothelial growth medium. Media and collagen 
construct samples were analysed separately. Collagen constructs were removed from 
culture and snap frozen in liquid nitrogen for 5min. They were powderized with a 
Mikro-dismembranator (Sartorius, Germany) and dissolved in 1.2ml PBS. For each 
factor, triplicate samples were analysed per time point for each culture condition 
tested.  
 
Implantation of collagen constructs 
Subcutaneous implantations  
An institutional review committee of Shanghai Second Medical University approved 
all animal study protocols. Twelve adult female New Zealand white rabbits weighing 
2-2.5kg were used. Surgery was performed under general anaesthesia. A longitudinal 
skin incision was made on the rabbit’s back and implants were sutured onto 
subcutaneous tissue. Three acellular constructs were sutured onto the left side and 
three cellular constructs (of the same series) on the right. Cell densities were either 
low (5.8x10
6
 RDFs/ml) or high (23.2x10
6
 RDFs/ml) with pre-conditioning and high 
(23.2x10
6
 RDFs/ml) cell density with no pre-conditioning. Post-operative wounds 
were treated with topical benzylpenicillin-sodium antimicrobial powder. Rabbits 
were nursed until full recovery and returned to their single cage. Rabbits were 
sacrificed at 1 and 2 weeks. There were six rabbits in each of the 1-week and 2-week 
groups allowing testing of 6 constructs per condition for each implantation period. 
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Intramuscular implantations  
Acellular and cell-seeded compressed collagen constructs were spiralled along their 
short axis round 0.9mm diameter intravenous cannulas (Becton Dickinson Medical 
Devices Ltd., China). The cannula was withdrawn to expose half of the construct’s 
length (7.5mm) and the construct was sutured in place with a 5.0 surgical suture. A 
longitudinal skin incision was made on the rabbit’s back and the muscle layer 
immediately underlying the skin was divided. The cannula with a spiralled construct 
was inserted into a pouch made within the back muscles. The muscle and skin layers 
were closed with interrupted 3.0 sutures, such that the cannula’s opening protruded 
through the skin. The cannulas were sealed with cotton wool to prevent atmospheric 
exposure. One construct was implanted per rabbit with three rabbits used to test each 
condition; acellular, low (5.8x10
6
RDFs/ml) and high (23.2x10
6 
RDFs/ml) cell 
density constructs (no pre-conditioning). The rabbits were sacrificed at 2 weeks.  
 
In vivo Oxygen monitoring 
 O2 levels in the core of acellular and RDF-seeded intramuscularly implanted 
constructs were monitored in vivo over 2 weeks. Rabbits were removed from their 
cages and manually restrained. A fibre-optic O2 probe (Oxford Optronix Ltd, 
Oxford, UK) was inserted into the cannula of each rabbit. The insertion distance was 
measured for each construct prior implantation to ensure the probe was inserted into 
the cannula-free end of the construct’s core (Fig.6A), providing real-time 
measurement of pO2 (by luminescence quenching, see Chapter 8). Calibration of the 
optical O2 probe was accurate to 0.7mmHg. Readings were taken in real-time every 
30 seconds for 5min. Time zero values represent readings taken in constructs 
immediately after implantation. Fibre-optic probes were used in conjunction with an 
266 
 
OxyLab pO2ETM system (Oxford Optronix Ltd, UK). Results are presented as 
partial pressure values (pO2) in mmHg (7.6mmHg corresponds to 1% O2).  
 
Tissue processing and immunohistochemical staining 
For immunofluorescent staining in vitro cultured spiral constructs were unrolled, 
washed in 5ml PBS and fixed in 100% ice-cold methanol for 1h. The primary 
antibodies used were mouse anti-human CD31 (Dako, USA); rabbit anti-human 
vWF (Sigma, UK); rabbit anti-human anti-phospho-Integrin β3 (Sigma, UK). The 
secondary antibodies used were anti-mouse IgG-FITC (R&D, UK); anti-rabbit IgG-
FITC (Sigma), followed by DAPI (Sigma, UK) nuclear staining. Unrolled specimens 
were fixed, routinely processed and embedded in paraffin, transversely sectioned 
(4µm) and H&E stained (see Chapter 2).  Implanted spiral constructs were fixed 
(without unrolling), embedded and sectioned transversely and longitudinally (4µm). 
Immunohistochemical stainining was carried out using Vectastain ABC-HRP kit 
(Vector Laboratories, USA) (see Chapter 2).  Primary antibody used was mouse 
monoclonal anti-rabbit CD31 (Abcam, UK). Enzyme substrate used was DAB 
(brown) (Vector Laboratories, USA), with haematoxylin counterstaining. 
Image analysis 
Micrographs of immunofluorescent-stained specimens were captured with a 
fluorescent microscope (Olympus BX61) using a x10 objective, while H&E stained 
micrographs were captured with a light microscope (Olympus BH2) using x10 and 
x20 objectives. A minimum of 10 random fields were photographed per sample. An 
imaging software (Image J, NIH, USA) was used to determine the area of endothelial 
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cell clusters (aggregates of >2 endothelial cells with an elongation index (ratio of 
major/minor axis) of <2), the length of capillary-like structures (CLSs), the CLS 
elongation index (ratio of straight line separation of CLS ends / total CLS length), 
the total lumen area, the total area of red blood cell (RBC)-containing lumens, host 
blood vessel invasion distance (average radial distance from construct edge where 
RBC-containing lumens were present) and the total field area. Total number of CLSs 
and endothelial cell clusters was counted manually.  
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CHAPTER 10 
 
10.1 GENERAL DISCUSSION 
The aim of this work was to determine the effect and utility of physical cues as tools 
for controlling/regulating cell behaviour in biomimetic scaffolds. We have shown 
that Plastic Compression fabrication can be reliably employed to precisely and 
predictably control the material properties (e.g. matrix density, stiffness) and 
architecture (e.g. topography) of collagen hydrogel scaffolds. Processing can also 
generate structural anisotropy (e.g. collagen density gradients, zonal heterogeneity at 
the meso-scale) (Chapters 3, 4, 5, 6). Importantly, the process produces building-
block type scaffolds (i.e. dense sheets) whose 3D spatial organisation can be easily 
controlled (e.g. through layering, spiralling etc) to form complex integral 3D tissue 
structures (Chapters 7, 8, 9).  
 
The functionality of these biomimetic scaffolds as ‘bioresponse regulators’ was 
verified by testing a range of (semi) ‘closed’ cue -cell function coupling systems. 
These were; substrate surface/interface topography - cell alignment/stratification 
(Chapter 4), matrix stiffness - cell proliferation (Chapter 5), matrix stiffness gradient 
- cell migration (Chapter 6), matrix stiffness - cell-mediated interface integration 
(Chapter 7), scaffold 3D spatial organisation - cell O2 consumption (Chapter 8) and 
hypoxia-induced signalling - cell migration/differentiation (Chapter 9). Of course, in 
reality no system can be completely closed, i.e. isolated from its surrounding 
environment. As in other physical systems the presence of cue cross-interactions and 
cell-cue feedback regulating mechanisms means that only varying degrees of closure 
are feasible. This principle was encountered at multiple points throughout this work, 
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in the form of interdependence between inevitably coupled cues e.g. matrix density 
and ligand density (Chapter 6) or superimposed cues e.g. growth factor gradients 
acting in the background of the dominating 3D matrix structure (Chapter 9). Clearly, 
then, monitored bioresponse must be the weighted average of multiple, concurrent 
(even co-operating) effects.  Indeed, this realisation was evident in our finding that in 
every system tested there was concurrence of at least two of the four possible 
mechanisms of directed cell motility, i.e. durotaxis, haptotaxis, chemotaxis and 
topographic-based guidance (Chapters 6, 9). The key point, however, is that such 
engineered (defined) tissues suffer far less cross-talk (so allowing a clearer 
interpretation) than any other 3D system (in vivo, ex vivo etc). 
 
Dynamic functions (e.g. cell motility, ECM remodeling) are essential to 3D cell 
systems  as they not only depend upon, but are also used to generate biomimetic 
characteristics such as structural anisotropies, layers, zones, and fiber orientations 
[3,122]. The ability (and rate) of particular cell types to migrate through 3D scaffolds 
is a question of growing importance as we consider the relevance and operation of 
some of our 3D culture systems. For example, model tissues or systems may be 
designed to resemble metastatic cell invasion or wound cell recruitment in some 
instances. At the other extreme, they may need properties that prevent cells leaving 
or entering the scaffold material (e.g. secretory glands such as pancreas). Native 
protein materials will be degraded by migrating cells as long as the cell type can 
synthesize suitable levels of active enzyme (e.g., MMPs, plasmin, plasminogen 
activators, etc.) [3]. Understanding when and where resident cells will create, as 
opposed to use existing migration tracts in dense homogeneous materials hinges on 
the cell’s ability to degrade such tracks versus the suitability of existing guidance 
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topography. Lysis of substrate material ahead of a migrating cell will depend on the 
composition of the substrate material and the rate at which extracellular proteases 
(chiefly MMPs) are secreted and activated.  However, entry into these analyses 
already implies that the scaffold is being designed to facilitate, rather than to 
regulate cell migration (in any given plane). Rather, we have shown that the key to 
control cell migration, ECM remodeling, and ultimately tissue structure is to build 
strong directional cues into the scaffold structure (e.g. channels, lamellae, cleavage 
planes and/or density/stiffness gradients), irrespective of how fast resident cells can 
degrade or remodel the bulk matrix (Chapters 6, 9). The intended utility of a scaffold 
then shifts from a simple, inert cell carrier into a powerful tool that can be used to 
regulate cell function.  
 
While it has generally been assumed that control of cell orientation/motility and 
ECM remodeling through topography will lead to control of 3D tissue structure, cell 
utilization of gaps between scaffold elements is only one extreme example of the 
principle that cells tend to follow the path of least resistance (e.g. a channel larger 
than 1 cell diameter provides zero resistance). It is now becoming clear that the 
detailed operation of such guidance is more complex than that implied by contact 
guidance. Rather, it is achieved by the physical interplay of at least four key factors: 
(1) ability of cells to generate tensional forces (cytoskeletal motor[4]), (2) ability to 
apply those forces to the solid support (by integrin‐ligand linkage), (3) nature of the 
material properties of the supporting scaffold elements (surface chemistry, 
mechanical properties, anisotropy/orientation) [3]), and (4) ability of repetitive 
external force vectors to influence scaffold stiffness and anisotropy (e.g. connective 
tissues around joint articulations[3,329]. The fact that support elements of 
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biomimetic scaffolds are normally deformable in three dimensions (unlike a stiff 2D 
plastic surface) introduces a control element, which is both unfamiliar in 
conventional biology and yet simplifying. This is the parameter of anisotropic 
material properties, that effectively links mechanical, chemical and topographic cell 
control processes in 3D scaffolds [3,330] (Fig.1a).  
 
A 
 
Fig.1 Anisotropic material properties form the link between mechanical, chemical and 
topographic cell control processes. (A) Schematic showing movement of cells over three 
different types of anisotropic substrates by haptotaxis (i.e. along a gradient of 
increasing ligand density), durotaxis (i.e. over a gradient of increasingly stiff lignads), 
and topographic-based guidance (i.e. within channels or between aligned fibres). 
Substrate anisotropy (in all three cases) guides cell direction by increasing cell velocity 
in one plane over another. Clearly, in native tissues combinations of such mechanisms 
operate together to control cell locomotion. 
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 (B) Schematic showing how cell‐force generation during cell traction and locomotion 
inevitably works within the matrix structure, accentuating the inititial anisotropy. As a 
cell moves through a substrate comprising of anisotropic structures (e.g. channels, 
aligned fibres etc.) it generates force onto that substrate. Part of that force (F) will 
move the cell over the substrate, but an equal and opposite force (F’) is applied to the 
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attachment points, resulting in local matrix compaction. This will inevitably result in 
changes in the number of integrin‐ECM interactions per unit area, producing changes 
in local matrix stiffness. Matrix surface chemistry could be further modified by 
exposure of cryptic motifs within ECM proteins through mechanical distortion (e.g. 
stretching) or proteolytic cleavage by enzymes (e.g. MMPs) released by the cell as it 
moves. Through such mechanisms, dynamic cell functions (i.e. motility, ECM 
remodelling) play a key role in generating energetically favourable gradients (e.g. 
haptotactic and durotactic gradients) within native tissues.  
 
 
In cell biology terms, perhaps the best initial illustration of this linkage can be found 
in the process of durotaxis. As discussed in Chapter 6, durotaxis describes the 
behavior in which cells apparently migrate from less stiff to more stiff substrate 
areas. The mechano‐interpretation of durotaxis can be most clearly understood in the 
context of Newton’s Third Law of Motion which states that action and reaction are 
equal and opposite. In cell terms, this means that contraction forces generated within 
the cell cytoskeleton are equally liable to move the cell and the immediate substrate 
to which it is attached. In other words, if a cell generates force onto a compliant 
substrate, part of that force will move the cell over the substrate, but an equal and 
opposite force (reaction) is applied to the attachment points, which may also move. 
Where the underlying substrate is stiff, it will move or deform very little, and most 
of the force will go to moving the cell. However, when the same cell force is applied 
to a more compliant substrate, the substrate material is deformed, absorbing a 
substantial proportion of the applied force, with a corresponding reduction in net cell 
motion. This almost inevitably leads to substrate deformation in the most compliant 
direction(s) and cell movement in the plane of greatest stiffness. In other words, cell 
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movement is greater on stiffer substrates (or stiffer planes of a given substrate), and 
so, statistically, cells move along stiffness gradients. Importantly, stiffness of the 
cell‐ECM ligand interface will be proportional to the number of integrin‐ECM 
interactions per unit area, as well as ligand elasticity[3]. Indeed, as we have 
previously discussed, durotaxis and haptotaxis (cell movement up a ligand density 
gradient) are highly coupled variables (Chapter 6). The dynamic mechanical 
consequence of cell force generation will be that the cell‐substrate coupling proteins 
are most highly deformed when both the cell and bulk substrate material move little. 
Therefore, for stiff bulk materials less or more stiff ECM ligand elements such as 
fibronectin vs. type I collagen, respectively, will influence cell‐matrix coupling. In 
contrast, more compliant bulk scaffold materials will be maximally deformed and 
will gradually come to dominate cell‐substrate coupling.  
 
The reciprocal nature of this mechano‐interaction means that the motion of many 
cells through soft substrates causes compaction and physical remodeling; stiffer 
substrates are little affected. This is demonstrated most clearly by the fibroblast 
contraction of native collagen gels, which are highly compliant in the first instance. 
However, in contrast to the circular gel model that it is predominantly symmetrical 
and isotropic in nature, rectangular gels have been shown to contract anisotropically, 
as compaction propagates from the edges of the matrix into the bulk (i.e. gel 
contraction is a boundary effect) [331]. Similarly, shape asymmetry and anisotropic 
structures are normal in natural systems[3], and in these cases, cell‐force generation 
during cell traction and locomotion inevitably works within the structures and 
frequently preserves, or even accentuates, the starting structure (Fig.1b). Indeed, 
forces exerted by cells embedded within a collagen gel irreversibly compact the 
275 
 
matrix and permanently render it anisotropic  [331], i.e. cell contraction results in 
plastic deformation of the gel, similar to Plastic Compression. The dynamic 
interdependent nature of this relationship, then, means that cell contraction in soft 
substrates tends to produce low motility but leads to increased ECM compaction, 
even alignment, as the past strain history of the matrix is permanently stored in its 
microstructure [4,210,331]. Furthermore, it has been suggested that as a consequence 
of the convoluted nature of protein folding, cryptic binding sites hidden within the 
structure of ECM molecules may be exposed through mechanisms that 
proteolytically cleave or mechanically distort  (e.g. stretching) the proteins of the 
ECM, as occurs  during cell locomotion. In time, this mechano‐modelling will feed 
back to increase cell motility and alignment, as the substrate’s surface chemistry is 
modified and is made stiffer and/or anisotropic [331] (Fig.1b). In this way, 
apparently complex cell ‘behaviors’ will be driven by non-biological (physical) 
factors inherent in the matrix materials and the external loads they carry. These will 
include any fiber direction, points of tethering to adjacent structures (force vector 
generators) and interaction of external loading with the ECM material[122]. 
 
A major question relating to the development of biomimetic anisotropy is how do 
pre-aligned fibrils (e.g. collagen fibrils) in engineered tissue constructs cause cell-
produced ECM fibrils to exhibit the same alignment.  One possibility is through 
direct influence, by providing a physical template for assembly of the nascent ECM 
fibrils. Another possibility is by indirect influence via the cell alignment associated 
with the contact guidance response (i.e., new ECM fibrils grow in direct association 
with the cell surface). Since a cell is typically elongated and aligned with fibrils and 
moves bi-directionally with respect to them, new ECM fibrils become aligned with 
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pre-aligned fibrils. In this mechanism, cell alignment/migration would clearly play a 
key role in generating nano-/micro-scale structural anisotropy.  
 
In the foregoing discussion cell motility has been used as a ‘bridge’ concept. It partly 
provides a starting point in understanding how mechanical forces act through the 3D 
cell substrate to influence behavior. However, it also illustrates the hidden level of 
dependence between the apparently distinct substrate controls considered so far. This 
makes cell motility a key linker between the familiar intracellular biological control 
cues (e.g., receptor‐mediated second messenger systems) and the ability of the 
physical microenvironment to directly regulate cell behaviors. In effect, it may be 
possible to reverse the need to generate ever more complex theories of 
receptor‐mediated signaling (and ‘cell decision’), such as in the ‘rigidity sensing’ 
mechanism proposed for cell durotaxis [332], where the unavoidable effects of 
substrate mechanics are considered. The intimate interdependence of surface 
chemistry, mesoscale topography, and mechanics in 3D substrates is only just 
becoming clear in cell biological systems as the importance of mechano‐biological 
controls is understood. It is now clear that data management and interpretation by 
resident cells based largely, let along simply, on receptor recognition and molecular 
signaling would be implausibly complex. For example, while vital genetic and 
biochemical signals drive developmental processes during embryogenesis, they are 
not sufficient alone to explain how 3D tissues are physically constructed so that they 
exhibit unique forms (e.g., glandular epithelium, branching vascular networks) and 
mechanical load-bearing functions (tension-generating muscle, compression-resistant 
bone) [333]. On the other hand, incorporation of current concepts of cytomechanics 
with the well‐understood mechanical behavior of materials now makes it possible to 
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understand how a much more reasonable form of substrate/ECM control system 
might operate. Indeed, both epithelial and lung morphogenesis have been shown to 
be under micro-mechanical control[333]. Interestingly, this suggests that 3D spatial 
controls could operate through far simpler mechanisms, based on physical factors, 
producing energetically favorable gradients to drive cell responses. Not only are 
such energetic drivers more plausible models of cell control systems, but also they 
would be present and act on cells, even in the absence of complex molecular control 
systems. In such biosensing systems activation of cell receptors and second 
messenger systems are neither precluded nor necessary for cytomechanical control 
mechanisms, but they would operate against the background of these ‘Newtonian 
rules of engagement’.  
 
Although it is clearly wrong to suggest that cytomechanical cues always dominate 
3D cell systems, it is likely that they are hugely important in musculoskeletal 
connective tissues and culture models. Examples of these are the familiar 
tension‐dominated mechanics of fibroblasts (tendon, skin, etc. [139,334]) and 
compression‐dominated mechanics typical of chondrocytes and osteoblasts 
[335,336].  In contrast, it is interesting that receptor/second messenger signaling 
mechanisms of mechano-transduction (more correctly, mechano‐sensing) are 
presently so ill‐defined and apparently complex.  Indeed, the molecular basis for 
most of these mechano‐sensing effects is presently uncertain and ranges from 
stretch‐ and voltage‐ dependent ion‐transport channels in the cell membrane (leading 
to strain‐related disturbances in intracellular ion levels, normally Ca2+) [336] to 
second messenger activation resulting from simple integrin occupancy [337] or 
deformation of the integrin‐cytoskeletal system [338]. It has been suggested that 
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similar signal transduction pathways may play a role in the mechanism by which 
cells respond to substrate topography. These include integrin-mediated signaling 
cascades such as extracellular signal–regulated protein kinase, focal adhesion kinase, 
and protein kinase A[339]. Nanoscale surface features may also affect the adsorption 
and conformation of integrin binding proteins, changing the availability of binding 
sites and modifying integrin signalling. However, an important aspect applicable to 
cell behavior on patterned surfaces is the bidirectional nature of cell signalling[123]. 
It has been shown, for example, that micro-patterning and anisotropic topography 
induce dramatic changes in cell shape (and cell shape-dependent modulation of 
cytoskeletal tension and nucleus shape), i.e. outside-in signalling, which alters 
cytoskeletal tension, that then feeds back to induce local changes in focal adhesion 
assembly, i.e. inside-out signalling. This provides further evidence to the significant 
role that physical cues might play in controlling such processes. Importantly, the 
minimum effective dimension of grooved features has now fallen to as low as 11 nm 
[72], emphasizing the likely importance of cell‐matrix attachment. Interestingly, this 
size scale falls within the scale of collagen fibrils, which makes up the majority of 
ECM in native tissues. It seems very possible, then, that cellular mechano-sensing 
systems are far simpler than commonly imagined but appear to be complex because 
they operate in conjunction with cytomechanical controls built into the ECM and cell 
cytoskeleton.  
 
This interplay makes it easier to understand intricate cell behaviors (e.g. 
developmental processes) without the need to postulate implausibly complex 
biological controls with neocognitive sensory‐motor feedbacks. For example, it has 
been shown  that tissue shape crucially influences the development of tension by 
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contractile cells and modulates cell behaviour,  giving rise to spatial patterns of cell 
and matrix organization (i.e. irreversible changes in matrix microstructure) [331].  
Such a purely mechanical structure-follows-shape principle may be crucial for 
explaining complex cell behaviours as found in embryogenesis, where large 
deformations are involved and mechanical tension is known to be essential. 
Furthermore, it carries important implications for regulating cell behaviour in 
engineered tissues through fabrication of scaffold structural controllers. A promising 
example, illustrated by this work, is the ability to control physiological angiogenesis 
by Hypoxia-Induced Signaling (Chapter 9). Here, we have shown that despite our 
current inability to reproduce the complex chemical language of a complete 
angiogenic factor cascade, it is possible to control the end bioresponse (i.e. 
endothelial cell differentiation, migration and tubule formation) by engineering the 
onset of the process, i.e. local cell-mediated hypoxia, through control of physical 
parameters such as cell density and spatial positioning, diffusion/consumption path 
length and anisotropy. Clearly, this does not replace the importance of biomolecular 
mechanisms (signaling, attachment, protease control, etc.), which constantly operate 
in the backround of such drivers. Rather, it provides an inevitable context in the form 
of a rapidly acting, simplifying framework of physical rules into which simple cell 
systems must integrate. 
 
It is now becoming evident that the many different types of information encoded into 
the extracellular environment combine to form a ‘multidimensional map’[5]. Cells 
use this map to guide their activities and maintain their differentiation within tissues. 
Dynamic changes in physicochemical cue gradients across the map provide 
directionally encoded signals, while each cell type fabricates (through synthesis and 
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degradation) its own network of precisely encoded ECM proteins to enable an exact 
tailoring of the structural properties and information content of each ECM 
environment throughout the body [5]. Indeed, in a fascinating and well-accepted, yet 
poorly understood feedback process, cell phenotype, which dictates the nature of a 
cell’s future ECM remodeling ability (through migration/differential traction 
generation, proliferation, ECM degradation/synthesis, and gene expression) is 
determined by the nature of its past ECM remodeling as this determines the current 
local ECM composition and mechanics [13]. This framework then provides a starting 
point for understanding how multiple behaviour maps form the basis of tissue-
specific function and cell-matrix adaptation to external events (e.g. tissue damage or 
deformation). Importanlty, this work illustrates that engineering these dynamic ECM 
mechanisms into the initial structure of 3D scaffolds could provide a tool for 
controling/regulating future cell behaviour in a manner that closely recapitulates 
native tissue operation. It could indeed be envisaged that scaffolds could be 
‘programed’ into bio-functional devices through a simple physical cue-based 
language that contains all the required information (in the form of a 
multidimensional map) for control/regulation of cell (and engineered tissue) function 
(Fig 2).  
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Fig 2. Schematic illustration of how a tissue-like multidimensional map could be 
‘encoded’ into the structure of a 3D biomimetic scaffold for driving/regulating cell 
function. The map represents a network linking the nano/micro-scale elements of 
scaffold structure (i.e. matrix architecture, surface chemistry and mechanical 
properties) and macro-scale structure (i.e. 3D spatial organisation) with various cell 
functions. These can be categorised into collective, dynamic and metabolic functions. 
The map highlights the interdependence of the four elements of scaffold structure and 
how each element can be used to control multiple cell functions, directly or indirectly. 
It  also demonstrates the key role of dynamic functions (e.g. cell motility, matrix 
remodelling) as these not only depend upon, but are also used to generate biomimetic 
characteristics such as structural anisotropies, layers, zones, and fiber orientations 
through feedback regulation of all elements of scaffold structure. 
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It is sometimes possible in refined models of 3D cell spatial control to postulate that 
we can provide clear, unambiguous cues to cells via their substrates. However, as we 
have previously discussed, the impression that we can deliver a single scaffold cue 
(or multiple cues, one‐at‐a‐time) is, in most instances, an illusion or an impractical 
experimental system. Like most forms of communication and information 
collection/propagation, it is neither possible nor even desirable to base strategies on 
single cue systems because cells react to complex, language‐like, dynamic signals 
from their environment.  This realization can be best understood through the 
example of mesenchymal cells and their continuous monitoring of local substrate 
stiffness and anisotropic mechanical properties through small contractile forces and 
the resulting matrix deformation. This is directly analogous to how we measure 
material properties at the human scale [44,330]. It is almost inevitable that 
substitution of scaffold surfaces with large biomimetic attachment molecules will 
increase/decrease the substrate mechanics, as perceived by the cell (depending on the 
stiffness of the added ligand). On the other hand, controlling substrate mechanics 
(e.g. stiffness) by varying matrix density will inevitably be accompanied by changes 
in ligand density. Consequently, the effects of a mechanical gradient (i.e., durotaxis) 
would be influenced by the effects of a co-existing ligand gradient (i.e., haptotaxis), 
and vice versa (as discussed in Chapter 6). Similarly, practical biomimetic 
topographic cues (e.g. fibers and flexible channels) are most likely to be incorporated 
into relatively compliant scaffolds. By definition, structures such as these will 
deform the matrix, introducing accompanying predictable gradients in mechanical 
properties of the cell substrate.  
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Evidently, then, the driving capacity of such biomimetic scaffolds must inevitably 
rely on all three elements of physical scaffold structure, i.e. matrix mechanics, 
architecture, and surface chemistry. The proposition here is that the statistically 
dominant cue(s) at any one stage would dynamically move from one factor to 
another, depending on the cell system and the target mimetic feature (Fig.3).  A 
further layer of complexity, in terms of a temporal ‘4th dimension’ could be 
introduced in any given system, such that the interplay of the three structural 
elements is regulated in a time-dependent manner. This dynamic, temporal control 
could, for example, be achieved by incorporating into the scaffold vehicles with 
controlled release kinetics for delivering proteolytic enzymes that alter the matrix 
chemistry and/or architecture.  
          
                                 
Fig.3 Schematic showing the proposed model of dynamic interplay of scaffold 
structural elements for regulation of cell function. The obligatory interdependence 
(dashed lines) of matrix architecture (e.g.substrate topography), cell-matrix interface 
chemistry, and cell-matrix mechanics means that in practical terms all three factors 
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inevitably contribute to the overall cell response seen in any given substrate. However, 
it is likely that the diversity of responses seen in 3D scaffolds is a consequence of 
shifting importance between the three control elements for any given system, similar to 
multiple behavioral maps seen in natural tissues, where their context is dependent  on 
tissue type and/or external events (e.g. tissue damage or deformation). Modified from 
Brown and Phillips, 2007 [3]. 
 
Fabrication of biofunctional scaffolds could inspire new strategies for tissue repair 
and regeneration. It has been suggested, for example, that in the future it may be 
possible to regenerate injured tissues (e.g. infracted myocardium) by using self-
assembling nanoscale biomaterials with unique physicochemical properties that 
mimic natural ECMs, while simultaneously harnessing the inherent regenerative 
potential of host stem cells[333]. It is envisaged that cues built-in within scaffolds 
could stimulate proliferation and differentiation of recruited stem cells and 
endothelial progenitor cells to form vascular networks, while stimulating 
development of functional tissue structures (e.g., muscle bundles, nerves, connective 
tissue), thus mimicking normal embryological development. In this manner, ‘fractal-
like’ tissue structures could be formed that contain key 3D anisotropic nano-
/microscale patterns, mimicing those observed during normal development. This 
type of ‘in situ’, and by extrapolation ‘in vivo tissue engineering’ approach may 
potentially lead to development of simpler, and hence more cost-effective, 
therapeutics for tissue and organ regeneration.  
 
 
 
 
 
286 
 
10.2 CONCLUSIONS 
In this study, the use of a cell independent method (Plastic Compression fabrication) 
for engineering the physical micro-environment removed the need to rely on cellular 
activity from the initial scaffold fabrication stage, therefore allowing us to position 
desired cues (matrix mesoscale anisotropy, surface/interface topography, 
density/stiffness gradients, and 3D spatial organisation) into the scaffold structure, to 
test their propagating effect on cell function. Inevitably, as resident cells modify 
these structures through ECM synthesis and remodelling, dynamic cue-cell function 
systems are established based on continuous feedback regulation. The ability to 
deliberately introduce such cues into the initial scaffold structure, through cell-
independent fabrication, means that bioresponse monitoring can be carried out at the 
very beginning of a physiological feedback cycle. This has important implications 
for achieving effective temporal control over a range (or combination) of cues that 
could be potentially presented to cells within 3D biomimetic scaffolds, both for in 
vitro tissue modelling and repair/regeneration applications.  
 
The findings of this work not only suggest that we may indeed be closer to 
understanding spatiotemporal control (e.g. how to control the onset/direction of 
engineered angiogenesis) in 3D cell culture systems than we think, but it also 
indicates that the key to its control is early imposition of mesoscale, biomimetic 
scaffold structure and mechanics, as cell responses seem to preserve and enhance 
such early cues. This study demonstrates the utility of cell-independent fabrication as 
a tool for transforming the function of scaffolds from that of inert cell carriers to 
dynamic cell drivers.  
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10.3 SUMMARY 
 
The main experimental findings of this study were:  
 
1. Fluid expulsion during plastic compression of collagen hydrogel scaffolds 
produces anisotropic structuring (i.e. a collagen density gradient) along the 
compression axis and can be modelled as an ultrafiltration process with cake 
formation at the fluid leaving surface. 
 
2. Pattern template embossing can be used to engineer topography in plastically 
compressed 3D collagen hydrogel scaffolds for surface, as well as interface 
regulation of epithelial cell function (e.g. alignment, attachment, differentiation).  
 
3. The hydration level of a collagen hydrogel, which determines matrix collagen 
density, is directly related to matrix stiffness. 
 
4. Collagen matrix stiffness directly influences fibroblast proliferation such that 
matrices of increasing stiffness support greater cell growth, while fibroblast 
quiescence in compliant matrices is reversible by increasing matrix stiffness in situ. 
 
5. Collagen matrix stiffness/density gradients can be used to guide fibroblast 
migration in 3D collagen scaffolds through durotaxis/haptotaxis. 
 
6. Interface matrix stiffness influences the cell-mediated integration of adjacent (e.g. 
layered) collagen matrices by, in part at least, regulating cell migration across the 
interface. 
  
 
7. Cell O2 consumption is the major factor determining O2 tension in a (plastically 
compressed) nano-fibrillar collagen matrix. 
 
8. Fibroblasts exposed to spatially-controlled, cell-mediated hypoxia within a 3D 
collagen matrix upregulate production of angiogenic factor protein cascades which 
can induce a directed, functional angiogenic response in vitro and in vivo. 
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10.4 FUTURE WORK 
The findings of this study lay down the foundation for understanding how directing 
physical cues could be built into the structure of 3D biomimetic scaffolds for control 
and regulation of cell function. As we have shown, a key feature of plastically 
compressed collagen scaffolds is their tunable structural characteristics (e.g. collagen 
density) which directly determine their mechanical properties (e.g. stiffness 
modulus), and can be precisely controlled by varying the matrix hydration level. 
Importantly, collagen density can be increased to levels approaching those of native 
tissue (i.e. 20-30% w/w). Since most tissue engineering applications are likely to 
require cell seeding of scaffolds, it is important to be able to precisely control fluid 
expulsion from cellular, as well as acellular, collagen hydrogels.  In the present 
model the effect of cell seeding (and downstream effects of cell-mediated matrix 
remodelling) on fluid loss kinetics during compression was not tested. Extension of 
the model’s predictive capacity to cellular gels would improve its applicability to 
engineering biomimetic constructs for in vitro tissue modelling and 
repair/regeneration purposes.   
Plastic compressed collagen sheets provide an example of engineered bio-functional 
units (i.e. basic building blocks) that can be assembled into complex (e.g. 
heterogeneous) 3D tissue structures. This strongly contrasts with the ‘farming’ 
approach where tissues are gradually grown through cell-dependent cultivation (e.g. 
in a bioreactor). As we have shown, the advantage of relying on tissue engineering 
(as opposed to tissue farming) is that it creates the opportunity to embed cell guiding 
mechanisms into the initial scaffold structure (e.g. mechanical and topographic cues) 
that facilitate optimal tissue function and development. However, reconstruction of 
complex 3D tissue structure from such simple units critically relies on the ability to 
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organise and integrate them successfully, without compromising their functionality. 
For example, engineering large tissue constructs of clinically relevant dimensions 
(e.g. thickness in the cm range) is limited by inadequate deep cell O2 and nutrient 
perfusion that inevitably leads to reduction in core cell viability. This problem could 
be further aggravated by the high collagen density of each sheet/layer which, while 
not significantly restricting O2 diffusion, could limit macromolecular (e.g. growth 
factor) transport and removal of harmful metabolic products.  Engineering the 
angiogenic component of integration is therefore an important prerequisite for any 
attempt to build large/complex 3D tissues. One of the early processes mediating 
physiological angiogenesis is directed endothelial cell migration. In this study we 
used hypoxia-induced angiogenic factor gradients to drive endothelial cell migration 
to specific locations within 3D matrices. However, while it was hypothesised that 
gradients developed in this system, this was not directly tested. To optimise the 
induced angiogenic response (i.e. its extent, timing and direction) it is important to 
establish quantitative correlations between hypoxia trigger levels, angiogenic factor 
protein levels, and the magnitude/range of operating angiogenic factor gradients. 
Future studies could also investigate the effect of modifying key cell-scaffold 
controllers (e.g. consumption path length, matrix density/diffusion coefficient, 
matrix anisotropy, cell type and density) for optimizing the angiogenic effectiveness 
of implantable HIS cell depots.  
In addition, the ability to regulate endothelial cell migration through a combination 
of HIS cell guidance (i.e. chemotaxis) and other guiding cues (e.g. 
durotaxis/haptotaxis, topographic guidance) could be tested.  As we have discussed, 
presenting cells with more than one cue at a time faithfully complies with 
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physiological rules of tissue function regulation, and would thus be expected to 
produce improved bioresponses.  
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APPENDIX 
TABLE OF ABBREVIATIONS 
  
2D: 2-Dimensional  
3D: 3-Dimensional  
CLS: Capillary-like structure 
DMEM: Dulbecco's Modification of Eagle's Medium  
ECC: Endothelial Cell Cluster 
ECM: Extracellular Matrix  
FCS: Fetal Calf Serum 
FEA: Finite Element Analysis  
FLS: Fluid Leaving Surface 
HDF: Human Dermal Fibroblast  
HIF: Hypoxia-Inducible Factor 
HIS: Hypoxia-Induced Signaling 
HUVEC: Human Umbilical Vein Endothelial Cell 
MEM: Minimum Essential Medium  
MMP-2: Matrix Metalloproteinase - 2  
MMP-9: Matrix Metalloproteinase - 9  
PASMC: Pulmonary Artery Smooth Muscle Cell 
PBS: Phosphate buffered saline  
PC: Plastic Compression  
t-CFM: Tensioning-Culture Force Monitor 
VEGF: Vascular Endothelial Growth Factor  
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LIST OF SYMBOLS 
A = Area (m
2
) 
E = Elastic (Young’s) Modulus (Pa) 
g = Standard gravity (m/s
2
) 
J = Volumetric flux (m
3
.s
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.m
-2
) 
k = Permeability (m
2
) 
L = Length (m) 
M = Mass (Kg) 
µ = Dynamic Viscosity (Pa.s) 
P = Pressure (Pa) 
Q = Volumetric flow rate (m
3
.s
-1
) 
R
2
 = Coefficient of determination 
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